200,000+ products from a single source!
sales@angenechem.com
147127-20-6 | Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-
CAS No: 147127-20-6 Catalog No: AG001EMI MDL No:MFCD00943794
Product Description
Catalog Number:
AG001EMI
Chemical Name:
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-
CAS Number:
147127-20-6
Molecular Formula:
C9H14N5O4P
Molecular Weight:
287.2123
MDL Number:
MFCD00943794
IUPAC Name:
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
InChI:
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
InChI Key:
SGOIRFVFHAKUTI-ZCFIWIBFSA-N
SMILES:
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(O)O
EC Number:
604-571-2
UNII:
W4HFE001U5
Properties
Complexity:
354
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
287.078g/mol
Formal Charge:
0
Heavy Atom Count:
19
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
287.216g/mol
Monoisotopic Mass:
287.078g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
136A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.6
Literature
| Title | Journal |
|---|---|
| Role for NF-κB inflammatory signalling pathway in tenofovir disoproxil fumarate (TDF) induced renal damage in rats. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20170101 |
| Lon protease and eiF2α are involved in acute, but not prolonged, antiretroviral induced stress response in HepG2 cells. | Chemico-biological interactions 20160525 |
| Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41. | European journal of medicinal chemistry 20151201 |
| A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation. | Toxicology and applied pharmacology 20150615 |
| Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir. | Toxicology in vitro : an international journal published in association with BIBRA 20150201 |
| Synthesis of an apionucleoside family and discovery of a prodrug with anti-HIV activity. | The Journal of organic chemistry 20140606 |
| Polyacetylenes and anti-hepatitis B virus active constituents from Artemisia capillaris. | Fitoterapia 20140601 |
| Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents. | Bioorganic & medicinal chemistry letters 20140515 |
| PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer. | European journal of medicinal chemistry 20140506 |
| Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide. | Nanomedicine : nanotechnology, biology, and medicine 20140401 |
| Competitive fitness assays indicate that the E138A substitution in HIV-1 reverse transcriptase decreases in vitro susceptibility to emtricitabine. | Antimicrobial agents and chemotherapy 20140401 |
| Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug. | Antimicrobial agents and chemotherapy 20140401 |
| Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors. | Science translational medicine 20140312 |
| Highly active antiretroviral therapies are effective against HIV-1 cell-to-cell transmission. | PLoS pathogens 20140201 |
| Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy. | Journal of acquired immune deficiency syndromes (1999) 20131201 |
| In vitro cross-resistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations. | Antimicrobial agents and chemotherapy 20131101 |
| Three new secoiridoids, swermacrolactones A-C and anti-hepatitis B virus activity from Swertia macrosperma. | Fitoterapia 20130901 |
| Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine. | Antimicrobial agents and chemotherapy 20130901 |
| Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. | Journal of acquired immune deficiency syndromes (1999) 20130801 |
| Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. | Antimicrobial agents and chemotherapy 20130601 |
| Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers. | Journal of clinical pharmacy and therapeutics 20130401 |
| Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages. | Antimicrobial agents and chemotherapy 20130301 |
| Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors. | Bioorganic & medicinal chemistry letters 20130301 |
| Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. | Retrovirology 20130101 |
| Tenofovir use and pregnancy among women initiating HAART. | AIDS (London, England) 20121128 |
| Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices. | Pharmaceutical research 20121101 |
| Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: a case-control study. | Scandinavian journal of infectious diseases 20121101 |
| Current status of topical antiretroviral chemoprophylaxis. | Current opinion in HIV and AIDS 20121101 |
| Oral antiretroviral chemoprophylaxis: current status. | Current opinion in HIV and AIDS 20121101 |
| The clinical pharmacology of antiretrovirals for HIV prevention. | Current opinion in HIV and AIDS 20121101 |
| Animal models of antiretroviral prophylaxis for HIV prevention. | Current opinion in HIV and AIDS 20121101 |
| Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders. | Digestive diseases and sciences 20121101 |
| Rectal microbicide development. | Current opinion in HIV and AIDS 20121101 |
| Next-generation oral preexposure prophylaxis: beyond tenofovir. | Current opinion in HIV and AIDS 20121101 |
| Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. | Clinical pharmacology and therapeutics 20121101 |
| Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients. | Journal of viral hepatitis 20121101 |
| Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature. | Expert opinion on pharmacotherapy 20121101 |
| The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs. | Current opinion in HIV and AIDS 20121101 |
| Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. | Journal of controlled release : official journal of the Controlled Release Society 20121028 |
| Blunted fetal growth by tenofovir in late pregnancy. | AIDS (London, England) 20121023 |
| Chemico-physical investigation of tenofovir loaded polymeric nanoparticles. | International journal of pharmaceutics 20121015 |
| Predicting product adherence in a topical microbicide safety trial in Pune, India. | AIDS and behavior 20121001 |
| A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study. | Biomedical chromatography : BMC 20121001 |
| Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. | HIV medicine 20121001 |
| Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy. | AIDS research and human retroviruses 20121001 |
| Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir. | HIV medicine 20121001 |
| Renal toxicity of long-term therapy with tenofovir in HIV-infected patients. | Journal of pharmacy practice 20121001 |
| Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation. | Transplant infectious disease : an official journal of the Transplantation Society 20121001 |
| Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients. | The Journal of antimicrobial chemotherapy 20121001 |
| Antiretroviral neurotoxicity. | Journal of neurovirology 20121001 |
| Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. | The Journal of infectious diseases 20121001 |
| High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. | Antiviral research 20121001 |
| Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a guide to its use in HIV-1 infection. | Clinical drug investigation 20121001 |
| Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation. | Expert opinion on drug metabolism & toxicology 20121001 |
| Quantification of tenofovir in human plasma by solid-phase extraction and high-performance liquid chromatography coupled with UV detection. | Therapeutic drug monitoring 20121001 |
| Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens. | Expert opinion on pharmacotherapy 20121001 |
| The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection. | The Netherlands journal of medicine 20121001 |
| Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. | AIDS (London, England) 20120924 |
| Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. | The Analyst 20120921 |
| Osteoporosis and bone health in HIV. | Current HIV/AIDS reports 20120901 |
| Reformulated tenofovir gel for use as a dual compartment microbicide. | The Journal of antimicrobial chemotherapy 20120901 |
| Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. | Scandinavian journal of infectious diseases 20120901 |
| Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo. | Antimicrobial agents and chemotherapy 20120901 |
| The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients. | Current HIV research 20120901 |
| Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies. | Journal of acquired immune deficiency syndromes (1999) 20120901 |
| Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. | Journal of medical virology 20120901 |
| Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF. | Expert opinion on pharmacotherapy 20120901 |
| E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure. | AIDS (London, England) 20120824 |
| High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen. | AIDS (London, England) 20120824 |
| Mulberrofuran G and isomulberrofuran G from Morus alba L.: anti-hepatitis B virus activity and mass spectrometric fragmentation. | Journal of agricultural and food chemistry 20120822 |
| Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. | MMWR. Morbidity and mortality weekly report 20120810 |
| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. | The New England journal of medicine 20120802 |
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. | The New England journal of medicine 20120802 |
| Preexposure prophylaxis for HIV infection among African women. | The New England journal of medicine 20120802 |
| Preexposure prophylaxis for HIV--where do we go from here? | The New England journal of medicine 20120802 |
| Clinical decisions. Preexposure prophylaxis for HIV prevention. | The New England journal of medicine 20120802 |
| The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells. | Investigational new drugs 20120801 |
| Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor. | British journal of clinical pharmacology 20120801 |
| Formulation, pharmacokinetics and pharmacodynamics of topical microbicides. | Best practice & research. Clinical obstetrics & gynaecology 20120801 |
| Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. | Liver international : official journal of the International Association for the Study of the Liver 20120801 |
| Overview of microbicides for the prevention of human immunodeficiency virus. | Best practice & research. Clinical obstetrics & gynaecology 20120801 |
| Future strategies in microbicide development. | Best practice & research. Clinical obstetrics & gynaecology 20120801 |
| Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. | HIV medicine 20120801 |
| Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation. | Best practice & research. Clinical obstetrics & gynaecology 20120801 |
| Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era. | Biochemical pharmacology 20120801 |
| Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. | Journal of hepatology 20120801 |
| Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120801 |
| Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery. | Journal of materials science. Materials in medicine 20120801 |
| Case report of cytomegalovirus retinitis in an HIV-positive patient with a CD4-count nadir of 254 cells per μl. | Eye (London, England) 20120801 |
| An intravaginal ring for the simultaneous delivery of multiple drugs. | Journal of pharmaceutical sciences 20120801 |
| Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract. | Antiviral research 20120801 |
| Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents. | European journal of medicinal chemistry 20120801 |
| From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework. | Journal of pharmacokinetics and pharmacodynamics 20120801 |
| Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B. | Revista brasileira de reumatologia 20120801 |
| [A single tablet against HIV: new combination preparation improves therapy]. | Deutsche medizinische Wochenschrift (1946) 20120801 |
| Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. | Expert review of gastroenterology & hepatology 20120801 |
| Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic? | Minnesota medicine 20120801 |
| FDA paves the way for pre-exposure HIV prophylaxis. | Lancet (London, England) 20120728 |
| Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. | AIDS (London, England) 20120717 |
| Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. | AIDS (London, England) 20120717 |
| Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. | The Cochrane database of systematic reviews 20120711 |
| Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinics. | Journal of acquired immune deficiency syndromes (1999) 20120701 |
| Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. | AIDS and behavior 20120701 |
| Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. | The Journal of antimicrobial chemotherapy 20120701 |
| CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. | The Journal of infectious diseases 20120701 |
| Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)? | Medicinal research reviews 20120701 |
| Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats. | Biopharmaceutics & drug disposition 20120701 |
| HIV-2 encephalitis: case report and literature review. | AIDS patient care and STDs 20120701 |
| Current practice of chronic hepatitis B treatment in Southern Italy. | European journal of internal medicine 20120701 |
| The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition. | Pharmacological reviews 20120701 |
| Update on raltegravir and the development of new integrase strand transfer inhibitors. | Southern medical journal 20120701 |
| Five-year review of HIV-hepatitis B virus (HBV) co-infected patients in a New York City AIDS center. | Journal of Korean medical science 20120701 |
| FDA treads carefully with PrEP. | The Lancet. Infectious diseases 20120701 |
| Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. | Lancet (London, England) 20120630 |
| Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. | Lancet (London, England) 20120630 |
| Differentiation of enantiomeric drugs by iodo-substituted L-amino acid references under electrospray ionization mass spectrometric conditions. | Rapid communications in mass spectrometry : RCM 20120615 |
| Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptase. | Bioorganic & medicinal chemistry letters 20120615 |
| Topical microbicides for prevention of sexually transmitted infections. | The Cochrane database of systematic reviews 20120613 |
| Antiretroviral prophylaxis for HIV prevention reaches a key milestone. | Lancet (London, England) 20120602 |
| How to manage HIV-infected patients with chronic kidney disease in the HAART era. | Clinical and experimental nephrology 20120601 |
| Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population. | AIDS (London, England) 20120601 |
| Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial. | Journal of acquired immune deficiency syndromes (1999) 20120601 |
| HIV therapies and the kidney: some good, some not so good? | Current HIV/AIDS reports 20120601 |
| Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens. | The Journal of antimicrobial chemotherapy 20120601 |
| Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen. | The Journal of antimicrobial chemotherapy 20120601 |
| Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. | AIDS (London, England) 20120601 |
| Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. | Human reproduction (Oxford, England) 20120601 |
| Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120601 |
| Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. | Alimentary pharmacology & therapeutics 20120601 |
| First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice. | Journal of viral hepatitis 20120601 |
| Does maternal use of tenofovir during pregnancy affect growth of HIV-exposed uninfected infants? | AIDS (London, England) 20120601 |
| Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. | AIDS patient care and STDs 20120601 |
| Standing genetic variation and the evolution of drug resistance in HIV. | PLoS computational biology 20120601 |
| Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia. | The Korean journal of internal medicine 20120601 |
| A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. | PLoS pathogens 20120601 |
| Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120601 |
| Prevention. Using PrEP cost-effective in high-risk MSM groups. | AIDS policy & law 20120601 |
| Research. Fetuses unaffected by tenofovir, 1-year-olds appear slightly smaller. | AIDS policy & law 20120601 |
| Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | Journal of medicinal chemistry 20120524 |
| [Pharmacological treatment of acute hepatitis B]. | Medicina clinica 20120519 |
| WITHDRAWN: Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV. | The Cochrane database of systematic reviews 20120516 |
| Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients. | AIDS (London, England) 20120515 |
| Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. | Bioorganic & medicinal chemistry letters 20120515 |
| Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men. | HIV medicine 20120501 |
| Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? | Gut 20120501 |
| Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir. | Hepato-gastroenterology 20120501 |
| A randomized study of tenofovir disoproxil fumarate in treatment-experienced HIV-1 infected adolescents. | The Pediatric infectious disease journal 20120501 |
| Design of tenofovir-UC781 combination microbicide vaginal gels. | Journal of pharmaceutical sciences 20120501 |
| Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120501 |
| A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection. | Expert opinion on investigational drugs 20120501 |
| Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers. | Clinical drug investigation 20120501 |
| Safety of long-term nucleos(t)ide treatment in chronic hepatitis B. | Expert opinion on drug safety 20120501 |
| Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings. | Journal of biomedical materials research. Part B, Applied biomaterials 20120501 |
| New advances in chronic hepatitis B. | Current opinion in gastroenterology 20120501 |
| Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents. | Bioorganic & medicinal chemistry 20120501 |
| New perspectives in the therapy of chronic hepatitis B. | Gut 20120501 |
| Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes. | Memorias do Instituto Oswaldo Cruz 20120501 |
| Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. | Gastroenterology 20120501 |
| Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. | PLoS medicine 20120501 |
| Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. | International journal of STD & AIDS 20120501 |
| Hepatitis B virus and HIV infection. | Seminars in liver disease 20120501 |
| Effect of tenofovir, an antiretroviral drug, on hepatic and renal functional indices of Wistar rats: protective role of vitamin E. | Journal of basic and clinical physiology and pharmacology 20120426 |
| Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. | AIDS (London, England) 20120424 |
| Association of tenofovir exposure with kidney disease risk in HIV infection. | AIDS (London, England) 20120424 |
| Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. | AIDS (London, England) 20120424 |
| What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. | Journal of acquired immune deficiency syndromes (1999) 20120415 |
| A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. | International journal of pharmaceutics 20120415 |
| Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120401 |
| Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic. | AIDS research and human retroviruses 20120401 |
| Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120401 |
| Evaluation of functional respiratory parameters in AIDS patients assisted in the infectious diseases ambulatory care clinic of a tertiary care university hospital in Brazil. | Respiratory care 20120401 |
| Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? | Liver international : official journal of the International Association for the Study of the Liver 20120401 |
| Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. | HIV medicine 20120401 |
| Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. | Journal of acquired immune deficiency syndromes (1999) 20120401 |
| Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. | Journal of pharmaceutical sciences 20120401 |
| Discovery of drugs that possess activity against feline leukemia virus. | The Journal of general virology 20120401 |
| Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence. | Journal of acquired immune deficiency syndromes (1999) 20120401 |
| Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120401 |
| Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals. | AIDS patient care and STDs 20120401 |
| Selection of chronic hepatitis B therapy with high barrier to resistance. | The Lancet. Infectious diseases 20120401 |
| Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy. | Clinics and research in hepatology and gastroenterology 20120401 |
| Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission. | Expert opinion on drug delivery 20120401 |
| A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. | Clinical nephrology 20120401 |
| Role of raltegravir in HIV-1 management. | The Annals of pharmacotherapy 20120401 |
| An 'escape clock' for estimating the turnover of SIV DNA in resting CD4⁺ T cells. | PLoS pathogens 20120401 |
| HIV exposure through contact with body fluids. | Prescrire international 20120401 |
| [New drugs of treatment of patients with chronic hepatitis B]. | Nihon rinsho. Japanese journal of clinical medicine 20120401 |
| Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings. | AIDS (London, England) 20120327 |
| A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120315 |
| Least among equals. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120315 |
| Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. | AIDS (London, England) 20120313 |
| [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. | Orvosi hetilap 20120311 |
| Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. | AIDS research and human retroviruses 20120301 |
| Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. | Journal of hepatology 20120301 |
| Pre-exposure chemoprophylaxis of HIV infection: quo vadis? | Biochemical pharmacology 20120301 |
| Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies. | The Journal of antimicrobial chemotherapy 20120301 |
| Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine. | AAPS PharmSciTech 20120301 |
| [Kidney and HIV infection]. | Presse medicale (Paris, France : 1983) 20120301 |
| Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis. | Alimentary pharmacology & therapeutics 20120301 |
| Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir. | Journal of viral hepatitis 20120301 |
| Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providers. | Sexually transmitted infections 20120301 |
| Exploring the complexity of the HIV-1 fitness landscape. | PLoS genetics 20120301 |
| High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B. | The Korean journal of hepatology 20120301 |
| Therapy for HBV Infection in Hemodialysis Patients: Is it Possible? | Hepatitis monthly 20120301 |
| Hepatitis B immune globulin in liver transplantation prophylaxis: an update. | Hepatitis monthly 20120301 |
| Pathogenesis and treatment of human immunodeficiency virus lipodystrophy. | Indian journal of endocrinology and metabolism 20120301 |
| A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. | International journal of pharmaceutics 20120227 |
| Predicting hydrophilic drug encapsulation inside unilamellar liposomes. | International journal of pharmaceutics 20120227 |
| Antiretroviral medication and HIV prevention: new steps forward and new questions. | Annals of internal medicine 20120221 |
| WITHDRAWN. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV. | The Cochrane database of systematic reviews 20120215 |
| An unrecognised case of tenofovir-associated Fanconi syndrome. | The Medical journal of Australia 20120206 |
| Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. | International journal of epidemiology 20120201 |
| Cystatin C and baseline renal function among HIV-infected persons in the SUN Study. | AIDS research and human retroviruses 20120201 |
| Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy. | Transplant infectious disease : an official journal of the Transplantation Society 20120201 |
| Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice. | AIDS research and human retroviruses 20120201 |
| High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on. | Digestive diseases and sciences 20120201 |
| Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. | The Lancet. Infectious diseases 20120201 |
| Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors. | Antimicrobial agents and chemotherapy 20120201 |
| Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. | The Journal of clinical endocrinology and metabolism 20120201 |
| Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in Mexico. | Journal of acquired immune deficiency syndromes (1999) 20120201 |
| Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study. | The Journal of antimicrobial chemotherapy 20120201 |
| Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. | Current opinion in infectious diseases 20120201 |
| Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus. | Clinical and vaccine immunology : CVI 20120201 |
| Testing of viscous anti-HIV microbicides using Lactobacillus. | Journal of microbiological methods 20120201 |
| Adefovir dipivoxil in chronic hepatitis B: history and current uses. | Expert opinion on pharmacotherapy 20120201 |
| Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. | Sexually transmitted infections 20120201 |
| Microbicides: topical prevention against HIV. | Cold Spring Harbor perspectives in medicine 20120201 |
| Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection. | Pharmacotherapy 20120201 |
| Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. | AIDS (London, England) 20120128 |
| Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. | AIDS (London, England) 20120128 |
| Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases. | Chemical research in toxicology 20120113 |
| More trials are cut short, but not the debate over their trajectory. | Nature medicine 20120106 |
| Antiviral drug resistance testing in patients with chronic hepatitis B. | Digestive diseases and sciences 20120101 |
| Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. | AIDS care 20120101 |
| Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B. | Hepato-gastroenterology 20120101 |
| Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20120101 |
| CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study. | The Journal of antimicrobial chemotherapy 20120101 |
| A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz. | Journal of acquired immune deficiency syndromes (1999) 20120101 |
| The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness. | Journal of acquired immune deficiency syndromes (1999) 20120101 |
| Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120101 |
| Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. | Liver international : official journal of the International Association for the Study of the Liver 20120101 |
| Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B. | Liver international : official journal of the International Association for the Study of the Liver 20120101 |
| Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir. | AIDS patient care and STDs 20120101 |
| The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. | The Journal of infectious diseases 20120101 |
| Recent HIV-1 infection: to treat or not to treat, that is the question. | The Journal of infectious diseases 20120101 |
| Clinical practice guidelines within the Southern African Development Community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases. | Health research policy and systems 20120101 |
| Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients. | PloS one 20120101 |
| Tenofovir-induced nephrotoxicity: myths and facts. | Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20120101 |
| Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection. | PloS one 20120101 |
| Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. | PloS one 20120101 |
| Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG. | AIDS research and therapy 20120101 |
| Reverse transcriptase inhibitors as microbicides. | Current HIV research 20120101 |
| Combination of antiretroviral drugs as microbicides. | Current HIV research 20120101 |
| 'Now we are in a different time; various bad diseases have come.' Understanding men's acceptability of male circumcision for HIV prevention in a moderate prevalence setting. | BMC public health 20120101 |
| Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir. | Antiviral therapy 20120101 |
| Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors. | BMC infectious diseases 20120101 |
| Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals. | PloS one 20120101 |
| HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection. | PLoS computational biology 20120101 |
| Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. | Journal of the International AIDS Society 20120101 |
| Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature. | BMC infectious diseases 20120101 |
| Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. | Antiviral therapy 20120101 |
| Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir. | Antiviral therapy 20120101 |
| Management of treatment failure in chronic hepatitis B. | Journal of hepatology 20120101 |
| Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbones. | Antiviral therapy 20120101 |
| Effect of abacavir on acute changes in biomarkers associated with cardiovascular dysfunction. | Antiviral therapy 20120101 |
| Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study. | PloS one 20120101 |
| HIV incidence and prevalence among cohorts of women with higher risk behaviour in Bloemfontein and Rustenburg, South Africa: a prospective study. | BMJ open 20120101 |
| Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. | BMC infectious diseases 20120101 |
| Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir. | Indian journal of pharmacology 20120101 |
| Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings. | HIV/AIDS (Auckland, N.Z.) 20120101 |
| The use of preexposure treatments for HIV prophylaxis. | HIV/AIDS (Auckland, N.Z.) 20120101 |
| Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. | PloS one 20120101 |
| Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing. | PloS one 20120101 |
| Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal. | PloS one 20120101 |
| The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. | International journal of STD & AIDS 20120101 |
| Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir. | International journal of STD & AIDS 20120101 |
| Hyperhidrosis related to nevirapine therapy. | International journal of STD & AIDS 20120101 |
| Immune reconstitution renal-limited sarcoidosis presenting as acute kidney injury. | International journal of STD & AIDS 20120101 |
| Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation. | PloS one 20120101 |
| Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. | BMC clinical pharmacology 20120101 |
| Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial. | Antiviral therapy 20120101 |
| Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. | PloS one 20120101 |
| Spillover adherence effects of fixed-dose combination HIV therapy. | Patient preference and adherence 20120101 |
| Successes and Challenges in an Integrated Tuberculosis/HIV Clinic in a Rural, Resource-Limited Setting: Experiences from Kericho, Kenya. | AIDS research and treatment 20120101 |
| Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes. | PloS one 20120101 |
| Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand. | AIDS research and therapy 20120101 |
| Conference highlights of the 5th international workshop on HIV persistence during therapy, 6-9 December 2011, St. Maartin, West Indies. | AIDS research and therapy 20120101 |
| Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa. | Journal of the International AIDS Society 20120101 |
| Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. | PloS one 20120101 |
| HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand. | BMC public health 20120101 |
| Clinical implications of HBsAg quantification in patients with chronic hepatitis B. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101 |
| Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa. | PloS one 20120101 |
| Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. | Substance abuse treatment, prevention, and policy 20120101 |
| An autopsy study describing causes of death and comparing clinico-pathological findings among hospitalized patients in Kampala, Uganda. | PloS one 20120101 |
| Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks. | Scientific reports 20120101 |
| Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C. | PloS one 20120101 |
| Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. | BMC public health 20120101 |
| Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults. | AIDS research and treatment 20120101 |
| Antiretroviral outcomes in South African prisoners: a retrospective cohort analysis. | PloS one 20120101 |
| Rickets-vitamin D deficiency and dependency. | Indian journal of endocrinology and metabolism 20120101 |
| A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients. | Clinical & developmental immunology 20120101 |
| Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial. | PloS one 20120101 |
| Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. | PloS one 20120101 |
| Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection? | Annals of hepatology 20120101 |
| Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. | Case reports in medicine 20120101 |
| HIV RNA suppression and immune restoration: can we do better? | Clinical & developmental immunology 20120101 |
| HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone. | PloS one 20120101 |
| HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury. | International journal of hepatology 20120101 |
| Impact of baseline virologic, immunologic, and demographic characteristics on virologic responses in the Gemini study. | HIV clinical trials 20120101 |
| Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. | PloS one 20120101 |
| Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing. | PloS one 20120101 |
| Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women. | PloS one 20120101 |
| Risk factors for suboptimal vitamin D levels among adults with HIV attending an inner-city clinic of New Orleans, Louisiana. | The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20120101 |
| HIV incidence remains high in KwaZulu-Natal, South Africa: evidence from three districts. | PloS one 20120101 |
| Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings. | AIDS research and treatment 20120101 |
| Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases. | Malaria journal 20120101 |
| Molecular Understanding of HIV-1 Latency. | Advances in virology 20120101 |
| Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission. | PloS one 20120101 |
| The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. | PloS one 20120101 |
| Failure to Control Caries in an AIDS-Affected Individual: A Case Report. | Case reports in dentistry 20120101 |
| New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir. | HIV/AIDS (Auckland, N.Z.) 20120101 |
| Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. | Advances in hematology 20120101 |
| Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals. | PloS one 20120101 |
| Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients. | PloS one 20120101 |
| A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011. | The Pan African medical journal 20120101 |
| Stress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulation. | TheScientificWorldJournal 20120101 |
| K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data. | PloS one 20120101 |
| Efficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1. | PloS one 20120101 |
| Measuring the efficacy of antiretroviral therapy. | International journal of trichology 20120101 |
| Cultural differences in acceptability of a vaginal microbicide: a comparison between potential users from Nashville, Tennessee, USA, and Kafue and Mumbwa, Zambia. | HIV/AIDS (Auckland, N.Z.) 20120101 |
| The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients. | Mediators of inflammation 20120101 |
| How good is 'good enough'? The case for varying standards of evidence according to need for new interventions in HIV prevention. | The American journal of bioethics : AJOB 20120101 |
| Viral infection in renal transplant recipients. | TheScientificWorldJournal 20120101 |
| Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. | PloS one 20120101 |
| Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response. | Advances in virology 20120101 |
| Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile. | PloS one 20120101 |
| Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. | PloS one 20120101 |
| Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia. | AIDS research and treatment 20120101 |
| The antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipes. | PloS one 20120101 |
| Antiretroviral drugs: critical issues and recent advances. | Indian journal of pharmacology 20120101 |
| Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study in India. | ISRN pediatrics 20120101 |
| Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort. | AIDS research and therapy 20120101 |
| Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required. | Mediterranean journal of hematology and infectious diseases 20120101 |
| [HIV preexposure prophylaxis]. | Przeglad epidemiologiczny 20120101 |
| Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy. | Internal medicine (Tokyo, Japan) 20120101 |
| Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. | Retrovirology 20120101 |
| Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection. | PloS one 20120101 |
| Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101 |
| Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment. | AIDS reviews 20120101 |
| Proximal tubular renal dysfunction or damage in HIV-infected patients. | AIDS reviews 20120101 |
| Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010. | Antiviral therapy 20120101 |
| Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101 |
| Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi. | PloS one 20120101 |
| Renal toxicity associated with antiretroviral therapy. | HIV clinical trials 20120101 |
| Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy. | HIV clinical trials 20120101 |
| Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. | HIV clinical trials 20120101 |
| Effects of antiretroviral therapy on autonomic function in early HIV infection: a preliminary report. | International journal of medical sciences 20120101 |
| Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients. | BMC nephrology 20120101 |
| Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy. | Antiviral therapy 20120101 |
| Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring. | PloS one 20120101 |
| Laboratory evaluation of three regimens of treatment of chronic hepatitis B: tenofovir, entecavir and combination of lamivudine and adefovir. | Journal of laboratory physicians 20120101 |
| Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females. | International journal of women's health 20120101 |
| High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy. | Journal of clinical gastroenterology 20120101 |
| Drug-induced acute interstitial nephritis mimicking acute tubular necrosis after initiation of tenofovir-containing antiretroviral therapy in patient with HIV-1 infection. | Internal medicine (Tokyo, Japan) 20120101 |
| The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity. | PloS one 20120101 |
| Cost-effectiveness analysis of antiviral treatments for HBeAg-positive chronic hepatitis B in Canada. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101 |
| First reported case of tenofovir-induced photoallergic reaction. | Indian journal of pharmacology 20120101 |
| Antiretroviral prophylaxis: a defining moment in HIV control. | Lancet (London, England) 20111217 |
| Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia. | Journal of acquired immune deficiency syndromes (1999) 20111215 |
| Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost? | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111215 |
| Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension. | The Journal of infectious diseases 20111215 |
| Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. | Science translational medicine 20111207 |
| Drugs in traffic: the road to approval. | Nature medicine 20111206 |
| Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents. | British journal of clinical pharmacology 20111201 |
| Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. | Journal of hepatology 20111201 |
| Treatment induced seroconversion to HBsAb following HBV reactivation in the immunosuppressed haematology and oncology patient: a clinical survey of 5 cases in Catania, Italy. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20111201 |
| Specific microbicides in the prevention of HIV infection. | Journal of internal medicine 20111201 |
| Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. | The Lancet. Infectious diseases 20111201 |
| Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus. | The Journal of antimicrobial chemotherapy 20111201 |
| Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. | The Journal of antimicrobial chemotherapy 20111201 |
| Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201 |
| Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications. | Current HIV/AIDS reports 20111201 |
| Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective. | PharmacoEconomics 20111201 |
| Drug resistance in HIV-1. | Current opinion in virology 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Factors predicting the efficacy of adefovir dipivoxil on treatment-naïve chronic hepatitis B patients at 48 weeks. | Gut and liver 20111201 |
| Emerging pipeline drugs for hepatitis B infection. | Expert opinion on emerging drugs 20111201 |
| HIV preexposure prophylaxis: new data and potential use. | Topics in antiviral medicine 20111201 |
| Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients. | The Korean journal of hepatology 20111201 |
| Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B. | The Korean journal of hepatology 20111201 |
| The evolving Indian AIDS epidemic: hope & challenges of the fourth decade. | The Indian journal of medical research 20111201 |
| 'Getting to zero': a steep path ahead. | The Indian journal of medical research 20111201 |
| Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to? | The Indian journal of medical research 20111201 |
| Human immunodeficiency virus & cardiovascular risk. | The Indian journal of medical research 20111201 |
| HIV serodiscordant relationships in India: translating science to practice. | The Indian journal of medical research 20111201 |
| Paediatric HIV--trends & challenges. | The Indian journal of medical research 20111201 |
| HIV in Indian MSM: reasons for a concentrated epidemic & strategies for prevention. | The Indian journal of medical research 20111201 |
| Microbicides for HIV prevention. | The Indian journal of medical research 20111201 |
| Microbicides: a new hope for HIV prevention. | The Indian journal of medical research 20111201 |
| Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient. | AIDS (London, England) 20111128 |
| The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis. | AIDS (London, England) 20111128 |
| Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy. | The Journal of infectious diseases 20111115 |
| How much do antiretroviral drugs penetrate into the central nervous system? | Journal of medicine and life 20111114 |
| Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity. | AIDS (London, England) 20111113 |
| Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains. | Journal of viral hepatitis 20111101 |
| Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine. | AIDS care 20111101 |
| pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101 |
| Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho. | Journal of acquired immune deficiency syndromes (1999) 20111101 |
| Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. | HIV medicine 20111101 |
| HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20111101 |
| Population pharmacokinetics of tenofovir in HIV-1-infected pediatric patients. | Journal of acquired immune deficiency syndromes (1999) 20111101 |
| The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication. | Antiviral research 20111101 |
| Application of kinase bypass strategies to nucleoside antivirals. | Antiviral research 20111101 |
| Antiviral activity of tenofovir against Cauliflower mosaic virus and its metabolism in Brassica pekinensis plants. | Antiviral research 20111101 |
| Inhibition of HIV-1 by octadecyloxyethyl esters of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] nucleosides and evaluation of their mechanism of action. | Antimicrobial agents and chemotherapy 20111101 |
| Association of increased upper trunk and decreased leg fat with 2-h glucose in control and HIV-infected persons. | Diabetes care 20111101 |
| The management of chronic hepatitis B in Asian Americans. | Digestive diseases and sciences 20111101 |
| Review article: current antiviral therapy of chronic hepatitis B. | Alimentary pharmacology & therapeutics 20111101 |
| [Human immunodeficiency virus infection and viral hepatitis]. | Enfermedades infecciosas y microbiologia clinica 20111101 |
| Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. | PLoS medicine 20111101 |
| FDA notifications. Complera approved. | AIDS alert 20111101 |
| A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. | International journal of pharmaceutics 20111031 |
| Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. | Cell host & microbe 20111020 |
| Optimizing initial therapy for HIV infection. | The Journal of infectious diseases 20111015 |
| Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. | The Journal of infectious diseases 20111015 |
| Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria. | Antiviral chemistry & chemotherapy 20111007 |
| Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir. | Minerva anestesiologica 20111001 |
| Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111001 |
| Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. | Scandinavian journal of infectious diseases 20111001 |
| Successful tenofovir treatment for fulminant hepatitis B infection in an infant. | The Pediatric infectious disease journal 20111001 |
| Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa. | Journal of acquired immune deficiency syndromes (1999) 20111001 |
| Hepatitis B virus infection and pregnancy. | Clinics and research in hepatology and gastroenterology 20111001 |
| Pitfall of hepatitis B surface antigen testing in a kidney transplant recipient presenting hepatitis B reactivation. | Clinics and research in hepatology and gastroenterology 20111001 |
| Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection. | Clinical and experimental nephrology 20111001 |
| Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study. | Antiviral research 20111001 |
| Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy. | The Journal of antimicrobial chemotherapy 20111001 |
| Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. | AIDS patient care and STDs 20111001 |
| Modeling interventions to assess HIV epidemic impact in Africa. | Journal of acquired immune deficiency syndromes (1999) 20111001 |
| Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir. | Alimentary pharmacology & therapeutics 20111001 |
| Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients. | Therapeutic drug monitoring 20111001 |
| HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. | Journal of viral hepatitis 20111001 |
| Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy. | Journal of the American Academy of Dermatology 20111001 |
| Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111001 |
| Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. | Obstetrics and gynecology 20111001 |
| Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach. | PLoS computational biology 20111001 |
| Design and validation of a multiplexed low coherence interferometry instrument for in vivo clinical measurement of microbicide gel thickness distribution. | Biomedical optics express 20111001 |
| Deep molecular characterization of HIV-1 dynamics under suppressive HAART. | PLoS pathogens 20111001 |
| Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20111001 |
| Chronic hepatitis B: management challenges in resource-poor countries. | Hepatitis monthly 20111001 |
| Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies. | Hepatitis monthly 20111001 |
| [Fulminant hepatic failure by hepatitis B virus in a patient with human immunodeficiency virus infection: report of one case]. | Revista medica de Chile 20111001 |
| Association of osteonecrosis and osteoporosis in HIV-1-infected patients. | AIDS (London, England) 20110924 |
| Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. | AIDS (London, England) 20110924 |
| Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110918 |
| Product and process understanding of a novel pediatric anti-HIV tenofovir niosomes with a high-pressure homogenizer. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110918 |
| [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report]. | Medicina clinica 20110910 |
| Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. | Journal of pharmaceutical and biomedical analysis 20110910 |
| Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. | AIDS (London, England) 20110910 |
| The cost-effectiveness of alternative strategies against HBV in Italy. | Health policy (Amsterdam, Netherlands) 20110901 |
| Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD. | Bone marrow transplantation 20110901 |
| Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence. | Journal of hepatology 20110901 |
| Short communication: decrease in mitochondrial transmembrane potential in peripheral blood mononuclear cells of HIV-uninfected subjects undergoing HIV postexposure prophylaxis. | AIDS research and human retroviruses 20110901 |
| A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States. | AIDS care 20110901 |
| HIV prevention in southern Africa: why we must reassess our strategies? | Tropical medicine & international health : TM & IH 20110901 |
| Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. | Journal of acquired immune deficiency syndromes (1999) 20110901 |
| Renal excretion of apricitabine in rats: ex vivo and in vivo studies. | European journal of drug metabolism and pharmacokinetics 20110901 |
| IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. | Blood 20110901 |
| Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients. | AIDS patient care and STDs 20110901 |
| Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C. | Virology 20110901 |
| Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication. | European journal of medicinal chemistry 20110901 |
| A case of lactic acidosis (LA) after administration of tenofovir and metformin in a diabetic patient with recently diagnosed HIV infection. | Journal of renal care 20110901 |
| Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. | PLoS pathogens 20110901 |
| Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B. | Gut and liver 20110901 |
| Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti. | PLoS medicine 20110901 |
| Microbicide might protect pregnant women from HIV. Susceptibility is high for them. | AIDS alert 20110901 |
| Molecular epidemiology of hepatitis B virus. | The Korean journal of internal medicine 20110901 |
| Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far. | Hematology reports 20110831 |
| Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates. | Journal of medicinal chemistry 20110825 |
| Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. | Journal of medicinal chemistry 20110825 |
| Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination. | AIDS (London, England) 20110824 |
| Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir. | AIDS (London, England) 20110824 |
| Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. | AIDS (London, England) 20110824 |
| Antiretroviral therapy alone resulted in successful resolution of large idiopathic esophageal ulcers in a patient with acute retroviral syndrome. | AIDS (London, England) 20110824 |
| The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations. | Antiviral chemistry & chemotherapy 20110823 |
| Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. | Nature 20110817 |
| Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis. | Journal of acquired immune deficiency syndromes (1999) 20110815 |
| Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110815 |
| Viral hepatitis in solid organ transplantation other than liver. | Journal of hepatology 20110801 |
| Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure. | Hepatology (Baltimore, Md.) 20110801 |
| Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention. | Journal of pharmaceutical sciences 20110801 |
| Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients. | Scandinavian journal of infectious diseases 20110801 |
| Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. | Journal of acquired immune deficiency syndromes (1999) 20110801 |
| Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. | Kidney international 20110801 |
| One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. | Journal of virology 20110801 |
| Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. | Infection 20110801 |
| Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss. | The Journal of infectious diseases 20110801 |
| Severe acute renal failure in an HIV-infected patient after only 2 weeks of tenofovir-based antiretroviral therapy. | AIDS patient care and STDs 20110801 |
| Optimizing antiretroviral product selection: a sample approach to improving patient outcomes, saving money, and scaling-up health services in developing countries. | Journal of acquired immune deficiency syndromes (1999) 20110801 |
| Tsetse salivary gland hypertrophy virus: hope or hindrance for tsetse control? | PLoS neglected tropical diseases 20110801 |
| Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa. | Journal of health, population, and nutrition 20110801 |
| Recent advances in the management of chronic hepatitis B. | Hepatitis monthly 20110801 |
| Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin. | Hepatitis monthly 20110801 |
| Life-threatening hypophosphataemia in a cirrhotic patient with jaundice. | Archives of medical science : AMS 20110801 |
| Mothers and babies: widening the HIV safety net. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20110725 |
| Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report. | The Journal of bone and joint surgery. American volume 20110720 |
| Renal dysfunction among HIV-infected patients starting antiretroviral therapy. | AIDS (London, England) 20110717 |
| Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage. | AIDS (London, England) 20110717 |
| Rilpivirine: a step forward in tailored HIV treatment. | Lancet (London, England) 20110716 |
| Antiretrovirals for HIV prevention: translating promise into praxis. | Lancet (London, England) 20110716 |
| Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. | Lancet (London, England) 20110716 |
| Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. | Lancet (London, England) 20110716 |
| Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. | Lancet (London, England) 20110716 |
| Battles with donors cloud Malawi's HIV prevention plan. | Lancet (London, England) 20110716 |
| The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond. | Biochemical pharmacology 20110715 |
| Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm. | BMJ (Clinical research ed.) 20110715 |
| Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study). | HIV medicine 20110701 |
| Risk factors of chronic kidney disease in HIV-infected patients. | Clinical journal of the American Society of Nephrology : CJASN 20110701 |
| Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy. | The Journal of infectious diseases 20110701 |
| Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. | The Journal of infectious diseases 20110701 |
| Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110701 |
| Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. | PLoS medicine 20110701 |
| Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo. | Journal of acquired immune deficiency syndromes (1999) 20110701 |
| In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. | AIDS patient care and STDs 20110701 |
| [Protective role of antiretroviral treatment in the impairment of renal function in a cohort of human immunodeficiency virus patients]. | Medicina clinica 20110625 |
| Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. | AIDS (London, England) 20110619 |
| Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. | The Journal of infectious diseases 20110615 |
| Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. | Journal of viral hepatitis 20110601 |
| Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only. | Transplant infectious disease : an official journal of the Transplantation Society 20110601 |
| 'Who is Helsinki?' Sex workers advise improving communication for good participatory practice in clinical trials. | Health education research 20110601 |
| Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. | Journal of clinical immunology 20110601 |
| Microbial biofilms on the surface of intravaginal rings worn in non-human primates. | Journal of medical microbiology 20110601 |
| The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. | Antimicrobial agents and chemotherapy 20110601 |
| Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters. | Laboratory investigation; a journal of technical methods and pathology 20110601 |
| Topical prophylaxis for HIV prevention in women: becoming a reality. | Current HIV/AIDS reports 20110601 |
| Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. | Scandinavian journal of gastroenterology 20110601 |
| Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz. | AIDS care 20110601 |
| Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). | Antiviral research 20110601 |
| Management of HIV infection in treatment-naive patients: a review of the most current recommendations. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110601 |
| Early end for FEM-PrEP HIV prevention trial. | AIDS patient care and STDs 20110601 |
| Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. | Best practice & research. Clinical endocrinology & metabolism 20110601 |
| Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used. | Journal of acquired immune deficiency syndromes (1999) 20110601 |
| A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. | Journal of the National Medical Association 20110601 |
| [Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B]. | Orvosi hetilap 20110529 |
| Study halted: no benefit seen from antiretroviral pill in preventing HIV in women. | JAMA 20110518 |
| Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients. | AIDS (London, England) 20110515 |
| Major HIV resistance mutations in untreated Romanian patients. | Journal of medicine and life 20110515 |
| [Efavirenz in fixed combination with tenofovir and emtricitabine. Long-term effectiveness verified in new studies]. | MMW Fortschritte der Medizin 20110505 |
| Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. | Joint, bone, spine : revue du rhumatisme 20110501 |
| From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir. | Expert opinion on drug safety 20110501 |
| Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. | Contemporary clinical trials 20110501 |
| Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study. | The Journal of infection 20110501 |
| Low incidence of renal impairment observed in tenofovir-treated patients. | The Journal of antimicrobial chemotherapy 20110501 |
| Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20110501 |
| HIV-1 integrase inhibitor resistance and its clinical implications. | The Journal of infectious diseases 20110501 |
| Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients. | Nephrology (Carlton, Vic.) 20110501 |
| [Characteristics of antiretroviral drugs]. | Enfermedades infecciosas y microbiologia clinica 20110501 |
| Novel nephrotoxins. | Advances in chronic kidney disease 20110501 |
| CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. | PLoS pathogens 20110501 |
| Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting. | The Southeast Asian journal of tropical medicine and public health 20110501 |
| Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. | Viruses 20110501 |
| Re.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. | The Journal of urology 20110501 |
| [New drugs of treatment of patients with chronic hepatitis B]. | Nihon rinsho. Japanese journal of clinical medicine 20110501 |
| Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. | Transplantation 20110427 |
| Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection. | AIDS (London, England) 20110424 |
| Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection. | Journal of acquired immune deficiency syndromes (1999) 20110415 |
| Atazanavir pharmacokinetics with and without tenofovir during pregnancy. | Journal of acquired immune deficiency syndromes (1999) 20110415 |
| A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet. | Journal of acquired immune deficiency syndromes (1999) 20110415 |
| Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. | Virology 20110410 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. | Annals of internal medicine 20110405 |
| Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110401 |
| Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients. | The Journal of infection 20110401 |
| Pre-exposure prophylaxis and the promise of combination prevention approaches. | AIDS and behavior 20110401 |
| [HIV infected women with intense bone and muscular pain and general weakness]. | Enfermedades infecciosas y microbiologia clinica 20110401 |
| Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used. | Journal of acquired immune deficiency syndromes (1999) 20110401 |
| Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. | Bioorganic & medicinal chemistry 20110401 |
| Fibrosis in chronic viral hepatitis. | Best practice & research. Clinical gastroenterology 20110401 |
| Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects. | International journal of STD & AIDS 20110401 |
| [Investigation of occult hepatitis B in HIV infected patients]. | Mikrobiyoloji bulteni 20110401 |
| Clinical management of HIV drug resistance. | Viruses 20110401 |
| Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract. | Journal of immunological methods 20110331 |
| Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. | AIDS (London, England) 20110327 |
| Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study. | Basic & clinical pharmacology & toxicology 20110301 |
| Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. | Journal of general internal medicine 20110301 |
| The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. | Journal of hepatology 20110301 |
| Lipid-lowering effect of tenofovir in HIV-infected patients. | The Journal of antimicrobial chemotherapy 20110301 |
| Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years. | Journal of acquired immune deficiency syndromes (1999) 20110301 |
| Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy? | Alimentary pharmacology & therapeutics 20110301 |
| Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection. | Journal of renal care 20110301 |
| Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. | Hepatology (Baltimore, Md.) 20110301 |
| Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. | AIDS patient care and STDs 20110301 |
| Is tenofovir-related renal toxicity incompletely reversible? | Journal of acquired immune deficiency syndromes (1999) 20110301 |
| Type 2 diabetes and impaired glucose tolerance in two young adults infected with HIV early in life. | Diabetes care 20110301 |
| No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus. | Hepatology (Baltimore, Md.) 20110301 |
| Mycobacterium lentiflavum in drinking water supplies, Australia. | Emerging infectious diseases 20110301 |
| Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry. | Journal of mass spectrometry : JMS 20110301 |
| Chronic hepatitis B in pregnancy: unique challenges and opportunities. | The Korean journal of hepatology 20110301 |
| Viral hepatitis B and hepatocellular carcinoma. | Acta gastro-enterologica Belgica 20110301 |
| Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice. | Gastroenterology & hepatology 20110301 |
| Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. | British journal of cancer 20110215 |
| Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents. | Bioorganic & medicinal chemistry 20110215 |
| [Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast]. | Medecine et maladies infectieuses 20110201 |
| Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing. | AIDS research and human retroviruses 20110201 |
| Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. | Gut 20110201 |
| Acute kidney injury in the setting of AIDS, bland urine sediment, minimal proteinuria and normal-sized kidneys: a presentation of renal lymphoma. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110201 |
| Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. | The Journal of antimicrobial chemotherapy 20110201 |
| Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. | The Journal of antimicrobial chemotherapy 20110201 |
| Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection. | Current atherosclerosis reports 20110201 |
| Tenofovir salvage for nucleoside experienced patients: muddy waters? | Gut 20110201 |
| Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. | AIDS patient care and STDs 20110201 |
| [Tenofovir, an antiviral agent with low spermiostatic activity]. | Actas urologicas espanolas 20110201 |
| [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201 |
| Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. | PLoS medicine 20110201 |
| Initial results reported on raltegravir once-daily dosing. | AIDS patient care and STDs 20110201 |
| Genital tract sequestration of SIV following acute infection. | PLoS pathogens 20110201 |
| [Viral hepatitis B in a patient with follicular lymphoma treated with biological therapy]. | Klinicka mikrobiologie a infekcni lekarstvi 20110201 |
| Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy. | AIDS (London, England) 20110128 |
| Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. | MMWR. Morbidity and mortality weekly report 20110128 |
| HIV prevention in women: next steps. | Science (New York, N.Y.) 20110121 |
| AIDS: Drugs that prevent HIV infection. | Nature 20110120 |
| [HIV and AIDS: what's new in 2010?]. | Revue medicale suisse 20110119 |
| Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. | The Journal of infectious diseases 20110115 |
| Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens. | AIDS (London, England) 20110114 |
| Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. | AIDS (London, England) 20110114 |
| No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. | AIDS (London, England) 20110114 |
| Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. | Journal of medicinal chemistry 20110113 |
| Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. | The Journal of biological chemistry 20110107 |
| European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. | AIDS (London, England) 20110102 |
| Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. | AIDS (London, England) 20110102 |
| Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. | HIV medicine 20110101 |
| Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. | HIV medicine 20110101 |
| A 40-year journey in search of selective antiviral chemotherapy. | Annual review of pharmacology and toxicology 20110101 |
| Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. | Journal of hepatology 20110101 |
| Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functions. | AIDS research and human retroviruses 20110101 |
| Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. | Gastroenterology 20110101 |
| Implications of HIV PrEP trials results. | AIDS research and human retroviruses 20110101 |
| [Immune reconstitution inflammatory syndrome associated with eosinophilic pustular folliculitis in an HIV-infected patient]. | Medecine et maladies infectieuses 20110101 |
| [Rate of genotypic mutations and resistance to antiretroviral drugs in a general hospital]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101 |
| Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma. | Pathology research international 20110101 |
| Long-term safety from the raltegravir clinical development program. | Current HIV research 20110101 |
| Treatment of chronic hepatitis B: Evolution over two decades. | Journal of gastroenterology and hepatology 20110101 |
| Chronic hepatitis B: peginterferon or nucleos(t)ide analogues? | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| Hepatitis B virus resistance to antiviral drugs: where are we going? | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| The impact of human immunodeficiency virus on viral hepatitis. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| Renal disease associated with antiretroviral therapy in the treatment of HIV. | Nephron. Clinical practice 20110101 |
| The ART of preventing HIV. | Nature medicine 20110101 |
| Understanding diabetes in patients with HIV/AIDS. | Diabetology & metabolic syndrome 20110101 |
| Timing of antiretroviral therapy for HIV in the setting of TB treatment. | Clinical & developmental immunology 20110101 |
| Neurosyphilis manifesting with unilateral visual loss and hyponatremia: a case report. | BMC infectious diseases 20110101 |
| Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs. | BMC medicine 20110101 |
| An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. | PloS one 20110101 |
| K70Q adds high-level tenofovir resistance to 'Q151M complex' HIV reverse transcriptase through the enhanced discrimination mechanism. | PloS one 20110101 |
| Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. | Hepatology (Baltimore, Md.) 20110101 |
| A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus. | Virology journal 20110101 |
| Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy. | AIDS research and therapy 20110101 |
| Finding a cure for HIV: will it ever be achievable? | Journal of the International AIDS Society 20110101 |
| Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study. | BMC public health 20110101 |
| Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI. | BMC infectious diseases 20110101 |
| Access and use of human tissues from the developing world: ethical challenges and a way forward using a tissue trust. | BMC medical ethics 20110101 |
| A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel. | PloS one 20110101 |
| Clinical use of CCR5 inhibitors in HIV and beyond. | Journal of translational medicine 20110101 |
| Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. | Journal of medical economics 20110101 |
| Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. | Reviews in medical virology 20110101 |
| Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir. | BMC infectious diseases 20110101 |
| A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. | Journal of the International AIDS Society 20110101 |
| Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy. | Antiviral therapy 20110101 |
| Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis. | Antiviral therapy 20110101 |
| Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues. | The Indian journal of medical research 20110101 |
| Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis. | Virology journal 20110101 |
| Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature. | Journal of medical case reports 20110101 |
| Sulfated polysaccharides in marine sponges: extraction methods and anti-HIV activity. | Marine drugs 20110101 |
| HIV-2 infection, end-stage renal disease and protease inhibitor intolerance: which salvage regimen? | Clinical drug investigation 20110101 |
| HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. | Lipids in health and disease 20110101 |
| Update on microbicide research and development - seeking new HIV prevention tools for women. | European journal of medical research 20110101 |
| Bioequivalence study of two oral tablet formulations containing tenofovir disoproxil fumarate in healthy volunteers. | Arzneimittel-Forschung 20110101 |
| Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. | PloS one 20110101 |
| Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication. | AIDS research and therapy 20110101 |
| Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. | BMC infectious diseases 20110101 |
| Timely HAART initiation may pave the way for a better viral control. | BMC infectious diseases 20110101 |
| Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. | PloS one 20110101 |
| Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort. | PloS one 20110101 |
| Rilpivirine: a new addition to the anti-HIV-1 armamentarium. | Drugs of today (Barcelona, Spain : 1998) 20110101 |
| Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment. | PloS one 20110101 |
| Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations. | AIDS research and therapy 20110101 |
| Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. | Trials 20110101 |
| Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation. | Molecular vision 20110101 |
| Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: a systematic review. | Virology journal 20110101 |
| 'Dynamic range' of inferred phenotypic HIV drug resistance values in clinical practice. | PloS one 20110101 |
| Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho. | PloS one 20110101 |
| Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. | Retrovirology 20110101 |
| Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series. | Radiation oncology (London, England) 20110101 |
| [Renal adverse reactions of antiretroviral medication: proximal tubular dysfunction associated with tenofovir]. | Nederlands tijdschrift voor geneeskunde 20110101 |
| Mucoadhesive drug delivery systems. | Journal of pharmacy & bioallied sciences 20110101 |
| High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia. | Journal of the International AIDS Society 20110101 |
| Driving a decade of change: HIV/AIDS, patents and access to medicines for all. | Journal of the International AIDS Society 20110101 |
| HIV knowledge, risk perception, and safer sex practices among female sex workers in Port Moresby, Papua New Guinea. | International journal of women's health 20110101 |
| Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients. | Antiviral therapy 20110101 |
| [Treatment of chronic hepatitis B]. | La Revue du praticien 20110101 |
| Machine learning on normalized protein sequences. | BMC research notes 20110101 |
| HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs. | PloS one 20110101 |
| Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients. | Cardiovascular ultrasound 20110101 |
| Changes in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients. | European journal of medical research 20110101 |
| Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda. | PloS one 20110101 |
| Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. | PloS one 20110101 |
| Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. | Journal of the International AIDS Society 20110101 |
| Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010. | Journal of translational medicine 20110101 |
| The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patients. | European journal of medical research 20110101 |
| Complete recovery of ischemic cardiomyopathy from thrombotic thrombocytopenic purpura. | Clinical Medicine Insights. Cardiology 20110101 |
| Tinea incognito Caused by Microsporum gypseum in a Patient with Advanced HIV Infection: A Case Report. | Case reports in dermatology 20110101 |
| Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings. | AIDS research and treatment 20110101 |
| Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia. | AIDS research and treatment 20110101 |
| Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries. | AIDS research and treatment 20110101 |
| Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa. | AIDS research and treatment 20110101 |
| A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. | PloS one 20110101 |
| Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP). | PloS one 20110101 |
| Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. | Clinical drug investigation 20110101 |
| T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis. | PloS one 20110101 |
| [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?]. | Gastroenterologia y hepatologia 20110101 |
| Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial. | Antiviral therapy 20110101 |
| Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. | BMC pediatrics 20110101 |
| The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains. | Retrovirology 20110101 |
| Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. | PloS one 20110101 |
| Rapid dissemination of SIV follows multisite entry after rectal inoculation. | PloS one 20110101 |
| The role of HIV and antiretroviral therapy in bone disease. | AIDS reviews 20110101 |
| Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects. | PloS one 20110101 |
| Safety and tolerability of antiretrovirals during pregnancy. | Infectious diseases in obstetrics and gynecology 20110101 |
| Monitoring of Renal Function among HIV-Infected Patients Receiving Tenofovir in a Resource-Limited Setting. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20110101 |
| Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study. | PloS one 20110101 |
| Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice. | PloS one 20110101 |
| HIV treatment for prevention. | Journal of the International AIDS Society 20110101 |
| Severe acute hepatitis B treated with entecavir. | Mediterranean journal of hematology and infectious diseases 20110101 |
| Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. | PloS one 20110101 |
| Outcome assessment of a dedicated HIV positive health care worker clinic at a central hospital in Malawi: a retrospective observational study. | PloS one 20110101 |
| Development and validation of an LC/MS/MS method for the determination of tenofovir in monkey plasma. | Biological & pharmaceutical bulletin 20110101 |
| Contraception in HIV-positive female adolescents. | AIDS research and therapy 20110101 |
| HIV and HAART-Associated Dyslipidemia. | The open cardiovascular medicine journal 20110101 |
| Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. | Molecular brain 20110101 |
| Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials. | BMC infectious diseases 20110101 |
| WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. | PloS one 20110101 |
| A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1. | PloS one 20110101 |
| Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy. | Patient preference and adherence 20110101 |
| Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective. | Pathology research international 20110101 |
| High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo. | Journal of the International AIDS Society 20110101 |
| Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. | Retrovirology 20110101 |
| A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice. | PloS one 20110101 |
| Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome. | Annals of hepatology 20110101 |
| Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect. | Retrovirology 20110101 |
| Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir. | Antiviral therapy 20110101 |
| Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients. | Antiviral therapy 20110101 |
| Safety and efficacy of entecavir for the treatment of chronic hepatitis B. | Infection and drug resistance 20110101 |
| Patterns of resistance development with integrase inhibitors in HIV. | Infection and drug resistance 20110101 |
| Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations. | BMC infectious diseases 20110101 |
| Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV. | AIDS research and therapy 20110101 |
| Immune reconstitution and inflammatory syndrome due to disseminated tuberculosis in a case of human immunodeficiency virus 2 infection. | Indian journal of pharmacology 20110101 |
| Tenofovir nephrotoxicity: 2011 update. | AIDS research and treatment 20110101 |
| Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy. | AIDS research and treatment 20110101 |
| Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand. | BMC public health 20110101 |
| Tuberculosis: current situation, challenges and overview of its control programs in India. | Journal of global infectious diseases 20110101 |
| Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. | PloS one 20110101 |
| Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. | PloS one 20110101 |
| Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. | BMC infectious diseases 20110101 |
| Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection. | PloS one 20110101 |
| Non-cirrhotic portal hypertension in human immunodeficiency virus-infected patients: a new challenge in antiretroviral therapy era. | The open AIDS journal 20110101 |
| Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment. | Methods in molecular biology (Clifton, N.J.) 20110101 |
| Does HAART efficacy translate to effectiveness? Evidence for a trial effect. | PloS one 20110101 |
| Recurrent Meningitis and Subarachnoid Hemorrhage Due to Salmonella in an HIV+ Patient: Case Report and Mini-Review of the Literature. | The open AIDS journal 20110101 |
| High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure. | Journal of clinical gastroenterology 20110101 |
| Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). | PloS one 20110101 |
| Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. | BMC pediatrics 20110101 |
| Pre-exposure prophylaxis of HIV. | Indian journal of sexually transmitted diseases and AIDS 20110101 |
| Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing. | PloS one 20110101 |
| Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load. | PloS one 20110101 |
| Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients. | PloS one 20110101 |
| Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. | PloS one 20110101 |
| Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. | European journal of medical research 20110101 |
| Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment. | Virology journal 20110101 |
| Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort. | BMC women's health 20110101 |
| Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. | Antiviral therapy 20110101 |
| Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis. | Virology journal 20110101 |
| Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. | Infectious diseases in obstetrics and gynecology 20110101 |
| Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice. | Acta reumatologica portuguesa 20110101 |
| Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. | Patient preference and adherence 20110101 |
| Kaposi sarcoma of the adrenal gland resembling epithelioid angiosarcoma: a case report. | Sarcoma 20110101 |
| HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. | PloS one 20110101 |
| HIV prevalence and incidence among sexually active females in two districts of South Africa to determine microbicide trial feasibility. | PloS one 20110101 |
| Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. | PloS one 20110101 |
| Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? | PloS one 20110101 |
| Nephrotoxicity of HAART. | AIDS research and treatment 20110101 |
| Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study. | BMC nephrology 20110101 |
| Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. | PloS one 20110101 |
| Diffuse interstitial lung infiltrates in a smoker with human immunodeficiency virus infection. | Lung India : official organ of Indian Chest Society 20110101 |
| State of the Globe: The Immunological Quest for an HIV/AIDS Vaccine Continues. | Journal of global infectious diseases 20110101 |
| HIV, Hepatitis B, and Hepatitis C in Zambia. | Journal of global infectious diseases 20110101 |
| X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI. | PloS one 20110101 |
| HIV incidence among men who have sex with men in China: a meta-analysis of published studies. | PloS one 20110101 |
| Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. | PloS one 20110101 |
| Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system. | Antiviral therapy 20110101 |
| Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels. | Antiviral therapy 20110101 |
| Acute kidney injury in the tropics. | Annals of Saudi medicine 20110101 |
| Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand. | PloS one 20110101 |
| A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. | BMC infectious diseases 20110101 |
| Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review. | Journal of medical case reports 20110101 |
| Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. | PloS one 20110101 |
| Increased prevalence of albuminuria in HIV-infected adults with diabetes. | PloS one 20110101 |
| Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations. | PloS one 20110101 |
| Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil. | BMC infectious diseases 20110101 |
| Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. | BMC cancer 20110101 |
| A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy. | ClinicoEconomics and outcomes research : CEOR 20110101 |
| SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. | PloS one 20110101 |
| Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective study. | Virology journal 20110101 |
| First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. | AIDS research and therapy 20110101 |
| Inhibition of HIV-1 infection in ex vivo cervical tissue model of human vagina by palmitic acid; implications for a microbicide development. | PloS one 20110101 |
| Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. | Journal of the International AIDS Society 20110101 |
| The first decade of antiretroviral therapy in Africa. | Globalization and health 20110101 |
| Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa. | Journal of the International AIDS Society 20110101 |
| Treatment as prevention: preparing the way. | Journal of the International AIDS Society 20110101 |
| The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research. | Journal of the International AIDS Society 20110101 |
| Epistemic fault lines in biomedical and social approaches to HIV prevention. | Journal of the International AIDS Society 20110101 |
| Framing the social in biomedical HIV prevention trials: a 20-year retrospective. | Journal of the International AIDS Society 20110101 |
| First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy. | PloS one 20110101 |
| Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand. | PloS one 20110101 |
| High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. | PloS one 20110101 |
| HIV as a chronic disease considerations for service planning in resource-poor settings. | Globalization and health 20110101 |
| Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy. | BMC infectious diseases 20110101 |
| Promoting male involvement to improve PMTCT uptake and reduce antenatal HIV infection: a cluster randomized controlled trial protocol. | BMC public health 20110101 |
| Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients. | ISRN gastroenterology 20110101 |
| A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries. | Globalization and health 20110101 |
| The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma. | International journal of hepatology 20110101 |
| Treatment of hepatitis B in decompensated liver cirrhosis. | International journal of hepatology 20110101 |
| Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. | PloS one 20110101 |
| Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. | Journal of the International AIDS Society 20110101 |
| Meeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: the hybrid design. | BMJ open 20110101 |
| Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil. | PloS one 20110101 |
| Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study. | European journal of medical research 20110101 |
| Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. | Antiviral therapy 20110101 |
| Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. | Antiviral therapy 20110101 |
| South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome. | Indian journal of endocrinology and metabolism 20110101 |
| Nephrogenic diabetes insipidus with idiopathic Fanconi's syndrome in a child who presented as vitamin D resistant rickets. | Indian journal of endocrinology and metabolism 20110101 |
| Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro. | PloS one 20110101 |
| A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel. | PloS one 20110101 |
| Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population. | PloS one 20110101 |
| Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudine. | PloS one 20110101 |
| Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study. | BMC infectious diseases 20110101 |
| Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. | BMC infectious diseases 20110101 |
| Complete Healing of a Giant Wart in a Severely Immune-Compromised Patient with HIV Infection Treated with Acupuncture. | Case reports in dermatology 20110101 |
| An autoimmune disease prevented by anti-retroviral drugs. | Retrovirology 20110101 |
| Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART. | PloS one 20110101 |
| An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors. | PloS one 20110101 |
| Optimal antiviral switching to minimize resistance risk in HIV therapy. | PloS one 20110101 |
| Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. | BMJ (Clinical research ed.) 20110101 |
| CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. | BMJ (Clinical research ed.) 20110101 |
| Improved Bevirimat resistance prediction by combination of structural and sequence-based classifiers. | BioData mining 20110101 |
| Effect of anemia on hepatotoxicity of HAART in HIV patients in Benin city. | Nigerian medical journal : journal of the Nigeria Medical Association 20110101 |
| It is time to consider third-line options in antiretroviral-experienced paediatric patients? | Journal of the International AIDS Society 20110101 |
| A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B. | Hepatitis monthly 20110101 |
| Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives? | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Role of raltegravir in the management of HIV-1 infection. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety. | PloS one 20110101 |
| Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis. | Case reports in gastroenterology 20110101 |
| Tenofovir induced acute kidney injury in a patient with unilateral renal agenesis despite initially non-impaired renal function. | European journal of medical research 20110101 |
| Using HIV transmission networks to investigate community effects in HIV prevention trials. | PloS one 20110101 |
| AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus. | BMC research notes 20110101 |
| Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians. | West African journal of medicine 20110101 |
| Oral tenofovir arm of VOICE trial discontinued early. | IAVI report : newsletter on international AIDS vaccine research 20110101 |
| Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model. | Journal of biomedicine & biotechnology 20110101 |
| Biomarkers of acute kidney injury. | Journal of toxicology 20110101 |
| Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis. | PloS one 20110101 |
| Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy. | PloS one 20110101 |
| Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy. | Retrovirology 20110101 |
| Are dual-method messages undermining STI/HIV prevention? | Infectious diseases in obstetrics and gynecology 20110101 |
| Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid). | Antiviral therapy 20110101 |
| In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers. | Antiviral therapy 20110101 |
| Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells. | Antiviral therapy 20110101 |
| Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. | PloS one 20110101 |
| Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. | ClinicoEconomics and outcomes research : CEOR 20110101 |
| SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses. | PloS one 20110101 |
| Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease. | BMC infectious diseases 20110101 |
| Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected. | PloS one 20110101 |
| Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results. | HIV clinical trials 20110101 |
| Toll-like receptors signaling contributes to immunopathogenesis of HBV infection. | Gastroenterology research and practice 20110101 |
| Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa. | BMC research notes 20110101 |
| Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland. | PloS one 20110101 |
| Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden? | Patient preference and adherence 20110101 |
| Lipodystrophy in HIV patients: its challenges and management approaches. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease. | Acta clinica Belgica 20110101 |
| Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance. | Scientific reports 20110101 |
| A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. | BMC public health 20110101 |
| Undiagnosed HIV Presenting with Lymphoid Interstitial Pneumonitis. | Case reports in infectious diseases 20110101 |
| Symptomatic Mixed Cryoglobulinemia during HIV Primary Infection: A Case Report. | Case reports in infectious diseases 20110101 |
| Intractable chronic vulval ulceration presenting as immune reconstitution inflammatory syndrome in a treatment-failure patient: a case observation. | Case reports in obstetrics and gynecology 20110101 |
| Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects. | Acta naturae 20110101 |
| Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. | BMJ case reports 20110101 |
| Approach to chronic hepatitis B virus infection. | JNMA; journal of the Nepal Medical Association 20110101 |
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. | The New England journal of medicine 20101230 |
| Oral preexposure prophylaxis for HIV--another arrow in the quiver? | The New England journal of medicine 20101230 |
| Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20101215 |
| HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. | The Journal of infectious diseases 20101215 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection. | Drugs 20101203 |
| Pharmaceutical development of microbicide drug products. | Pharmaceutical development and technology 20101201 |
| Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. | Journal of viral hepatitis 20101201 |
| Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study. | Journal of hepatology 20101201 |
| Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. | Gastroenterology 20101201 |
| Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. | Kidney international 20101201 |
| Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201 |
| Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201 |
| The risk of HIV drug resistance following implementation of pre-exposure prophylaxis. | Current opinion in infectious diseases 20101201 |
| A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience. | AIDS research and human retroviruses 20101201 |
| Virologic and clinical outcomes in HIV/HBV coinfected patients on tenofovir-containing HAART. | Gastroenterology 20101201 |
| Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. | Kidney international 20101201 |
| Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. | Antiviral research 20101201 |
| Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09. | International journal of epidemiology 20101201 |
| Efficacy of initial treatment with clevudine in naive patients with chronic hepatitis B. | The Korean journal of internal medicine 20101201 |
| Avascular necrosis of the talus in a HIV-infected patient. | Foot & ankle international 20101201 |
| [What's new in dermatological treatments?]. | Annales de dermatologie et de venereologie 20101201 |
| Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. | PLoS medicine 20101201 |
| Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. | Viruses 20101201 |
| Need for improved access to HIV prevention programmes. | The Indian journal of medical research 20101201 |
| Microbicides & their implications in HIV prevention. | The Indian journal of medical research 20101201 |
| HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes. | The Indian journal of medical research 20101201 |
| Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai. | The Indian journal of medical research 20101201 |
| Cidofovir Activity against Poxvirus Infections. | Viruses 20101201 |
| High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. | AIDS (London, England) 20101127 |
| A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. | AIDS (London, England) 20101127 |
| Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients. | World journal of gastroenterology 20101121 |
| [Tenofovir associated hypokalaemia in a patient with normal renal function]. | Enfermedades infecciosas y microbiologia clinica 20101101 |
| [Fanconi syndrome associated with tenofovir treatment: a presentation of two cases]. | Enfermedades infecciosas y microbiologia clinica 20101101 |
| Lack of interaction between the HIV integrase inhibitor S/GSK1349572 and tenofovir in healthy subjects. | Journal of acquired immune deficiency syndromes (1999) 20101101 |
| Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV. | Journal of acquired immune deficiency syndromes (1999) 20101101 |
| Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. | Journal of acquired immune deficiency syndromes (1999) 20101101 |
| Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains. | Protein science : a publication of the Protein Society 20101101 |
| Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215). | AIDS research and human retroviruses 20101101 |
| Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients. | Clinical pharmacology and therapeutics 20101101 |
| Biomarkers of impaired renal function. | Current opinion in HIV and AIDS 20101101 |
| First real success for anti-HIV gel: a new start for HIV microbicides? | Future microbiology 20101101 |
| First-line raltegravir. No evidence of comparative effectiveness. | Prescrire international 20101101 |
| Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs. | Viruses 20101101 |
| Molecular Basis for Drug Resistance in HIV-1 Protease. | Viruses 20101101 |
| Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance. | AIDS (London, England) 20101023 |
| PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. | Lancet (London, England) 20101016 |
| Preventing HIV infection: turning the tide for young women. | Lancet (London, England) 20101016 |
| Fate of the antiretroviral drug tenofovir in agricultural soil. | The Science of the total environment 20101015 |
| Low bone mineral density with tenofovir: does statistically significant mean clinically significant? | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101015 |
| Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101015 |
| Antiretroviral therapies in women after single-dose nevirapine exposure. | The New England journal of medicine 20101014 |
| Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. | The Cochrane database of systematic reviews 20101006 |
| Adherence and its measurement in phase 2/3 microbicide trials. | AIDS and behavior 20101001 |
| Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. | Digestive diseases and sciences 20101001 |
| Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial. | AIDS and behavior 20101001 |
| Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. | Gastroenterology 20101001 |
| Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. | Gastroenterology 20101001 |
| Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R. | The Journal of infection 20101001 |
| Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring. | Journal of acquired immune deficiency syndromes (1999) 20101001 |
| The impact of gender and anchor drugs on TDF renal toxicity. | Journal of acquired immune deficiency syndromes (1999) 20101001 |
| Systemic preexposure prophylaxis for human immunodeficiency virus infection. | Pharmacotherapy 20101001 |
| Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects. | Journal of chromatographic science 20101001 |
| Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. | Expert review of anti-infective therapy 20101001 |
| Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant. | Transplantation proceedings 20101001 |
| Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight. | Current HIV research 20101001 |
| Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. | Journal of Crohn's & colitis 20101001 |
| Lower arterial stiffness and Framingham score after switching abacavir to tenofovir in men at high cardiovascular risk. | AIDS (London, England) 20100924 |
| Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation. | AIDS (London, England) 20100924 |
| Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. | AIDS (London, England) 20100910 |
| Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. | AIDS (London, England) 20100910 |
| Still a long wait for approved HIV-protective gel. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20100907 |
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. | Science (New York, N.Y.) 20100903 |
| Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. | Journal of acquired immune deficiency syndromes (1999) 20100901 |
| Interactions between antifungal and antiretroviral agents. | Expert opinion on drug safety 20100901 |
| Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline. | HIV medicine 20100901 |
| Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100901 |
| Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. | Journal of acquired immune deficiency syndromes (1999) 20100901 |
| Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study. | Journal of acquired immune deficiency syndromes (1999) 20100901 |
| Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. | The Journal of antimicrobial chemotherapy 20100901 |
| Identification of adenovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia. | Yonsei medical journal 20100901 |
| High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B. | Journal of medical virology 20100901 |
| Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. | The Journal of asthma : official journal of the Association for the Care of Asthma 20100901 |
| Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100901 |
| KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy. | Emerging infectious diseases 20100901 |
| [Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor]. | Medecine et maladies infectieuses 20100901 |
| Trial results finally show potential for microbicidal HIV gel. | The Lancet. Infectious diseases 20100901 |
| Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. | PLoS pathogens 20100901 |
| Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil. | Memorias do Instituto Oswaldo Cruz 20100901 |
| Prevention. Study reveals that vaginal gel reduces HIV, herpes. | AIDS policy & law 20100901 |
| [Analogs combination therapy in chronic hepatitis B: when and how?]. | Gastroenterologie clinique et biologique 20100901 |
| [Long-term therapy for chronic hepatitis B in HIV co-infected patients]. | Gastroenterologie clinique et biologique 20100901 |
| [Treatment has a positive impact on the long-term evolution of chronic hepatitis B]. | Gastroenterologie clinique et biologique 20100901 |
| After CAPRISA 004: time to re-evaluate the HIV lexicon. | Lancet (London, England) 20100814 |
| Methadone, buprenorphine, and street drug interactions with antiretroviral medications. | Current HIV/AIDS reports 20100801 |
| How ethical is your clinical trial? | International journal of clinical practice 20100801 |
| Drug therapy: tenofovir. | Hepatology (Baltimore, Md.) 20100801 |
| Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. | Journal of immunology (Baltimore, Md. : 1950) 20100801 |
| Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. | Journal of acquired immune deficiency syndromes (1999) 20100801 |
| Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. | AIDS research and human retroviruses 20100801 |
| Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the randomized trial M05-730. | AIDS research and human retroviruses 20100801 |
| The curative efficiency of tenofovir for patients with chronic hepatitis B after failure of nucleoside/nucleotide analogues. | Hepatology (Baltimore, Md.) 20100801 |
| HIV-1 Populations in Semen Arise through Multiple Mechanisms. | PLoS pathogens 20100801 |
| [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20100801 |
| Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report. | Viruses 20100801 |
| Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. | Toxins 20100801 |
| Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. | AIDS (London, England) 20100731 |
| Antiretroviral vaginal gel shows promise against HIV. | Lancet (London, England) 20100731 |
| HIV/AIDS. At last, vaginal gel scores victory against HIV. | Science (New York, N.Y.) 20100723 |
| [Treatment of chronic hepatitis B. High response rate in general practice]. | MMW Fortschritte der Medizin 20100722 |
| A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206. | AIDS (London, England) 20100717 |
| Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. | AIDS (London, England) 20100717 |
| Yet another ten stories on antiviral drug discovery (part D): paradigms, paradoxes, and paraductions. | Medicinal research reviews 20100701 |
| Renal toxicity associated with tenofovir use. | Expert opinion on drug safety 20100701 |
| Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. | Antimicrobial agents and chemotherapy 20100701 |
| Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20100701 |
| Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data. | The Journal of antimicrobial chemotherapy 20100701 |
| Microbicide research: current and future directions. | Current opinion in HIV and AIDS 20100701 |
| Resistance management in chronic hepatitis B complicated by renal failure. | Clinical nephrology 20100701 |
| Influenza A pandemic (H1N1) 2009 virus and HIV. | Emerging infectious diseases 20100701 |
| Misindentification of Mycobacterium kumamotonense as M. tuberculosis. | Emerging infectious diseases 20100701 |
| Analysis of resistance testing in South Trinidad. | The West Indian medical journal 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| Advantages of low-cost generic tenofovir instead of D4T for first-line antiretroviral therapy in Burma: a 2-year experience. | AIDS (London, England) 20100619 |
| Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. | Journal of the National Cancer Institute 20100602 |
| Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. | Archives of sexual behavior 20100601 |
| Connection domain mutations in treatment-experienced patients in the OPTIMA trial. | Journal of acquired immune deficiency syndromes (1999) 20100601 |
| Near-infrared investigations of novel anti-HIV tenofovir liposomes. | The AAPS journal 20100601 |
| Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro. | Antiviral research 20100601 |
| Development of a validated liquid chromatographic method for the determination of related substances and assay of tenofovir disoproxil fumarate. | Journal of separation science 20100601 |
| Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study. | AIDS care 20100601 |
| [HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism]. | Deutsche medizinische Wochenschrift (1946) 20100601 |
| Prevalence and factors associated with renal dysfunction among HIV-infected patients. | AIDS patient care and STDs 20100601 |
| Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B. | Expert review of anti-infective therapy 20100601 |
| The exploitation of 'Exploitation' in the tenofovir prep trial in Cameroon: Lessons learned from media coverage of an HIV prevention trial. | Journal of empirical research on human research ethics : JERHRE 20100601 |
| Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. | Tropical medicine & international health : TM & IH 20100601 |
| Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. | Tropical medicine & international health : TM & IH 20100601 |
| AZT or tenofovir for patients with the K65R mutation? | Journal watch. AIDS clinical care 20100601 |
| Therapy with nucleos(t)ide analogues: current role in dialysis patients. | The International journal of artificial organs 20100601 |
| Zidovudine-induced reversible pure red cell aplasia. | Indian journal of pharmacology 20100601 |
| Antiviral treatment of chronic hepatitis B virus (HBV) infections. | Viruses 20100601 |
| Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. | World journal of gastroenterology 20100528 |
| High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. | AIDS (London, England) 20100515 |
| Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148. | Bioorganic & medicinal chemistry 20100515 |
| Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. | HIV medicine 20100501 |
| Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. | Journal of acquired immune deficiency syndromes (1999) 20100501 |
| Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon. | Liver international : official journal of the International Association for the Study of the Liver 20100501 |
| [Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab]. | Gastroenterologia y hepatologia 20100501 |
| Treatment outcomes of clevudine versus lamivudine at week 48 in naïve patients with HBeAg positive chronic hepatitis B. | Journal of Korean medical science 20100501 |
| Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients. | AIDS research and human retroviruses 20100501 |
| Recent FDA approvals and changes. | AIDS patient care and STDs 20100501 |
| Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection. | Health technology assessment (Winchester, England) 20100501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100501 |
| Economic evaluation of ART in resource-limited countries. | Current opinion in HIV and AIDS 20100501 |
| On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective. | Journal of gastroenterology and hepatology 20100501 |
| [Protease inhibitor or non-nucleoside reverse transcriptase inhibitor. ACTG study 5202 in focus]. | MMW Fortschritte der Medizin 20100429 |
| Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine. | AIDS (London, England) 20100424 |
| Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. | AIDS (London, England) 20100424 |
| Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence? | AIDS (London, England) 20100424 |
| Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100415 |
| [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation]. | Medicina clinica 20100410 |
| Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. | Lancet (London, England) 20100410 |
| Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion. | Liver international : official journal of the International Association for the Study of the Liver 20100401 |
| Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100401 |
| Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy. | AIDS patient care and STDs 20100401 |
| Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients. | AIDS research and human retroviruses 20100401 |
| Tenofovir/emtricitabine combination results in lower bone-mineral density. | AIDS patient care and STDs 20100401 |
| Report from the 17th Conference on Retroviruses and Opportunistic Infections. Randomized studies of once-daily darunavir and tenofovir/FTC + nevirapine. | Journal watch. AIDS clinical care 20100401 |
| Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B. | World journal of hepatology 20100327 |
| Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss. | Biochemical and biophysical research communications 20100326 |
| Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. | AIDS (London, England) 20100313 |
| Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients. | AIDS (London, England) 20100313 |
| A controlled trial of initial antiviral regimens for HIV-1 infection. | The New England journal of medicine 20100304 |
| Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers. | HIV medicine 20100301 |
| Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. | Journal of virology 20100301 |
| Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. | Journal of acquired immune deficiency syndromes (1999) 20100301 |
| Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients. | The Journal of antimicrobial chemotherapy 20100301 |
| New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients. | The Journal of antimicrobial chemotherapy 20100301 |
| Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100301 |
| The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity. | Kidney international 20100301 |
| Elvucitabine data released at CROI. | AIDS patient care and STDs 20100301 |
| Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. | Hepatology international 20100301 |
| The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond. | PLoS neglected tropical diseases 20100301 |
| Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis. | Expert review of clinical immunology 20100301 |
| More research needed to find new HIV-suppressive functions of cytotoxic T cells. | Immunotherapy 20100301 |
| [Economic evaluation of antiviral treatment for chronic hepatitis B: a systematic review]. | Revista peruana de medicina experimental y salud publica 20100301 |
| Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B. | Therapeutic advances in gastroenterology 20100301 |
| Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. | AIDS (London, England) 20100220 |
| Tenofovir and changes in renal function. | AIDS (London, England) 20100220 |
| Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100219 |
| HIV infection of the male genital tract--consequences for sexual transmission and reproduction. | International journal of andrology 20100201 |
| Microbicides for HIV prevention: reality or hope? | Current opinion in infectious diseases 20100201 |
| Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. | The Journal of antimicrobial chemotherapy 20100201 |
| Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. | The Journal of infectious diseases 20100201 |
| Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100201 |
| Antiretroviral prescribing patterns in treatment-naïve patients in the United States. | AIDS patient care and STDs 20100201 |
| Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker. | International journal of STD & AIDS 20100201 |
| Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate. | International journal of STD & AIDS 20100201 |
| Clinical management of hepatitis B virus infection correlated with liver transplantation. | Hepatobiliary & pancreatic diseases international : HBPD INT 20100201 |
| Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. | AIDS patient care and STDs 20100201 |
| Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study. | PLoS medicine 20100201 |
| Viral resistance in hepatitis B: prevalence and management. | Current gastroenterology reports 20100201 |
| HIV Genetic Diversity and Drug Resistance. | Viruses 20100201 |
| Prevalence and Immunization Status of Hepatitis B Virus in the HIV Cohort in Fife, Scotland. | Journal of clinical medicine research 20100201 |
| Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. | AIDS (London, England) 20100128 |
| Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs. | AIDS (London, England) 20100116 |
| N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations. | AIDS (London, England) 20100116 |
| Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts. | Biochemical and biophysical research communications 20100115 |
| Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. | Science translational medicine 20100113 |
| Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. | Archives of internal medicine 20100111 |
| DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions. | Archives of internal medicine 20100111 |
| Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. | Lancet (London, England) 20100109 |
| [Protocol for the antiviral therapy of hepatitis B and D]. | Orvosi hetilap 20100103 |
| Evaluation of antiretrovirals in animal models of HIV infection. | Antiviral research 20100101 |
| High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. | HIV medicine 20100101 |
| Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study. | HIV medicine 20100101 |
| Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. | Journal of acquired immune deficiency syndromes (1999) 20100101 |
| Viral hepatitis and HIV co-infection. | Antiviral research 20100101 |
| Factors influencing lopinavir and atazanavir plasma concentration. | The Journal of antimicrobial chemotherapy 20100101 |
| Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100101 |
| Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. | Hepatology (Baltimore, Md.) 20100101 |
| Antiretroviral medications: adverse effects on the kidney. | Advances in chronic kidney disease 20100101 |
| The cost and incidence of prescribing errors among privately insured HIV patients. | PharmacoEconomics 20100101 |
| Acute urinary retention due to viral coinfections (HIV, HBV, VZV). | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101 |
| Integrase inhibitors: a novel class of antiretroviral agents. | The Annals of pharmacotherapy 20100101 |
| Improving first-line antiretroviral therapy in resource-limited settings. | Current opinion in HIV and AIDS 20100101 |
| Modelling imperfect adherence to HIV induction therapy. | BMC infectious diseases 20100101 |
| Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient. | BMC gastroenterology 20100101 |
| The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults. | PloS one 20100101 |
| Predicting Bevirimat resistance of HIV-1 from genotype. | BMC bioinformatics 20100101 |
| Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV. | AIDS patient care and STDs 20100101 |
| Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. | PloS one 20100101 |
| Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. | PloS one 20100101 |
| CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. | PLoS pathogens 20100101 |
| Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir. | The American journal on addictions 20100101 |
| FDA notifications. Combination lamivudine and tenofovir tablet approved. | AIDS alert 20100101 |
| Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? | The open AIDS journal 20100101 |
| Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India. | The open AIDS journal 20100101 |
| HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008. | European journal of medical research 20100101 |
| Effect of newer oral antiviral agents on future therapy of chronic hepatitis B. | Antiviral therapy 20100101 |
| Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. | Antiviral therapy 20100101 |
| Tenofovir-associated bone density loss. | Therapeutics and clinical risk management 20100101 |
| Profile of etravirine for the treatment of HIV infection. | Therapeutics and clinical risk management 20100101 |
| Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir. | PloS one 20100101 |
| Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006. | Clinical therapeutics 20100101 |
| The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. | PloS one 20100101 |
| In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. | PloS one 20100101 |
| Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. | PloS one 20100101 |
| Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. | BMC public health 20100101 |
| Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics. | The open AIDS journal 20100101 |
| Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose. | Drug metabolism letters 20100101 |
| Development of an LC-MS method for measuring TNF in human vaginal tissue. | Journal of chromatographic science 20100101 |
| Technology Development Through Pooling ARV Drug Patents: A Vision from China. | The open AIDS journal 20100101 |
| Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. | Virology journal 20100101 |
| Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. | Retrovirology 20100101 |
| Abacavir/lamivudine combination in the treatment of HIV: a review. | Therapeutics and clinical risk management 20100101 |
| A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. | PloS one 20100101 |
| High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. | Journal of the International AIDS Society 20100101 |
| The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good. | The open AIDS journal 20100101 |
| Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors. | BMC infectious diseases 20100101 |
| When to start antiretroviral therapy in resource-limited settings: a human rights analysis. | BMC international health and human rights 20100101 |
| Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. | PloS one 20100101 |
| Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy. | Antiviral therapy 20100101 |
| Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. | Antiviral therapy 20100101 |
| The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients. | Antiviral therapy 20100101 |
| The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteers. | Antiviral therapy 20100101 |
| Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection. | Journal of the International AIDS Society 20100101 |
| HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the 'test-and-treat' approach to reduce HIV transmission. | PloS one 20100101 |
| [Use of a fixed-dose combination of Efavirenz-Emtricitabine-Tenofovir in a tertiary hospital]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101 |
| Increasing rates of obesity among HIV-infected persons during the HIV epidemic. | PloS one 20100101 |
| 'I will not let my HIV status stand in the way.' Decisions on motherhood among women on ART in a slum in Kenya- a qualitative study. | BMC women's health 20100101 |
| A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. | PloS one 20100101 |
| A modified method for determination of lumefantrine in human plasma by HPLC-UV and combination of protein precipitation and solid-phase extraction: application to a pharmacokinetic study. | Analytical chemistry insights 20100101 |
| Analogs and fibrosis regression in hepatitis B. | Gastroenterologie clinique et biologique 20100101 |
| Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity. | European journal of medical research 20100101 |
| The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. | European journal of medical research 20100101 |
| Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication. | Retrovirology 20100101 |
| Optimal management of cytomegalovirus retinitis in patients with AIDS. | Clinical ophthalmology (Auckland, N.Z.) 20100101 |
| Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula. | Journal of the International AIDS Society 20100101 |
| Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination. | PloS one 20100101 |
| Semen may harbor HIV despite effective HAART: another piece in the puzzle. | PloS one 20100101 |
| Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. | PloS one 20100101 |
| Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. | Globalization and health 20100101 |
| Recent key advances in human immunodeficiency virus medicine and implications for China. | AIDS research and therapy 20100101 |
| Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study. | PloS one 20100101 |
| Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors. | Antiviral therapy 20100101 |
| Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir. | Antiviral therapy 20100101 |
| Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy. | Antiviral therapy 20100101 |
| One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. | Patient preference and adherence 20100101 |
| Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. | PloS one 20100101 |
| Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study. | PloS one 20100101 |
| Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. | PloS one 20100101 |
| Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine. | HIV clinical trials 20100101 |
| Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia. | PloS one 20100101 |
| Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications? | European journal of medical research 20100101 |
| Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings. | AIDS research and therapy 20100101 |
| The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. | BMC infectious diseases 20100101 |
| Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV. | PharmacoEconomics 20100101 |
| A review of oral antiretroviral therapy for the treatment of chronic hepatitis B. | The Annals of pharmacotherapy 20100101 |
| Making it happen, level 2. | Global health action 20100101 |
| Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry. | PloS one 20100101 |
| Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. | PloS one 20100101 |
| One step forward, one step sideways? Expanding research capacity for neglected diseases. | BMC international health and human rights 20100101 |
| Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time. | PloS one 20100101 |
| Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case. | Virology journal 20100101 |
| A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. | PloS one 20100101 |
| Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. | Journal of translational medicine 20100101 |
| [Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101 |
| Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS. | PloS one 20100101 |
| Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information. | Yale journal of health policy, law, and ethics 20100101 |
| Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children. | Journal of the International AIDS Society 20100101 |
| Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands. | PloS one 20100101 |
| Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults. | Antiviral therapy 20100101 |
| Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report. | Journal of medical case reports 20100101 |
| In vivo binding and retention of CD4-specific DARPin 57.2 in macaques. | PloS one 20100101 |
| Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. | Retrovirology 20100101 |
| Structure activity relationship of dendrimer microbicides with dual action antiviral activity. | PloS one 20100101 |
| Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review. | Virology journal 20100101 |
| Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand. | Antiviral therapy 20100101 |
| Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen. | Antiviral therapy 20100101 |
| A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. | Journal of the International AIDS Society 20100101 |
| 'Rumours' and clinical trials: a retrospective examination of a paediatric malnutrition study in Zambia, southern Africa. | BMC public health 20100101 |
| Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. | PloS one 20100101 |
| Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. | Clinical epidemiology 20100101 |
| Tenofovir-associated severe bone pain: I cannot walk! | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101 |
| Aging, human immunodeficiency virus, and bone health. | Clinical interventions in aging 20100101 |
| Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C. | Retrovirology 20100101 |
| Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens. | AIDS research and therapy 20100101 |
| Subtype-associated differences in HIV-1 reverse transcription affect the viral replication. | Retrovirology 20100101 |
| Prevention of post-operative infections after surgical treatment of bite wounds. | GMS Krankenhaushygiene interdisziplinar 20100101 |
| Recent advances in managing hepatitis B. | F1000 medicine reports 20100101 |
| Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. | PloS one 20100101 |
| A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences. | AIDS research and therapy 20100101 |
| The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. | BMC pediatrics 20100101 |
| Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients. | European journal of medical research 20100101 |
| The origins of a research community in the Majengo Observational Cohort Study, Nairobi, Kenya. | BMC public health 20100101 |
| Routine HIV screening in France: clinical impact and cost-effectiveness. | PloS one 20100101 |
| A personalized approach to optimize hepatitis B treatment in treatment-naive patients. | Antiviral therapy 20100101 |
| Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. | Antiviral therapy 20100101 |
| Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire. | Antiviral therapy 20100101 |
| Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths. | Antiviral therapy 20100101 |
| Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. | Journal of the International AIDS Society 20100101 |
| Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. | PloS one 20100101 |
| Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models. | PloS one 20100101 |
| Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. | PloS one 20100101 |
| Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome. | PloS one 20100101 |
| Seroconversion of acute hepatitis B by antiretroviral therapy in an HIV-1 infected patient. | Acta gastro-enterologica Belgica 20100101 |
| Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. | BMC infectious diseases 20100101 |
| The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study. | BMJ (Clinical research ed.) 20100101 |
| Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. | AIDS research and therapy 20100101 |
| Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. | Trials 20100101 |
| Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability. | PloS one 20100101 |
| Comparison of antiviral activity of regimens containing nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue therapy (The NUCREST Study). | HIV clinical trials 20100101 |
| Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men. | Antiviral therapy 20100101 |
| In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients. | Antiviral therapy 20100101 |
| Trials planned to confirm efficacy of tenofovir microbicide gel. | IAVI report : newsletter on international AIDS vaccine research 20100101 |
| Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors. | PloS one 20100101 |
| Rituximab administration and reactivation of HBV. | Hepatitis research and treatment 20100101 |
| Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck. | Hepatitis research and treatment 20100101 |
| Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors. | PloS one 20100101 |
| Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. | PloS one 20100101 |
| Pseudogout Associated Hip Pain in a Patient with HIV Infection. | Case reports in medicine 20100101 |
| Simultaneous spectrophotometric estimation of tenofovir disoproxil fumarate and Lamivudine in three component tablet formulation containing efavirenz. | Indian journal of pharmaceutical sciences 20100101 |
| Computational Analysis of Molecular Interaction Networks Underlying Change of HIV-1 Resistance to Selected Reverse Transcriptase Inhibitors. | Bioinformatics and biology insights 20100101 |
| Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data. | The open AIDS journal 20100101 |
| Let the sun shine in. | Positively aware : the monthly journal of the Test Positive Aware Network 20100101 |
| Vaccine briefs. | IAVI report : newsletter on international AIDS vaccine research 20100101 |
| The North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action. | North Carolina medical journal 20100101 |
| Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems. | Cholesterol 20100101 |
| Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection. | Infection and drug resistance 20100101 |
| Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy. | Infection and drug resistance 20100101 |
| Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy. | Indian journal of sexually transmitted diseases and AIDS 20100101 |
| Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India. | Indian journal of sexually transmitted diseases and AIDS 20100101 |
| An update on the use of Atripla in the treatment of HIV in the United States. | HIV/AIDS (Auckland, N.Z.) 20100101 |
| Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1. | HIV/AIDS (Auckland, N.Z.) 20100101 |
| Long-term treatment of patients with HIV-1: the role of atazanavir. | HIV/AIDS (Auckland, N.Z.) 20100101 |
| New and emerging agents in the management of lipodystrophy in HIV-infected patients. | HIV/AIDS (Auckland, N.Z.) 20100101 |
| Molecular diagnosis of entecavir resistance. | Hepatitis monthly 20100101 |
| Entecavir therapy in Turkish adult patients with chronic hepatitis B: one-year results from Izmir province, Turkey. | Hepatitis monthly 20100101 |
| Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient. | Hepatitis monthly 20100101 |
| Hepatitis B Infection during Renal Replacement Therapy. | Hepatitis monthly 20100101 |
| The effectiveness of nucleoside analogues in chronic hepatitis B patients unresponsive to interferon therapy: our clinical trials for one year. | Hepatitis monthly 20100101 |
| Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. | Lancet (London, England) 20091219 |
| Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. | The Journal of biological chemistry 20091218 |
| Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. | The Journal of biological chemistry 20091211 |
| Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. | The New England journal of medicine 20091203 |
| Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients. | The Journal of antimicrobial chemotherapy 20091201 |
| Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20091201 |
| HTS and hit finding in academia--from chemical genomics to drug discovery. | Drug discovery today 20091201 |
| Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. | The Journal of infectious diseases 20091201 |
| Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure. | The Pediatric infectious disease journal 20091201 |
| A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate. | Expert opinion on pharmacotherapy 20091201 |
| Antiretroviral genotypic resistance mutations in HIV-1 infected Korean patients with virologic failure. | Journal of Korean medical science 20091201 |
| [Pre-exposure prophylaxis in HIV--a vision or soon a reality?]. | Deutsche medizinische Wochenschrift (1946) 20091201 |
| Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20091201 |
| [Chronic hepatitis B therapy]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| [Management of side effects during antiviral therapy]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201 |
| India refuses patent protection for two key HIV drugs. | HIV/AIDS policy & law review 20091201 |
| HBV and HCV therapy. | Viruses 20091201 |
| Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. | Viruses 20091201 |
| Affinities between the binding partners of the HIV-1 integrase dimer-lens epithelium-derived growth factor (IN dimer-LEDGF) complex. | The Journal of biological chemistry 20091127 |
| Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091115 |
| The art of managing human immunodeficiency virus infection: a balancing act. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091115 |
| Tenofovir disoproxil fumarate: in chronic hepatitis B. | Drugs 20091112 |
| Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20091101 |
| Efavirenz: a decade of clinical experience in the treatment of HIV. | The Journal of antimicrobial chemotherapy 20091101 |
| On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101 |
| Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. | Current HIV/AIDS reports 20091101 |
| Monotherapy versus combination therapy for the treatment of chronic hepatitis B. | Expert opinion on investigational drugs 20091101 |
| Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting. | Journal of acquired immune deficiency syndromes (1999) 20091101 |
| Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention. | AIDS research and human retroviruses 20091101 |
| FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir. | AIDS alert 20091101 |
| Combination treatment in HBeAg-negative chronic hepatitis B. | World journal of hepatology 20091031 |
| [Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. | Medizinische Klinik (Munich, Germany : 1983) 20091015 |
| Atazanavir-related renal insufficiency without concurrent tenofovir. | Enfermedades infecciosas y microbiologia clinica 20091001 |
| Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B. | Journal of hepatology 20091001 |
| Current management of hepatitis B virus infection before and after liver transplantation. | Liver international : official journal of the International Association for the Study of the Liver 20091001 |
| Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. | Journal of acquired immune deficiency syndromes (1999) 20091001 |
| Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934. | Journal of acquired immune deficiency syndromes (1999) 20091001 |
| Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. | Infection 20091001 |
| Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. | Infection 20091001 |
| A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. | Journal of medical virology 20091001 |
| Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone. | Clinical and experimental immunology 20091001 |
| The nephrotoxic effects of HAART. | Nature reviews. Nephrology 20091001 |
| Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients. | HIV medicine 20091001 |
| Tenofovir for the treatment of hepatitis B virus. | Pharmacotherapy 20091001 |
| Pharmacogenetics of tenofovir treatment. | Pharmacogenomics 20091001 |
| Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. | PLoS medicine 20091001 |
| Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance. | PLoS medicine 20091001 |
| [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091001 |
| FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval. | AIDS alert 20091001 |
| Renal function with use of a tenofovir-containing initial antiretroviral regimen. | AIDS (London, England) 20090924 |
| Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. | Lancet (London, England) 20090905 |
| Hepatitis B virus infected health care workers in The Netherlands, 2000-2008. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090901 |
| Tenofovir-associated renal and bone toxicity. | HIV medicine 20090901 |
| Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel. | Journal of medical virology 20090901 |
| Virological response to initial antiretroviral regimens containing abacavir or tenofovir. | The Journal of infectious diseases 20090901 |
| The history of antiretrovirals: key discoveries over the past 25 years. | Reviews in medical virology 20090901 |
| Chronic hepatitis B: update 2009. | Hepatology (Baltimore, Md.) 20090901 |
| The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. | Expert review of anti-infective therapy 20090901 |
| [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B]. | Revue de l'infirmiere 20090901 |
| [Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090901 |
| Tenofovir disoproxil fumarate for the treatment of hepatitis B infection. | Drugs of today (Barcelona, Spain : 1998) 20090901 |
| Microbicide research already benefiting thousands--experts. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20090901 |
| Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. | AIDS (London, England) 20090824 |
| A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals. | Journal of acquired immune deficiency syndromes (1999) 20090815 |
| Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. | The Journal of infectious diseases 20090815 |
| Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? | HIV medicine 20090801 |
| Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study. | AIDS patient care and STDs 20090801 |
| The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. | Journal of chemotherapy (Florence, Italy) 20090801 |
| Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. | Pharmacotherapy 20090801 |
| Raltegravir as effective as efavirenz in 144-week data. | AIDS patient care and STDs 20090801 |
| HIV therapy may be given safely in resource-limited settings without routine laboratory monitoring. | AIDS patient care and STDs 20090801 |
| Nucleoside diphosphate kinase and the activation of antiviral phosphonate analogs of nucleotides: binding mode and phosphorylation of tenofovir derivatives. | Nucleosides, nucleotides & nucleic acids 20090801 |
| Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. | AIDS (London, England) 20090731 |
| HIV clinics are halting enrolment of new patients as funding stalls, MSF warns. | BMJ (Clinical research ed.) 20090720 |
| Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. | Archives of internal medicine 20090713 |
| Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility. | Chinese medical journal 20090705 |
| The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir. | Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20090701 |
| Spectrum of chronic kidney disease in HIV-infected patients. | HIV medicine 20090701 |
| A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. | Journal of acquired immune deficiency syndromes (1999) 20090701 |
| A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients. | The Journal of antimicrobial chemotherapy 20090701 |
| Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir. | Journal of viral hepatitis 20090701 |
| Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors. | HIV medicine 20090701 |
| Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. | HIV medicine 20090701 |
| The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090701 |
| Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes. | AIDS patient care and STDs 20090701 |
| Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors. | The Pediatric infectious disease journal 20090701 |
| Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263). | AIDS research and human retroviruses 20090701 |
| Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. | PLoS medicine 20090701 |
| Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats. | Journal of acquired immune deficiency syndromes (1999) 20090701 |
| Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study. | Indian journal of nephrology 20090701 |
| Renal transplantation in a HIV positive patient. | Indian journal of nephrology 20090701 |
| Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20090601 |
| Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. | Antimicrobial agents and chemotherapy 20090601 |
| Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. | The Journal of antimicrobial chemotherapy 20090601 |
| Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. | The Journal of antimicrobial chemotherapy 20090601 |
| Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20090601 |
| Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues. | Current opinion in organ transplantation 20090601 |
| Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090601 |
| [Renal tuberculosis and human immunodeficiency virus infection]. | Enfermedades infecciosas y microbiologia clinica 20090601 |
| HIV infection and the central nervous system: a primer. | Neuropsychology review 20090601 |
| Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. | AIDS (London, England) 20090601 |
| The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. | AIDS (London, England) 20090601 |
| Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. | The Journal of infectious diseases 20090601 |
| Synthesis and antiviral activity evaluation of acyclic 2'-azanucleosides bearing a phosphonomethoxy function in the side chain. | Bioorganic & medicinal chemistry 20090601 |
| Safety evaluation of 1% tenofovir gel in healthy men. | International journal of STD & AIDS 20090601 |
| Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world. | International journal of STD & AIDS 20090601 |
| Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary? | International journal of STD & AIDS 20090601 |
| Chiral analysis of anti-acquired immunodeficiency syndrome drug, 9-(R)-[2-(phosphonomethoxy)propyl]adenine (tenofovir), and related antiviral acyclic nucleoside phosphonates by CE using beta-CD as chiral selector. | Electrophoresis 20090601 |
| FDA notifications. Tenofovir in India receives tentative approval. | AIDS alert 20090601 |
| Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090601 |
| Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible. | Prescrire international 20090601 |
| Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity. | Prescrire international 20090601 |
| Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. | World journal of gastroenterology 20090528 |
| [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines]. | MMW Fortschritte der Medizin 20090528 |
| Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead. | AIDS (London, England) 20090515 |
| Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. | The Journal of antimicrobial chemotherapy 20090501 |
| The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. | Antiviral research 20090501 |
| Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort. | HIV medicine 20090501 |
| [New molecules in the treatment of chronic hepatitis B]. | Presse medicale (Paris, France : 1983) 20090501 |
| Tenofovir renal toxicity targets mitochondria of renal proximal tubules. | Laboratory investigation; a journal of technical methods and pathology 20090501 |
| Update on viral hepatitis: 2008. | Current opinion in gastroenterology 20090501 |
| Antiviral resistance and hepatitis B therapy. | Hepatology (Baltimore, Md.) 20090501 |
| Benefits and risks of combination therapy for hepatitis B. | Hepatology (Baltimore, Md.) 20090501 |
| Side effects of long-term oral antiviral therapy for hepatitis B. | Hepatology (Baltimore, Md.) 20090501 |
| Generic Truvada approved. | AIDS patient care and STDs 20090501 |
| Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy. | Liver international : official journal of the International Association for the Study of the Liver 20090501 |
| Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. | Antiviral research 20090501 |
| Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin. | Current drug safety 20090501 |
| Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only? | Current HIV research 20090501 |
| Hepatitis B treatment: Current best practices, avoiding resistance. | Cleveland Clinic journal of medicine 20090501 |
| Management of hepatitis B in pregnancy: weighing the options. | Cleveland Clinic journal of medicine 20090501 |
| Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction. | Clinical nephrology 20090501 |
| Clevudine for hepatitis B. | Drugs of today (Barcelona, Spain : 1998) 20090501 |
| Rationing antiretroviral therapy in Africa--treating too few, too late. | The New England journal of medicine 20090430 |
| [Current data on antiretroviral therapy. CROI 2009: tenofovir DR convinces by high effectiveness and tolerance]. | MMW Fortschritte der Medizin 20090430 |
| Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. | AIDS (London, England) 20090427 |
| A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks. | Journal of acquired immune deficiency syndromes (1999) 20090415 |
| Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. | Journal of acquired immune deficiency syndromes (1999) 20090415 |
| Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090401 |
| Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry. | Biomedical chromatography : BMC 20090401 |
| Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. | International journal of antimicrobial agents 20090401 |
| Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy. | Hepatology (Baltimore, Md.) 20090401 |
| Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. | HIV medicine 20090401 |
| Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice. | Journal of hepatology 20090401 |
| Raltegravir: the first HIV type 1 integrase inhibitor. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090401 |
| The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. | Hepatology (Baltimore, Md.) 20090401 |
| Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease. | Infectious disorders drug targets 20090401 |
| Decision analysis model for hepatitis B prophylaxis one year after liver transplantation. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090401 |
| Chronic hepatitis B: who to treat and which choice of treatment? | Expert review of anti-infective therapy 20090401 |
| FDA approves three generics. | AIDS patient care and STDs 20090401 |
| Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. | AIDS research and human retroviruses 20090401 |
| Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques. | Virology 20090330 |
| Gilead is going strong. | Fortune 20090330 |
| Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. | AIDS (London, England) 20090327 |
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090315 |
| Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers. | HIV medicine 20090301 |
| Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland. | The Pediatric infectious disease journal 20090301 |
| Diagnosis and treatment of chronic hepatitis B: 2009 update. | Minerva gastroenterologica e dietologica 20090301 |
| Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090301 |
| Highly active antiretroviral therapy-associated ptosis in patients with human immunodeficiency virus. | Archives of ophthalmology (Chicago, Ill. : 1960) 20090301 |
| Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab. | Iranian journal of immunology : IJI 20090301 |
| Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases. | The AIDS reader 20090301 |
| Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice. | The AIDS reader 20090301 |
| Hepatitis B in HIV patients: what is the current treatment and what are the challenges? | Journal of HIV therapy 20090301 |
| Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. | Bioorganic & medicinal chemistry 20090215 |
| Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. | World journal of gastroenterology 20090214 |
| Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). | Clinical pharmacology and therapeutics 20090201 |
| Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir. | Antiviral research 20090201 |
| High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. | The Journal of antimicrobial chemotherapy 20090201 |
| Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. | The Journal of antimicrobial chemotherapy 20090201 |
| Recent developments in HIV and the kidney. | Current opinion in infectious diseases 20090201 |
| In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication. | Journal of medical virology 20090201 |
| Pharmacologic aspects of new antiretroviral drugs. | Current HIV/AIDS reports 20090201 |
| Hepatitis B virus viral load and treatment decision. | Hepatology (Baltimore, Md.) 20090201 |
| [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients]. | Deutsche medizinische Wochenschrift (1946) 20090201 |
| A preemptive strike against HIV. | Nature medicine 20090201 |
| Antiviral therapy for hepatitis B virus associated hepatic failure. | Hepatobiliary & pancreatic diseases international : HBPD INT 20090201 |
| Hepatitis B therapy in children. | Expert review of gastroenterology & hepatology 20090201 |
| Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study. | Journal of chromatographic science 20090201 |
| Telbivudine in the treatment of chronic hepatitis B. | Advances in therapy 20090201 |
| [Atazanavir-induced nephrolithiasis]. | Enfermedades infecciosas y microbiologia clinica 20090201 |
| Efficacy and tolerability of initial antiretroviral therapy: a systematic review. | AIDS (London, England) 20090128 |
| HIV-1 infection of human penile explant tissue and protection by candidate microbicides. | AIDS (London, England) 20090128 |
| Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. | The Cochrane database of systematic reviews 20090121 |
| Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090115 |
| Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients. | AIDS (London, England) 20090114 |
| Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient. | AIDS (London, England) 20090114 |
| Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients. | AIDS (London, England) 20090102 |
| Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects. | Biostatistics (Oxford, England) 20090101 |
| Hepatitis B and liver transplantation: 2008 update. | Reviews in medical virology 20090101 |
| Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. | Antimicrobial agents and chemotherapy 20090101 |
| Sensitivity of phenotypic susceptibility analyses for nonthymidine nucleoside analogues conferred by K65R or M184V in mixtures with wild-type HIV-1. | The Journal of infectious diseases 20090101 |
| Complex dynamics of hepatitis B virus resistance to adefovir. | Hepatology (Baltimore, Md.) 20090101 |
| The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients. | PPAR research 20090101 |
| An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors. | PLoS computational biology 20090101 |
| Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets. | Pakistan journal of pharmaceutical sciences 20090101 |
| Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males. | AIDS patient care and STDs 20090101 |
| Survey of physician knowledge regarding antiretroviral medications in hospitalized HIV-infected patients. | Journal of the International AIDS Society 20090101 |
| Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives? | AIDS research and therapy 20090101 |
| Treatment of HBeAg-positive patients with nucleos/tide analogues. | Liver international : official journal of the International Association for the Study of the Liver 20090101 |
| HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon. | Liver international : official journal of the International Association for the Study of the Liver 20090101 |
| HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues. | Liver international : official journal of the International Association for the Study of the Liver 20090101 |
| Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance. | Retrovirology 20090101 |
| How to compare antivirals in the treatment of chronic hepatitis B? | Annals of clinical microbiology and antimicrobials 20090101 |
| Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. | Journal of the International AIDS Society 20090101 |
| Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. | PloS one 20090101 |
| Darunavir: a review of its use in the management of HIV infection in adults. | Drugs 20090101 |
| Is PPARγ a prospective player in HIV-1-associated bone disease? | PPAR research 20090101 |
| Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues. | Antiviral chemistry & chemotherapy 20090101 |
| Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection. | European journal of medical research 20090101 |
| Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture. | AIDS research and therapy 20090101 |
| Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients. | Antiviral therapy 20090101 |
| Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure. | Antiviral therapy 20090101 |
| Life-threatening hemorrhage following subcutaneous heparin therapy. | Therapeutics and clinical risk management 20090101 |
| Tenofovir and its potential in the treatment of hepatitis B virus. | Therapeutics and clinical risk management 20090101 |
| Role of atazanavir in the treatment of HIV infection. | Therapeutics and clinical risk management 20090101 |
| The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. | Retrovirology 20090101 |
| Emtricitabine/tenofovir disoproxil fumarate: in combination with a protease inhibitor in HIV-1 infection. | Drugs 20090101 |
| Effect of mobile phase pH and organic content on LC-MS analysis of nucleoside and nucleotide HIV reverse transcriptase inhibitors. | Journal of chromatographic science 20090101 |
| Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. | PloS one 20090101 |
| Changes in hematological parameters after switching treatment of HIV-infected patients from zidovudine to abacavir or tenofovir DF. | HIV clinical trials 20090101 |
| Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. | BMC infectious diseases 20090101 |
| Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. | AIDS research and therapy 20090101 |
| Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection. | Therapeutics and clinical risk management 20090101 |
| Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT). | European journal of medical research 20090101 |
| Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. | Molecular pharmaceutics 20090101 |
| Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use. | PloS one 20090101 |
| Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. | PloS one 20090101 |
| Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). | Journal of the International AIDS Society 20090101 |
| Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study. | AIDS research and therapy 20090101 |
| The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era. | Antiviral therapy 20090101 |
| Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II). | HIV clinical trials 20090101 |
| Novel methodology for antiretroviral quantitation in the female genital tract. | HIV clinical trials 20090101 |
| Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. | Gastroenterologie clinique et biologique 20090101 |
| Analogs and fibrosis regression in hepatitis B. | Gastroenterologie clinique et biologique 20090101 |
| Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis. | The AIDS reader 20090101 |
| Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this? | The AIDS reader 20090101 |
| The utilization of humanized mouse models for the study of human retroviral infections. | Retrovirology 20090101 |
| Expert review of drug patent applications: improving health in the developing world. | Health affairs (Project Hope) 20090101 |
| Pharmacotherapy of pediatric and adolescent HIV infection. | Therapeutics and clinical risk management 20090101 |
| Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. | Therapeutics and clinical risk management 20090101 |
| Renal impairment in a rural African antiretroviral programme. | BMC infectious diseases 20090101 |
| Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101 |
| Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101 |
| [Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| XVII International AIDS Conference: From Evidence to Action - Clinical and biomedical prevention science. | Journal of the International AIDS Society 20090101 |
| Lower limb high arterial flow induced by tenofovir and emtricitabine treatment. | Antiviral therapy 20090101 |
| Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. | Journal of the International AIDS Society 20090101 |
| Meta-analysis: adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus. | Virology journal 20090101 |
| Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report. | Journal of medical case reports 20090101 |
| Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. | Journal of medical case reports 20090101 |
| Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy. | BMC infectious diseases 20090101 |
| Safety and efficacy of telbivudine for the treatment of chronic hepatitis B. | Therapeutics and clinical risk management 20090101 |
| Model and experiences of initiating collaboration with traditional healers in validation of ethnomedicines for HIV/AIDS in Namibia. | Journal of ethnobiology and ethnomedicine 20090101 |
| Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens. | Journal of the International AIDS Society 20090101 |
| Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy. | Journal of biomedicine & biotechnology 20090101 |
| RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy. | Retrovirology 20090101 |
| RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models. | AIDS research and therapy 20090101 |
| The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. | Applied health economics and health policy 20090101 |
| Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes. | Retrovirology 20090101 |
| Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine. | HIV clinical trials 20090101 |
| Safety and efficacy of once-daily nevirapine dosing: a multicohort study. | Antiviral therapy 20090101 |
| Factors influencing global antiretroviral procurement prices. | BMC public health 20090101 |
| German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. | European journal of medical research 20090101 |
| Two standards of care for HIV: why are Africans being short-changed? | Retrovirology 20090101 |
| Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. | BMC infectious diseases 20090101 |
| Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months. | Antiviral therapy 20090101 |
| Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. | Antiviral therapy 20090101 |
| Optimal cytoplasmic transport in viral infections. | PloS one 20090101 |
| Correlations between atazanavir C(trough )and hyperbilirubinemia: a case report. | Journal of medical case reports 20090101 |
| Hepatitis B associated monoclonal gammopathy that resolved after successful liver transplant. | Journal of transplantation 20090101 |
| Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study). | HIV clinical trials 20090101 |
| A Rough Set-Based Model of HIV-1 Reverse Transcriptase Resistome. | Bioinformatics and biology insights 20090101 |
| Tenofovir-induced osteomalacia. | Clinical and experimental rheumatology 20090101 |
| The treatment of chronic hepatitis C virus infection in HIV co-infection. | European journal of medical research 20090101 |
| Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-trial). | European journal of medical research 20090101 |
| HPTLC Method for the Simultaneous Estimation of Emtricitabine and Tenofovir in Tablet Dosage Form. | Indian journal of pharmaceutical sciences 20090101 |
| Fatal dual infection with Salmonella and Mycobacterium avium complex infection in a patient with advanced acquired immunodeficiency syndrome: a case report. | Cases journal 20090101 |
| Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients. | Indian journal of pharmaceutical sciences 20090101 |
| Raltegravir: The evidence of its therapeutic value in HIV-1 infection. | Core evidence 20090101 |
| Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy. | F1000 medicine reports 20090101 |
| Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature. | Journal of medical case reports 20090101 |
| Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Management of HBV infection during immunosuppressive treatment. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report. | BMJ case reports 20090101 |
| New approaches in the management of chronic hepatitis B: role of tenofovir. | Infection and drug resistance 20090101 |
| Pregnancy and sexually transmitted viral infections. | Indian journal of sexually transmitted diseases and AIDS 20090101 |
| Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. | HIV/AIDS (Auckland, N.Z.) 20090101 |
| [Protocol for the antiviral therapy of chronic hepatitis B]. | Orvosi hetilap 20081207 |
| Current treatment indications and strategies in chronic hepatitis B virus infection. | World journal of gastroenterology 20081207 |
| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | The New England journal of medicine 20081204 |
| Chronic hepatitis B--new goals, new treatment. | The New England journal of medicine 20081204 |
| Lack of evidence for an effect of lopinavir/ritonavir on tenofovir renal clearance. | Clinical pharmacology and therapeutics 20081201 |
| A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. | The Journal of antimicrobial chemotherapy 20081201 |
| A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20081201 |
| Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone. | The Journal of antimicrobial chemotherapy 20081201 |
| Disinhibition and risk compensation: scope, definitions, and perspective. | Sexually transmitted diseases 20081201 |
| Kidney disease in patients with HIV infection and AIDS. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081201 |
| Acute kidney injury in patients with human immunodeficiency virus infection. | Current opinion in critical care 20081201 |
| Clevudine: a promising therapy for the treatment of chronic hepatitis B. | Expert opinion on investigational drugs 20081201 |
| Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination. | International journal of clinical pharmacology and therapeutics 20081201 |
| Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. | Sexually transmitted diseases 20081201 |
| Atazanavir: its role in HIV treatment. | Expert review of anti-infective therapy 20081201 |
| Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. | Expert review of anti-infective therapy 20081201 |
| [Therapy of chronic hepatitis B]. | Acta gastroenterologica Latinoamericana 20081201 |
| Therapeutic strategies for chronic hepatitis B virus infection in 2008. | The American journal of medicine 20081201 |
| Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients. | Therapeutics and clinical risk management 20081201 |
| Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults. | AIDS (London, England) 20081112 |
| Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. | Journal of pharmaceutical and biomedical analysis 20081104 |
| Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection. | AIDS and behavior 20081101 |
| The discovery of antiviral agents: ten different compounds, ten different stories. | Medicinal research reviews 20081101 |
| Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. | Ophthalmology 20081101 |
| Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy. | AIDS care 20081101 |
| Population pharmacokinetics of tenofovir in AIDS patients. | Journal of clinical pharmacology 20081101 |
| Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy? | Journal of hepatology 20081101 |
| Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. | Journal of acquired immune deficiency syndromes (1999) 20081101 |
| Pharmacologic aspects of new antiretroviral drugs. | Current infectious disease reports 20081101 |
| Adverse effects of tenofovir use in HIV-infected pregnant women and their infants. | The Annals of pharmacotherapy 20081101 |
| Two-year data released on Viread for chronic hepatitis B. | AIDS patient care and STDs 20081101 |
| 96-week CASTLE data show similar efficacy results. | AIDS patient care and STDs 20081101 |
| [A case of acute renal failure involving high amounts of tenofovir after HAART start]. | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20081101 |
| [Chronic hepatitis B: current therapy]. | Bulletin de l'Academie nationale de medecine 20081101 |
| [Pharmacokinetics and interactions of raltegravir]. | Enfermedades infecciosas y microbiologia clinica 20081101 |
| Low trough levels of tipranavir in a combination antiretroviral therapy of tipranavir/ritonavir and tenofovir require therapeutic drug monitoring. | European journal of medical research 20081027 |
| Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient. | European journal of medical research 20081027 |
| Bayesian network analyses of resistance pathways against efavirenz and nevirapine. | AIDS (London, England) 20081018 |
| The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients. | AIDS (London, England) 20081018 |
| Rosiglitazone reverses tenofovir-induced nephrotoxicity. | Kidney international 20081001 |
| HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. | The Journal of antimicrobial chemotherapy 20081001 |
| Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements. | The Journal of antimicrobial chemotherapy 20081001 |
| A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand. | Hepatology (Baltimore, Md.) 20081001 |
| Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course. | Journal of acquired immune deficiency syndromes (1999) 20081001 |
| Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081001 |
| Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. | AIDS (London, England) 20081001 |
| The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. | AIDS (London, England) 20081001 |
| Resistance issues in treating chronic hepatitis B. | Future microbiology 20081001 |
| Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001 |
| Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen? | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001 |
| Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility. | AIDS research and human retroviruses 20081001 |
| [Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals]. | Recenti progressi in medicina 20081001 |
| [Darunavir in treatment-naïve patients. The ARTEMIS study]. | Enfermedades infecciosas y microbiologia clinica 20081001 |
| Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. | Therapeutics and clinical risk management 20081001 |
| [Liver diseases]. | Gastroenterologia y hepatologia 20081001 |
| Tenofovir-associated decline in renal function. | The Journal of infectious diseases 20080915 |
| HIV infection in the elderly. | Clinical interventions in aging 20080901 |
| Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus. | International journal of emergency medicine 20080901 |
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. | Hepatology international 20080901 |
| The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B. | Hepatology international 20080901 |
| Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. | Lancet (London, England) 20080823 |
| Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. | Journal of the American College of Cardiology 20080812 |
| Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study. | HIV medicine 20080801 |
| A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir. | Hepatology research : the official journal of the Japan Society of Hepatology 20080801 |
| The A62V and S68G mutations in HIV-1 reverse transcriptase partially restore the replication defect associated with the K65R mutation. | Journal of acquired immune deficiency syndromes (1999) 20080801 |
| Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir. | European journal of gastroenterology & hepatology 20080801 |
| Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? | AIDS research and human retroviruses 20080801 |
| Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. | PLoS medicine 20080801 |
| Can a topical microbicide prevent rectal HIV transmission? | PLoS medicine 20080801 |
| Tenofovir: what have over 1 million years of patient experience taught us? | International journal of clinical practice 20080801 |
| Two cases of multidrug-resistant human immunodeficiency virus infection treated with atazanavir and lopinavir/ritonavir combination therapy. | Journal of Korean medical science 20080801 |
| CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load. | The AIDS reader 20080801 |
| Combating HIV resistance - focus on darunavir. | Therapeutics and clinical risk management 20080801 |
| The treatment of chronic hepatitis B: Focus on adefovir-like antivirals. | Therapeutics and clinical risk management 20080801 |
| The Relationship Between HIV Infection and Cardiovascular Disease. | Current cardiology reviews 20080801 |
| Anti-retroviral and cytostatic activity of 2',3'-dideoxyribonucleoside 3'-disulfides. | Bioorganic & medicinal chemistry 20080715 |
| Risk factors for decreased bone density and effects of HIV on bone in the elderly. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701 |
| Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20080701 |
| Activation of 9-[(R)-2-[[(S)-[[(S)-1-(Isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases. | Molecular pharmacology 20080701 |
| Review article: current antiviral therapy of chronic hepatitis B. | Alimentary pharmacology & therapeutics 20080701 |
| Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. | Journal of acquired immune deficiency syndromes (1999) 20080701 |
| A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. | Journal of chromatographic science 20080701 |
| Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot study. | AIDS research and human retroviruses 20080701 |
| Genetic basis of variation in tenofovir drug susceptibility in HIV-1. | AIDS (London, England) 20080619 |
| HIV, hepatitis B and hepatitis C coinfection in Kenya. | AIDS (London, England) 20080619 |
| Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. | The Journal of infectious diseases 20080615 |
| Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy. | The Journal of antimicrobial chemotherapy 20080601 |
| Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir. | The Journal of antimicrobial chemotherapy 20080601 |
| Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080601 |
| A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. | AAPS PharmSciTech 20080601 |
| Current antiviral therapies for chronic hepatitis B. | Hepatology research : the official journal of the Japan Society of Hepatology 20080601 |
| Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring. | AIDS research and human retroviruses 20080601 |
| Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission. | Journal of acquired immune deficiency syndromes (1999) 20080601 |
| [Management of antiviral-resistant chronic hepatitis B virus infection]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080601 |
| Atriplatrade mark - HIV therapy in one pill. | Therapeutics and clinical risk management 20080601 |
| [Introduction. Tenofovir]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Tenofovir: pharmacology and interactions]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Tenofovir as a strategy to avoid or limit adverse effects]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Tenofovir DF in rescue regimens]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Role of tenofovir in HIV and hepatitis C virus coinfection]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Are all analogue combinations equal?]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Conclusions. Tenofovir]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| [Current role of tenofovir in clinical medicine]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia? | African health sciences 20080601 |
| Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure. | Hepatology international 20080601 |
| Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues. | Hepatology international 20080601 |
| Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV). | Hepatology international 20080601 |
| Stability of antiretroviral regimens in patients with viral suppression. | AIDS (London, England) 20080531 |
| [Chronic hepatitis B. Tenofovir--the right choice from the beginning]. | MMW Fortschritte der Medizin 20080522 |
| [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients]. | MMW Fortschritte der Medizin 20080522 |
| Management of hepatic complications in HIV-infected persons. | The Journal of infectious diseases 20080515 |
| Does tenofovir increase efavirenz hepatotoxicity? | AIDS (London, England) 20080511 |
| Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. | Journal of hepatology 20080501 |
| Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data. | Journal of acquired immune deficiency syndromes (1999) 20080501 |
| Experience with tenofovir disoproxil fumarate for antiretroviral therapy. | Expert opinion on pharmacotherapy 20080501 |
| Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood. | PLoS pathogens 20080501 |
| [Acute renal failure associated with the use of tenofovir combined with atazanavir in patients with HIV infection]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Severe hypokalemia and tenofovir]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| Management of hepatitis B virus co-infection on and off antiretroviral therapy. | Current HIV/AIDS reports 20080501 |
| [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Resistance in hepatitis B virus]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Clinical management of patients with chronic hepatitis B virus infection]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Hepatitis B in patients with HIV infection]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| Recent developments in the clinical pharmacology of anti-HIV nucleoside analogs. | Current opinion in HIV and AIDS 20080501 |
| Implications of gender and pregnancy for antiretroviral drug dosing. | Current opinion in HIV and AIDS 20080501 |
| [First line therapy. Tenofovir DF/emtricitabine--the potent backbone]. | MMW Fortschritte der Medizin 20080428 |
| Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080415 |
| Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma. | Clinical pharmacology and therapeutics 20080401 |
| Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center. | Journal of acquired immune deficiency syndromes (1999) 20080401 |
| Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients. | AIDS patient care and STDs 20080401 |
| Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080401 |
| Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080401 |
| Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. | Journal of women's health (2002) 20080401 |
| The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers. | British journal of clinical pharmacology 20080401 |
| A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects. | British journal of clinical pharmacology 20080401 |
| Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus. | The Journal of pediatrics 20080401 |
| Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. | AIDS research and human retroviruses 20080401 |
| Acyclic phosphonate nucleotides and human adenylate kinases: impact of a borano group on alpha-P position. | Nucleosides, nucleotides & nucleic acids 20080401 |
| An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen. | AIDS patient care and STDs 20080401 |
| Europe extends Viread indication for chronic hepatitis B. | AIDS patient care and STDs 20080401 |
| Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080401 |
| Test of new vaginal microbicide gel show promise for women. | The AIDS reader 20080401 |
| [AIDS: ethics and scientific investigation on human beings]. | Bulletin de la Societe de pathologie exotique (1990) 20080401 |
| Raltegravir: first in class HIV integrase inhibitor. | Therapeutics and clinical risk management 20080401 |
| 'One pill, once daily': what clinicians need to know about Atriplatrade mark. | Therapeutics and clinical risk management 20080401 |
| Enfuvirtide antiretroviral therapy in HIV-1 infection. | Therapeutics and clinical risk management 20080401 |
| Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202. | AIDS clinical care 20080401 |
| Potency of tenofovir in chronic hepatitis B: mono or combination therapy? | Journal of hepatology 20080301 |
| The pharmacokinetics and viral activity of tenofovir in the male genital tract. | Journal of acquired immune deficiency syndromes (1999) 20080301 |
| Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. | Journal of hepatology 20080301 |
| Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. | HIV medicine 20080301 |
| Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080301 |
| Efavirenz-induced hypersensitivity reaction manifesting in rash and hepatitis in a Latino male. | The Annals of pharmacotherapy 20080301 |
| Kidney biopsy in HIV: beyond HIV-associated nephropathy. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20080301 |
| Chronic hepatitis B: preventing, detecting, and managing viral resistance. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080301 |
| Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection. | Sexual health 20080301 |
| Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20080301 |
| pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute. | Journal of pharmaceutical sciences 20080201 |
| The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients. | Clinical pharmacology and therapeutics 20080201 |
| Specificity enhancement with LC-positive ESI-MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells. | Journal of mass spectrometry : JMS 20080201 |
| Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection. | Antimicrobial agents and chemotherapy 20080201 |
| Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. | Antimicrobial agents and chemotherapy 20080201 |
| Synthesis and anti-HIV activity of 2'-fluorine modified nucleoside phosphonates: analogs of GS-9148. | Bioorganic & medicinal chemistry letters 20080201 |
| Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada). | The Journal of antimicrobial chemotherapy 20080201 |
| Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor. | Bioorganic & medicinal chemistry letters 20080201 |
| Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080201 |
| Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression. | Journal of viral hepatitis 20080201 |
| Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. | PLoS medicine 20080201 |
| Antiretroviral therapy for prevention of HIV infection: new clues from an animal model. | PLoS medicine 20080201 |
| Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. | AIDS patient care and STDs 20080201 |
| A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort. | AIDS patient care and STDs 20080201 |
| Prevalence of chronic kidney disease in an urban HIV infected population. | The American journal of the medical sciences 20080201 |
| Vitamin D intoxication: a cause of hypocalcaemia and acute renal failure in a HIV patient. | International journal of STD & AIDS 20080201 |
| Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients. | Clinical therapeutics 20080201 |
| Urolithiasis under atazanavir boosted and tenofovir therapy: a case report. | Journal of chemotherapy (Florence, Italy) 20080201 |
| Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors. | European journal of pharmacology 20080128 |
| [Anti-viral therapy of type B chronic hepatitis. 3. Future of anti-viral agents]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20080110 |
| Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. | AIDS (London, England) 20080102 |
| Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080101 |
| In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2-(phosphonomethoxy)propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450. | Physiological research 20080101 |
| Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro. | Antimicrobial agents and chemotherapy 20080101 |
| Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. | Journal of acquired immune deficiency syndromes (1999) 20080101 |
| Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients. | The Journal of antimicrobial chemotherapy 20080101 |
| Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. | The Journal of antimicrobial chemotherapy 20080101 |
| Once-daily dosing of nevirapine in HAART. | The Journal of antimicrobial chemotherapy 20080101 |
| Treatment options for lipodystrophy in HIV-positive patients. | Expert opinion on pharmacotherapy 20080101 |
| Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. | The Pediatric infectious disease journal 20080101 |
| Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context. | The Journal of infectious diseases 20080101 |
| Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. | The Journal of infectious diseases 20080101 |
| Can the new humanized mouse model give HIV research a boost. | PLoS medicine 20080101 |
| Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. | PLoS medicine 20080101 |
| Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients. | HIV clinical trials 20080101 |
| The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal. | Retrovirology 20080101 |
| Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. | PloS one 20080101 |
| Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals. | Current HIV research 20080101 |
| Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA). | Tropical medicine & international health : TM & IH 20080101 |
| 6th international symposium on retroviral nucleocapsid. | Retrovirology 20080101 |
| Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. | Journal of neurovirology 20080101 |
| Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. | BMC infectious diseases 20080101 |
| Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses. | Retrovirology 20080101 |
| Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs. | Comparative hepatology 20080101 |
| Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation. | BMC musculoskeletal disorders 20080101 |
| Efficacy and safety of once-daily regimens in the treatment of HIV infection. | Drugs 20080101 |
| Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT. | AIDS research and therapy 20080101 |
| Acute renal failure in an AIDS patient on tenofovir: a case report. | Journal of medical case reports 20080101 |
| Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. | Antiviral therapy 20080101 |
| Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues. | Antiviral therapy 20080101 |
| FDA grants tentative approval to first generic version of antiretroviral Viread. | AIDS patient care and STDs 20080101 |
| European Commission approves Atripla. | AIDS patient care and STDs 20080101 |
| The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. | PloS one 20080101 |
| Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. | HIV clinical trials 20080101 |
| Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine. | HIV clinical trials 20080101 |
| Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database. | Antiviral therapy 20080101 |
| Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens. | Antiviral therapy 20080101 |
| FDA notifications. FDA's tentative approval for generic Tenofovir. | AIDS alert 20080101 |
| Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV. | Antiviral therapy 20080101 |
| Treatment of chronic hepatitis B infection: an update of Swedish recommendations. | Scandinavian journal of infectious diseases 20080101 |
| An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. | PloS one 20080101 |
| Persisting with prevention: the importance of adherence for HIV prevention. | Emerging themes in epidemiology 20080101 |
| [Treatment of chronic hepatitis B in HIV co-infected patients]. | Gastroenterologie clinique et biologique 20080101 |
| [Liver transplantation for chronic hepatitis B]. | Gastroenterologie clinique et biologique 20080101 |
| Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. | PloS one 20080101 |
| HIV-2 diagnosis and quantification in high-risk patients. | AIDS research and therapy 20080101 |
| Microbicides 2008 conference: from discovery to advocacy. | AIDS research and therapy 20080101 |
| Medical management of human immunodeficiency virus infection. | Indian journal of ophthalmology 20080101 |
| Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. | HIV clinical trials 20080101 |
| 'White coat compliance' limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. | HIV clinical trials 20080101 |
| Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication. | Antiviral therapy 20080101 |
| Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients. | Antiviral therapy 20080101 |
| Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations. | Antiviral therapy 20080101 |
| [Treatment of chronic hepatitis B]. | Gastroenterologie clinique et biologique 20080101 |
| Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules. | AIDS research and therapy 20080101 |
| Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy. | PloS one 20080101 |
| Renal dysfunction and tenofovir toxicity in HIV-infected patients. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20080101 |
| Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools. | Antiviral therapy 20080101 |
| Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study. | BMC infectious diseases 20080101 |
| Pharmacotherapy of hepatitis B infection: a brief review. | Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101 |
| Impending flop for brand antiretrovirals in the emerging markets? | The open AIDS journal 20080101 |
| Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India. | Medscape journal of medicine 20080101 |
| 25 years of HIV-1 research - progress and perspectives. | BMC medicine 20080101 |
| Ability of online drug databases to assist in clinical decision-making with infectious disease therapies. | BMC infectious diseases 20080101 |
| Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations. | Theoretical biology & medical modelling 20080101 |
| Prevention of the sexual transmission of HIV-1: preparing for success. | Journal of the International AIDS Society 20080101 |
| [Drugs treatment of hepatitis B]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101 |
| Acute renal failure in four HIV-infected patients: Potential association with tenofovir and nonsteroidal anti-inflammatory drugs. | The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20080101 |
| No residual activity of raltegravir after development of 148 complex mutations in vivo. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20080101 |
| Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. | Best practice & research. Clinical gastroenterology 20080101 |
| Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues. | Best practice & research. Clinical gastroenterology 20080101 |
| Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. | Antiviral therapy 20080101 |
| Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients. | Antiviral therapy 20080101 |
| Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop. | Antiviral therapy 20080101 |
| Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients. | HIV clinical trials 20080101 |
| Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated. | HIV clinical trials 20080101 |
| Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study). | HIV clinical trials 20080101 |
| High treatment success rates when switching to once daily nevirapine containing antiretroviral therapy. | The open AIDS journal 20080101 |
| Harnessing pharmacogenomics to tackle resistance to the 'nucleoside reverse trancripatse inhibitor' backbone of highly active antiretroviral therapy in resource limited settings. | The open AIDS journal 20080101 |
| Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India. | Journal of the International AIDS Society 20080101 |
| Raltegravir in the management of HIV-infected patients. | Drug design, development and therapy 20080101 |
| [Dietary recommendations with practical examples of menus for people living with HIV/AIDS in sub-Saharan Africa]. | The Pan African medical journal 20080101 |
| Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates. | Bioorganic & medicinal chemistry letters 20071215 |
| [HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy]. | Zhonghua yi xue za zhi 20071211 |
| Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients. | The Journal of antimicrobial chemotherapy 20071201 |
| Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone. | Infection 20071201 |
| Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. | Infection 20071201 |
| Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. | AIDS (London, England) 20071201 |
| Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. | The Journal of infectious diseases 20071201 |
| Resistance testing methodologies and mechanisms of resistance. | Journal of HIV therapy 20071201 |
| Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis B. | Journal of HIV therapy 20071201 |
| [Research ethics and developing countries]. | Journal international de bioethique = International journal of bioethics 20071201 |
| The role of entecavir in the treatment of chronic hepatitis B. | Therapeutics and clinical risk management 20071201 |
| Review of tenofovir-emtricitabine. | Therapeutics and clinical risk management 20071201 |
| Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen. | AIDS (London, England) 20071130 |
| Reply to Crane et al., 'Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir'. | AIDS (London, England) 20071130 |
| Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. | Lancet (London, England) 20071117 |
| Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro. | Bioorganic & medicinal chemistry letters 20071115 |
| Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. | AIDS (London, England) 20071112 |
| Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers. | British journal of clinical pharmacology 20071101 |
| Management of hepatitis B in liver transplant recipients. | Journal of viral hepatitis 20071101 |
| Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. | PLoS medicine 20071101 |
| Theme and variations in the evolutionary pathways to virulence of an RNA plant virus species. | PLoS pathogens 20071101 |
| Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. | Journal of acquired immune deficiency syndromes (1999) 20071101 |
| Acute renal failure in HIV patients. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071001 |
| Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. | Antiviral research 20071001 |
| Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults. | European journal of clinical pharmacology 20071001 |
| Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. | Journal of acquired immune deficiency syndromes (1999) 20071001 |
| Low-level K65R mutation in HIV-1 reverse transcriptase of treatment-experienced patients exposed to abacavir or didanosine. | Journal of acquired immune deficiency syndromes (1999) 20071001 |
| Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. | Journal of medical virology 20071001 |
| Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. | Journal of acquired immune deficiency syndromes (1999) 20071001 |
| Is phosphatemia the best tool to monitor renal tenofovir toxicity? | Journal of acquired immune deficiency syndromes (1999) 20071001 |
| Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen. | Therapeutic drug monitoring 20071001 |
| Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir. | The Pediatric infectious disease journal 20071001 |
| Female-initiated prevention strategies key to tackling HIV. | The Lancet. Infectious diseases 20071001 |
| Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting. | AIDS patient care and STDs 20071001 |
| Impact of the number of failed therapeutic regimes on the development of resistance mutations to HIV-1 in northeast Brazil. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071001 |
| Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. | AIDS (London, England) 20070912 |
| Diverse approaches useful for microbicide trials. | Nature 20070906 |
| Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. | Antiviral research 20070901 |
| Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways. | Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20070901 |
| Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20070901 |
| Adverse events experienced by three children taking tenofovir and didanosine in combination. | HIV medicine 20070901 |
| Pregnancy prevention practices among women with multiple partners in an HIV prevention trial. | Journal of acquired immune deficiency syndromes (1999) 20070901 |
| Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070901 |
| HIV-1 infection and the kidney: an evolving challenge in HIV medicine. | Mayo Clinic proceedings 20070901 |
| Determination of plasma tenofovir concentrations using a conventional LC-MS method. | Biological & pharmaceutical bulletin 20070901 |
| Grand challenges in global health: the ethical, social and cultural program. | PLoS medicine 20070901 |
| Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. | PLoS medicine 20070901 |
| Grand challenges in global health: community engagement in research in developing countries. | PLoS medicine 20070901 |
| Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). | AIDS care 20070901 |
| Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901 |
| Pharmacologic management of overactive bladder. | Clinical interventions in aging 20070901 |
| [Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20070901 |
| Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity. | The Journal of biological chemistry 20070824 |
| Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. | Journal of acquired immune deficiency syndromes (1999) 20070815 |
| Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs. | Bioorganic & medicinal chemistry 20070815 |
| Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. | World journal of gastroenterology 20070814 |
| Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine. | Antimicrobial agents and chemotherapy 20070801 |
| Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy. | Journal of clinical pharmacology 20070801 |
| Compromised immunologic recovery in patients receiving tipranavir/ritonavir coadministered with tenofovir and didanosine in Randomized Evaluation of Strategic Intervention in multidrug-resiStant patients with tipranavir (RESIST) studies. | Journal of acquired immune deficiency syndromes (1999) 20070801 |
| Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy. | Journal of medical primatology 20070801 |
| Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention. | Journal of medical primatology 20070801 |
| Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20070801 |
| Second tenofovir phase III study for the chronic HBV reaches primary endpoint. | AIDS patient care and STDs 20070801 |
| The renaissance of fixed dose combinations: Combivir. | Therapeutics and clinical risk management 20070801 |
| Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection. | Therapeutics and clinical risk management 20070801 |
| Review of tipranavir in the treatment of drug-resistant HIV. | Therapeutics and clinical risk management 20070801 |
| Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase. | AIDS (London, England) 20070711 |
| Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. | AIDS (London, England) 20070711 |
| Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate. | AIDS (London, England) 20070711 |
| Effect of tenofovir on renal glomerular and tubular function. | AIDS (London, England) 20070711 |
| Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report. | AIDS (London, England) 20070711 |
| Pre-exposure prophylaxis for HIV infection: what if it works? | Lancet (London, England) 20070707 |
| A second chance for microbicides. | Lancet (London, England) 20070707 |
| Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. | Journal of acquired immune deficiency syndromes (1999) 20070701 |
| Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701 |
| Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. | HIV medicine 20070701 |
| Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. | AIDS (London, England) 20070701 |
| A 21-base pair insertion/duplication at codon 69 of the HIV type 1 reverse transcriptase in a patient undergoing multiple nucleoside therapy. | AIDS research and human retroviruses 20070701 |
| The first once-daily single-tablet regimen for the treatment of HIV-infected patients. | Drugs of today (Barcelona, Spain : 1998) 20070701 |
| Tenofovir gel--the new HIV prevention 'banker'? | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20070701 |
| [Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir]. | Medicina clinica 20070630 |
| The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. | AIDS (London, England) 20070619 |
| Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). | AIDS (London, England) 20070619 |
| Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey. | AIDS (London, England) 20070619 |
| Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir. | AIDS (London, England) 20070619 |
| Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases. | AIDS (London, England) 20070619 |
| Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects. | AIDS (London, England) 20070619 |
| CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. | The Journal of antimicrobial chemotherapy 20070601 |
| Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies. | Virchows Archiv : an international journal of pathology 20070601 |
| Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070601 |
| Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. | Journal of clinical pharmacology 20070601 |
| Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus. | Infection control and hospital epidemiology 20070601 |
| HPV oral infection. Case report of an HIV-positive Nigerian sex worker. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070601 |
| Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome. | The AIDS reader 20070601 |
| Editorial comment: Fanconi syndrome and tenofovir--understanding proximal tubular function. | The AIDS reader 20070601 |
| Chronic renal failure among HIV-1-infected patients. | AIDS (London, England) 20070531 |
| Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents. | AIDS (London, England) 20070531 |
| Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. | AIDS (London, England) 20070531 |
| Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. | Biochemical pharmacology 20070515 |
| Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman. | AIDS (London, England) 20070511 |
| No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20070501 |
| No change in calculated creatinine clearance after tenofovir initiation among Thai patients. | The Journal of antimicrobial chemotherapy 20070501 |
| Unlikely association of multidrug-resistance protein 2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events. | The Journal of infectious diseases 20070501 |
| Update on viral hepatitis: 2006. | Current opinion in gastroenterology 20070501 |
| Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety. | Journal of viral hepatitis 20070501 |
| Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. | Journal of acquired immune deficiency syndromes (1999) 20070501 |
| Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation? | Journal of acquired immune deficiency syndromes (1999) 20070501 |
| Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. | PLoS clinical trials 20070501 |
| Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. | Current drug safety 20070501 |
| Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. | AIDS (London, England) 20070423 |
| Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study. | Epidemiology and infection 20070401 |
| Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. | Biochemical pharmacology 20070401 |
| Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir. | The Journal of antimicrobial chemotherapy 20070401 |
| Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). | Pharmaceutical research 20070401 |
| Atazanavir: simplicity and convenience in different scenarios. | Expert opinion on pharmacotherapy 20070401 |
| Tenofovir and abacavir combination therapy: lessons learned from an urban clinic population. | AIDS patient care and STDs 20070401 |
| Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients. | AIDS patient care and STDs 20070401 |
| Dyslipidaemia associated with the highly active antiretroviral therapy in AIDS patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir). | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20070401 |
| Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT. | AIDS (London, England) 20070330 |
| Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. | AIDS (London, England) 20070330 |
| Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'. | AIDS (London, England) 20070330 |
| Response to Blaas et al., 'Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases'. | AIDS (London, England) 20070330 |
| Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients. | Statistics in medicine 20070315 |
| Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. | Drug metabolism and disposition: the biological fate of chemicals 20070301 |
| New and emerging treatment of chronic hepatitis B. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070301 |
| Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. | Journal of viral hepatitis 20070301 |
| Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070301 |
| Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer? | Gut 20070301 |
| CD4+ cell count decline despite HIV suppression: a probable didanosine-valganciclovir interaction. | The Annals of pharmacotherapy 20070301 |
| Tenofovir-induced kidney injury. | Expert opinion on drug safety 20070301 |
| Treatment of chronic hepatitis B in HIV-infected patients in 2007. | Journal of HIV therapy 20070301 |
| Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients. | European journal of medical research 20070226 |
| Prevention. Anti-HIV drug could prevent transmission in women. | AIDS policy & law 20070223 |
| Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. | Molecular pharmacology 20070201 |
| Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study. | Journal of medical virology 20070201 |
| The management of HIV and hepatitis B coinfection. | Current opinion in infectious diseases 20070201 |
| Postexposure prophylaxis after sexual exposure to HIV. | Current opinion in infectious diseases 20070201 |
| Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. | The Journal of antimicrobial chemotherapy 20070201 |
| Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070201 |
| Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy. | Optometry (St. Louis, Mo.) 20070201 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? | Expert opinion on pharmacotherapy 20070201 |
| Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. | AJNR. American journal of neuroradiology 20070201 |
| Renal safety of tenofovir disoproxil fumarate. | The AIDS reader 20070201 |
| Editorial comment: tenofovir-related nephrotoxicity--who's at risk? | The AIDS reader 20070201 |
| Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection. | AIDS patient care and STDs 20070201 |
| Update in HIV care. | Journal of general internal medicine 20070201 |
| Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy. | Journal of medical primatology 20070201 |
| K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials. | AIDS (London, England) 20070111 |
| [Treatment of HIV infection in 2006: highlights]. | Revue medicale suisse 20070110 |
| Acyclic nucleoside phosphonate antivirals activate gene expression of monocyte chemotactic protein 1 and 3. | Journal of biomedical science 20070101 |
| Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. | The Journal of antimicrobial chemotherapy 20070101 |
| HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand. | International journal of medical sciences 20070101 |
| New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu. | Retrovirology 20070101 |
| Closing the access gap for health innovations: an open licensing proposal for universities. | Globalization and health 20070101 |
| HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare? | PloS one 20070101 |
| Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. | Retrovirology 20070101 |
| How labour intensive is a doctor-based delivery model for antiretroviral treatment (ART)? Evidence from an observational study in Siem Reap, Cambodia. | Human resources for health 20070101 |
| Treatment of HIV/HBV coinfection: clinical and virologic issues. | AIDS reviews 20070101 |
| Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. | Journal of medical case reports 20070101 |
| Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors. | Antiviral therapy 20070101 |
| Reversibility of cirrhosis in HIV/HBV coinfection. | Antiviral therapy 20070101 |
| Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir. | Antiviral therapy 20070101 |
| Does tenofovir influence efavirenz pharmacokinetics? | Antiviral therapy 20070101 |
| Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. | Antiviral therapy 20070101 |
| TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? | Globalization and health 20070101 |
| Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma. | Rapid communications in mass spectrometry : RCM 20070101 |
| AIDS in the Third World: how to stop the HIV infection? | Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101 |
| Anti-HIV drugs. | Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101 |
| Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts. | AIDS research and therapy 20070101 |
| Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children. | BMC infectious diseases 20070101 |
| Antiretroviral treatment of HIV infection: Swedish recommendations 2007. | Scandinavian journal of infectious diseases 20070101 |
| In vitro selection and characterization of human immunodeficiency virus type 1 resistant to Zidovudine and tenofovir. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz. | Antiviral therapy 20070101 |
| In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. | Antiviral therapy 20070101 |
| The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. | Antiviral therapy 20070101 |
| Didanosine enteric-coated capsule: current role in patients with HIV-1 infection. | Drugs 20070101 |
| Analysis of treatment costs for HIV RNA reductions and CD4 increases for darunavir versus other antiretrovirals in treatment-experienced, HIV-infected patients. | HIV clinical trials 20070101 |
| The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients. | HIV clinical trials 20070101 |
| Safety and tolerability of sequential pegylated IFN-alpha2a and tenofovir for hepatitis B infection in HIV(+) individuals. | HIV clinical trials 20070101 |
| Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up. | HIV clinical trials 20070101 |
| Nucleoside and nucleotide reverse transcriptase inhibitors in children. | Clinical drug investigation 20070101 |
| Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study. | Clinical drug investigation 20070101 |
| Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma. | Rapid communications in mass spectrometry : RCM 20070101 |
| Early onset of tenofovir-induced renal failure: case report and review of the literature. | TheScientificWorldJournal 20070101 |
| Update on the treatment of chronic hepatitis C in HIV-infected patients. | AIDS reviews 20070101 |
| Differential drug resistance acquisition in HIV-1 of subtypes B and C. | PloS one 20070101 |
| Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV. | Antiviral therapy 20070101 |
| A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. | Antiviral therapy 20070101 |
| Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients. | Antiviral therapy 20070101 |
| Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview. | HIV clinical trials 20070101 |
| [Advances in the treatment of hepatitis B]. | Revista da Sociedade Brasileira de Medicina Tropical 20070101 |
| Microbicide research in developing countries: have we given the ethical concerns due consideration? | BMC medical ethics 20070101 |
| Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. | PloS one 20070101 |
| Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. | Antiviral chemistry & chemotherapy 20070101 |
| Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. | AIDS research and therapy 20070101 |
| CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. | Antiviral therapy 20070101 |
| Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen. | HIV clinical trials 20070101 |
| Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART. | HIV clinical trials 20070101 |
| Health, human rights, and the conduct of clinical research within oppressed populations. | Globalization and health 20070101 |
| Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. | Antiviral therapy 20070101 |
| Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting. | AIDS research and therapy 20070101 |
| The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy. | HIV clinical trials 20070101 |
| [Analysis of the causes and predictive factors for discontinuing treatment with tenofovir in pretreated HIV patients]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101 |
| Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Acute renal failure after initiation of tenofovir disoproxil fumarate. | Renal failure 20070101 |
| Predicting tenofovir concentration on the basis of renal factors determined by routine tests. | American journal of therapeutics 20070101 |
| Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. | Antiviral therapy 20070101 |
| Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients. | Antiviral therapy 20070101 |
| Special considerations and treatment of patients with HBV-HIV coinfection. | Antiviral therapy 20070101 |
| Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. | Clinical & developmental immunology 20070101 |
| The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65r+M184V. | Antiviral chemistry & chemotherapy 20070101 |
| Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapy. | The open virology journal 20070101 |
| The 16th International Conference on AIDS: Will It Leave a Legacy? | Journal of the International AIDS Society 20070101 |
| Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal. | Journal of the International AIDS Society 20070101 |
| Maraviroc: the evidence for its potential in the management of HIV. | Core evidence 20070101 |
| Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine. | Journal of medicinal chemistry 20061228 |
| Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis. | Journal of acquired immune deficiency syndromes (1999) 20061215 |
| Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20061215 |
| Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort. | Journal of acquired immune deficiency syndromes (1999) 20061215 |
| In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine. | Antimicrobial agents and chemotherapy 20061201 |
| Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity. | The Journal of infectious diseases 20061201 |
| Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. | The Journal of infectious diseases 20061201 |
| Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen. | European journal of gastroenterology & hepatology 20061201 |
| Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. | PLoS medicine 20061201 |
| Experimental approaches to studies on drug metabolism and drug interactions in man: interaction of acyclic nucleoside phosphonates with human liver cytochromes P450 and flavin-containing monooxygenase 3. | Neuro endocrinology letters 20061201 |
| Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir. | Xenobiotica; the fate of foreign compounds in biological systems 20061201 |
| Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient. | The American journal of the medical sciences 20061201 |
| Aminotransferase elevation in HIV/hepatitis B virus co-infected patients treated with two active hepatitis B virus drugs. | AIDS patient care and STDs 20061201 |
| Atripla approval in Europe. | AIDS patient care and STDs 20061201 |
| Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients. | AIDS research and human retroviruses 20061201 |
| Five-year data out on Viread. | AIDS patient care and STDs 20061201 |
| Hepatitis B virus treatment in HIV-infected patients. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20061201 |
| [Resistance to adefovir in patients with chronic hepatitis B]. | The Korean journal of hepatology 20061201 |
| [Use study of tenofovir DF in highly active anti-retroviral therapy]. | Anales de medicina interna (Madrid, Spain : 1984) 20061201 |
| Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha. | International journal of nanomedicine 20061201 |
| A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient. | AIDS (London, England) 20061114 |
| Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107 |
| Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies. | Journal of leukocyte biology 20061101 |
| In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells. | Antimicrobial agents and chemotherapy 20061101 |
| Acquired Fanconi's syndrome associated with tenofovir therapy. | Journal of general internal medicine 20061101 |
| Hepatitis B in liver transplant recipients. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061101 |
| Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy. | Journal of viral hepatitis 20061101 |
| Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. | Hepatology (Baltimore, Md.) 20061101 |
| Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple-nucleoside/nucleotide regimen of trizivir and tenofovir. | Expert opinion on pharmacotherapy 20061101 |
| Metabolic abnormalities in HIV-infected patients: an update. | Current infectious disease reports 20061101 |
| Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir. | Journal of acquired immune deficiency syndromes (1999) 20061101 |
| Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection. | PLoS medicine 20061101 |
| HIV prophylaxis still has no clear cut answer. | AIDS alert 20061101 |
| Report from the XVI International AIDS Conference. Preexposure prophylaxis studies move forward. | AIDS clinical care 20061101 |
| A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. | AIDS (London, England) 20061024 |
| Effects of monotherapy with (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) on the evolution of a primary Simian immunodeficiency virus (SIV) isolate. | Virology 20061010 |
| Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. | AIDS (London, England) 20061003 |
| The role of tenofovir in the prevention of HIV infections. | AIDS (London, England) 20061003 |
| Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903. | HIV medicine 20061001 |
| Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy. | HIV medicine 20061001 |
| Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use. | HIV medicine 20061001 |
| Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061001 |
| Chemoprophylaxis of HIV infection: moving forward with caution. | The Journal of infectious diseases 20061001 |
| Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. | The Journal of infectious diseases 20061001 |
| Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. | Gastroenterology 20061001 |
| [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients]. | Gastroenterologie clinique et biologique 20061001 |
| A once-daily combination tablet (Atripla) for HIV. | The Medical letter on drugs and therapeutics 20060925 |
| Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus. | Journal of acquired immune deficiency syndromes (1999) 20060901 |
| Perspectives on the development of acyclic nucleotide analogs as antiviral drugs. | Antiviral research 20060901 |
| Antiviral acyclic nucleoside phosphonates structure activity studies. | Antiviral research 20060901 |
| Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. | Pediatrics 20060901 |
| Lamivudine treatment in patients with chronic hepatitis B and cirrhosis. | Expert opinion on pharmacotherapy 20060901 |
| Change to a once-daily combination including boosted atazanavir in HIV-1-infected children. | The Pediatric infectious disease journal 20060901 |
| Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant. | International journal of STD & AIDS 20060901 |
| Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy. | Archives of neurology 20060901 |
| Long-term follow-up of patients with initial early virologic failure after being treated with once-daily tenofovir/abacavir/lamivudine. | AIDS patient care and STDs 20060901 |
| Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. | AIDS research and human retroviruses 20060901 |
| A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase. | AIDS research and human retroviruses 20060901 |
| One pill, once daily: now an option for HIV patients. | AIDS clinical care 20060901 |
| Once-daily dosing and the treatment of HIV disease. | The AIDS reader 20060901 |
| Pre-exposure prophylaxis effective. | AIDS patient care and STDs 20060901 |
| [Renal toxicity in HIV-infected patients receiving HAART including tenofovir]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20060901 |
| Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond. | Current opinion in HIV and AIDS 20060901 |
| Antiretroviral therapy in coinfected patients: viral hepatitis and tuberculosis. | Current opinion in HIV and AIDS 20060901 |
| Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases. | AIDS (London, England) 20060822 |
| An update and review of antiretroviral therapy. | Pharmacotherapy 20060801 |
| Hypokalemia in HIV patients on tenofovir. | AIDS (London, England) 20060801 |
| Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. | Antimicrobial agents and chemotherapy 20060801 |
| Tenofovir disoproxil fumarate: role in hepatitis B treatment. | Hepatology (Baltimore, Md.) 20060801 |
| Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. | Hepatology (Baltimore, Md.) 20060801 |
| How do intellectual property law and international trade agreements affect access to antiretroviral therapy? | PLoS medicine 20060801 |
| Rapid improvement of liver function in a patient with HIV and hepatitis B coinfection treated with lamivudine and tenofovir. | Infection 20060801 |
| Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate. | AIDS research and human retroviruses 20060801 |
| Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone. | Expert review of anti-infective therapy 20060801 |
| [Advances in the study of nucleoside antiviral drugs]. | Yao xue xue bao = Acta pharmaceutica Sinica 20060801 |
| Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | The Journal of antimicrobial chemotherapy 20060701 |
| Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study. | Journal of acquired immune deficiency syndromes (1999) 20060701 |
| Virologic and immunologic efficacy of the tenofovir/didanosine/lamivudine regimen. | Journal of acquired immune deficiency syndromes (1999) 20060701 |
| Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients. | European journal of clinical pharmacology 20060701 |
| Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir. | Pediatric nephrology (Berlin, Germany) 20060701 |
| Moving toward assured access to treatment in microbicide trials. Global Campaign for Microbicides. | PLoS medicine 20060701 |
| Nephrotoxicity as a complication of antiretroviral therapy. | Advances in chronic kidney disease 20060701 |
| Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. | AIDS (London, England) 20060626 |
| Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir. | AIDS (London, England) 20060626 |
| Investigating new antiretroviral combinations. | The Journal of infectious diseases 20060615 |
| HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. | AIDS (London, England) 20060612 |
| Tenofovir DF and emtricitabine vs. zidovudine and lamivudine. | The New England journal of medicine 20060608 |
| Tenofovir DF and emtricitabine vs. zidovudine and lamivudine. | The New England journal of medicine 20060608 |
| HIV-associated nephropathy and drug-induced renal injury. | MedGenMed : Medscape general medicine 20060608 |
| Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060601 |
| Improving access to medicines in poor countries: the role of universities. | PLoS medicine 20060601 |
| Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060601 |
| The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060601 |
| Antiretroviral drug resistance and routine therapy, Cameroon. | Emerging infectious diseases 20060601 |
| FDA notifications. Two tenofovir containing products are approved. | AIDS alert 20060601 |
| Tenofovir disoproxil fumarate for the treatment of HIV infection. | Expert opinion on drug metabolism & toxicology 20060601 |
| AIDS drug trial turned away; protests by prostitutes in Cambodia ended Tenofovir testing. | The Washington post 20060523 |
| Indian pressure group challenges company's right to patent AIDS drug. | BMJ (Clinical research ed.) 20060520 |
| HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060515 |
| Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. | AIDS (London, England) 20060512 |
| Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults? | The Journal of infection 20060501 |
| Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060501 |
| Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | The Journal of antimicrobial chemotherapy 20060501 |
| Update on viral hepatitis: 2005. | Current opinion in gastroenterology 20060501 |
| Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir. | Journal of medical virology 20060501 |
| Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060501 |
| Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20060501 |
| Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects. | Journal of clinical pharmacology 20060501 |
| Truvada trials hold promise for new HIV prevention strategy. Once-a-day might keep HIV away. | AIDS alert 20060501 |
| FDA makes final approvals. | AIDS patient care and STDs 20060501 |
| Workshop explores racial PK differences, TDF-PI interaction. | IAPAC monthly 20060501 |
| Variant of hepatitis B virus with primary resistance to adefovir. | The New England journal of medicine 20060427 |
| DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. | Virology 20060425 |
| Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study). | Journal of acquired immune deficiency syndromes (1999) 20060415 |
| Creating effective partnerships for HIV prevention trials: report of a UNAIDS Consultation, Geneva 20-21 June 2005. | AIDS (London, England) 20060404 |
| Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia. | The Journal of infection 20060401 |
| Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. | PLoS biology 20060401 |
| Advances in human immunodeficiency virus therapeutics. | The Annals of pharmacotherapy 20060401 |
| Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients. | Expert opinion on pharmacotherapy 20060401 |
| Personal view: the management of chronic hepatitis B infection. | Alimentary pharmacology & therapeutics 20060401 |
| Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients. | The AIDS reader 20060401 |
| Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons. | AIDS patient care and STDs 20060401 |
| Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir. | AIDS research and human retroviruses 20060401 |
| Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. | Stem cells and development 20060401 |
| Report from the 13th retrovirus conference. Renal tenofovir debate continues. | AIDS clinical care 20060401 |
| 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures. | AIDS (London, England) 20060321 |
| Serum creatinine changes in HIV-seropositive patients receiving tenofovir. | AIDS (London, England) 20060321 |
| A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. | AIDS (London, England) 20060321 |
| Registration problems for antiretrovirals in Africa. | Lancet (London, England) 20060311 |
| Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy. | HIV medicine 20060301 |
| Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge. | PLoS medicine 20060301 |
| Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. | Hepatology (Baltimore, Md.) 20060301 |
| Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. | AIDS (London, England) 20060227 |
| Retrovirus meeting. Novel attacks on HIV move closer to reality. | Science (New York, N.Y.) 20060217 |
| Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure. | The Journal of infection 20060201 |
| Management of chronic hepatitis B virus infection: a new era of disease control. | Internal medicine journal 20060201 |
| Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication. | Scandinavian journal of gastroenterology 20060201 |
| Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance? | PLoS pathogens 20060201 |
| [Liver transplantation for complications of hepatitis B]. | Presse medicale (Paris, France : 1983) 20060201 |
| Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses. | Arzneimittel-Forschung 20060201 |
| Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. | The New England journal of medicine 20060119 |
| Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060115 |
| Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine. | European journal of pharmacology 20060113 |
| Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102 |
| Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101 |
| Improved lipid profiles and maintenance of virologic control in heavily pretreated HIV-infected patients who switched from stavudine to tenofovir treatment. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101 |
| Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20060101 |
| Assessment of treatment efficacy in HBV infection and disease. | Journal of hepatology 20060101 |
| Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. | Journal of hepatology 20060101 |
| Update on HAART in HIV. | Journal of hepatology 20060101 |
| Antiviral hepatitis and antiretroviral drug interactions. | Journal of hepatology 20060101 |
| The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses. | Cerebrospinal fluid research 20060101 |
| Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant. | Comparative hepatology 20060101 |
| Expanding access to HIV prevention. | AIDS research and therapy 20060101 |
| Case study: an active, 24-year-old woman positive for HIV. | JAAPA : official journal of the American Academy of Physician Assistants 20060101 |
| Longitudinal study on mitochondrial effects of didanosine-tenofovir combination. | AIDS research and human retroviruses 20060101 |
| Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Looking to the future: new agents for chronic hepatitis B. | The American journal of gastroenterology 20060101 |
| Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients. | Antiviral therapy 20060101 |
| An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy. | Antiviral therapy 20060101 |
| Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. | Antiviral therapy 20060101 |
| DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes. | BMC infectious diseases 20060101 |
| Assessing the effect of HAART on change in quality of life among HIV-infected women. | AIDS research and therapy 20060101 |
| Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11. | Virology journal 20060101 |
| Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. | Annals of clinical microbiology and antimicrobials 20060101 |
| Clinically stable treatment-experienced adults receiving tenofovir and didanosine. | HIV clinical trials 20060101 |
| The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations. | Antiviral therapy 20060101 |
| Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults. | Antiviral therapy 20060101 |
| Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial. | Antiviral therapy 20060101 |
| Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. | Antiviral therapy 20060101 |
| Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases. | Antiviral therapy 20060101 |
| A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil. | AIDS research and therapy 20060101 |
| In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine. | Antiviral therapy 20060101 |
| [Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir]. | Revista espanola de medicina nuclear 20060101 |
| Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcome. | HIV clinical trials 20060101 |
| Serious renal impairment occurs rarely with use of tenofovir DF. | HIV clinical trials 20060101 |
| Brazil: Gilead cuts tenofovir price in half. | AIDS treatment news 20060101 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. | Drugs 20060101 |
| [Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression]. | Enfermedades infecciosas y microbiologia clinica 20060101 |
| Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir. | Antiviral therapy 20060101 |
| Microbicides 2006 conference. | AIDS research and therapy 20060101 |
| Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment. | Clinical pharmacokinetics 20060101 |
| Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects. | Current medicinal chemistry 20060101 |
| Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome. | Journal of postgraduate medicine 20060101 |
| [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101 |
| Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention. | AIDS research and therapy 20060101 |
| [The Tenovofir trial in Cameroun. Analysis of the controversial positions and proposal for an ethical alternative]. | Sante (Montrouge, France) 20060101 |
| A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. | PloS one 20060101 |
| Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques. | Retrovirology 20060101 |
| Anti-HIV agents. Merck integrase inhibitor. | TreatmentUpdate 20060101 |
| Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study. | HIV clinical trials 20060101 |
| Drug interactions. Super pills-the treatments of the future? | TreatmentUpdate 20060101 |
| Drug interactions. Brecanavir--a new protease inhibitor. | TreatmentUpdate 20060101 |
| Switching strategies to improve lipid profile and morphologic changes. | AIDS reviews 20060101 |
| Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B. | TreatmentUpdate 20060101 |
| Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK. | Antiviral therapy 20060101 |
| Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimen. | Antiviral therapy 20060101 |
| Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients. | Antiviral therapy 20060101 |
| First of a kind in HIV treatment. | FDA consumer 20060101 |
| Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future. | Journal of the International AIDS Society 20060101 |
| Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. | Journal of hepatology 20051201 |
| Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen. | The Journal of infectious diseases 20051201 |
| Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects. | The Journal of infectious diseases 20051201 |
| Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. | The Journal of antimicrobial chemotherapy 20051201 |
| Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro. | Antiviral research 20051201 |
| A 12-month treatment with tenofovir does not impair bone mineral accrual in HIV-infected children. | Journal of acquired immune deficiency syndromes (1999) 20051201 |
| Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine. | Journal of clinical pharmacology 20051201 |
| Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. | Pediatrics 20051201 |
| Complications in treating chronic hepatitis B in patients with HIV. | Expert opinion on pharmacotherapy 20051201 |
| Should tenofovir ever be used in association with didanosine? | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20051201 |
| [The treatment of HIV infection]. | Presse medicale (Paris, France : 1983) 20051119 |
| Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. | AIDS (London, England) 20051118 |
| Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels. | AIDS (London, England) 20051118 |
| A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT. | AIDS (London, England) 20051104 |
| Acyclic nucleoside phosphonates: a key class of antiviral drugs. | Nature reviews. Drug discovery 20051101 |
| High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir. | AIDS (London, England) 20051014 |
| Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens. | AIDS (London, England) 20051014 |
| Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy. | Journal of acquired immune deficiency syndromes (1999) 20051001 |
| The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community. | PLoS medicine 20051001 |
| Response to Joep M. A. Lange. | PLoS medicine 20051001 |
| HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. | Lancet (London, England) 20051001 |
| HIV Pathogenesis and Treatment - Third International AIDS Society Conference. | IDrugs : the investigational drugs journal 20051001 |
| Hopes dashed for formulation. | AIDS patient care and STDs 20051001 |
| Sequencing antiretroviral drugs for long-lasting suppression of HIV replication. | The new microbiologica 20051001 |
| AIDS. Promote HIV chemoprophylaxis research, don't prevent it. | Science (New York, N.Y.) 20050930 |
| Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050915 |
| We must not let protestors derail trials of pre-exposure prophylaxis for HIV. | PLoS medicine 20050901 |
| The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong? | PLoS medicine 20050901 |
| CDC international HIV prevention research activities among injection drug users in Thailand and Russia. | Journal of urban health : bulletin of the New York Academy of Medicine 20050901 |
| The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. | HIV medicine 20050901 |
| Severe toxicity associated with the combination of tenofovir and didanosine: case report and review. | International journal of STD & AIDS 20050901 |
| [Use of thymidine-sparing regimens in first-line therapy and in switches from thymidine analogues]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20050901 |
| Tenofovir and changes in renal function. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050815 |
| Lack of antagonism between abacavir, lamivudine, and tenofovir against wild-type and drug-resistant HIV-1. | Journal of acquired immune deficiency syndromes (1999) 20050815 |
| Progression of renal impairment under therapy with tenofovir. | AIDS (London, England) 20050812 |
| HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread. | Science (New York, N.Y.) 20050812 |
| Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805 |
| Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). | The Journal of pharmacology and experimental therapeutics 20050801 |
| The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosing. | Journal of acquired immune deficiency syndromes (1999) 20050801 |
| Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens. | Journal of acquired immune deficiency syndromes (1999) 20050801 |
| Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration. | Journal of clinical pharmacology 20050801 |
| Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature. | The Journal of infection 20050801 |
| Managing hepatitis B coinfection in HIV-infected patients. | Current HIV/AIDS reports 20050801 |
| Tenofovir and didanosine: a dangerous liaison. | The AIDS reader 20050801 |
| Nucleoside/nucleotide backbones for the treatment of HIV infection. | Current opinion in investigational drugs (London, England : 2000) 20050801 |
| Protests may slow down trials. | AIDS patient care and STDs 20050801 |
| HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20050801 |
| Tenofovir trials raise ethical issues. | HIV/AIDS policy & law review 20050801 |
| Simultaneous analysis of several antiretroviral nucleosides in rat-plasma by high-performance liquid chromatography with UV using acetic acid/hydroxylamine buffer Test of this new volatile medium-pH for HPLC-ESI-MS/MS. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050725 |
| Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial. | AIDS (London, England) 20050722 |
| Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients. | Journal of medical virology 20050701 |
| Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. | The Journal of antimicrobial chemotherapy 20050701 |
| Fatal lactic acidosis associated with tenofovir and abacavir. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20050701 |
| Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results. | Transplant international : official journal of the European Society for Organ Transplantation 20050701 |
| Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. | AIDS (London, England) 20050701 |
| Reactivation of viral replication after replacement of tenofovir by adefovir. | Hepatology (Baltimore, Md.) 20050701 |
| An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir. | Journal of acquired immune deficiency syndromes (1999) 20050701 |
| Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants. | Journal of viral hepatitis 20050701 |
| Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study. | HIV medicine 20050701 |
| Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature. | The AIDS reader 20050701 |
| Editorial comment: tenofovir nephrotoxicity--vigilance required. | The AIDS reader 20050701 |
| Low frequency of renal function impairment during one-year of therapy with tenofovir-containing regimens in the real-world: a case-control study. | AIDS patient care and STDs 20050701 |
| Anti-HIV activity of (-)-(2R,4R)-1- (2-hydroxymethyl-1,3-dioxolan-4-yl)-thymine against drug-resistant HIV-1 mutants and studies of its molecular mechanism. | Journal of medicinal chemistry 20050616 |
| Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. | AIDS (London, England) 20050610 |
| SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. | Journal of medical primatology 20050601 |
| Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India. | Journal of acquired immune deficiency syndromes (1999) 20050601 |
| Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir. | Hepatology (Baltimore, Md.) 20050601 |
| Management of patients co-infected with hepatitis B virus and HIV. | The Lancet. Infectious diseases 20050601 |
| [Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir]. | La Revue de medecine interne 20050601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050601 |
| Stakeholder consultation to address issues related to tenofovir prophylactic research. | IAPAC monthly 20050601 |
| Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. | AIDS (London, England) 20050520 |
| Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. | Molecular pharmacology 20050501 |
| Update on viral hepatitis in 2004. | Current opinion in gastroenterology 20050501 |
| Tenofovir in chronic hepatitis B. | Hepatology (Baltimore, Md.) 20050501 |
| Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. | Antimicrobial agents and chemotherapy 20050501 |
| Antiviral drug-induced nephrotoxicity. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050501 |
| The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily. | HIV medicine 20050501 |
| The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis. | HIV medicine 20050501 |
| Unethical clinical trials in Thailand: a community response. | Lancet (London, England) 20050501 |
| Unethical clinical trials in Thailand: a community response. | Lancet (London, England) 20050501 |
| The development of vaginal microbicides for the prevention of HIV transmission. | PLoS medicine 20050501 |
| Tenofovir helpful for patients with HBV. | AIDS patient care and STDs 20050501 |
| Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures. | AIDS (London, England) 20050429 |
| High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir. | AIDS (London, England) 20050429 |
| [Simply convincing. New fixed combination for HIV therapy]. | MMW Fortschritte der Medizin 20050425 |
| Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050415 |
| Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients. | Journal of acquired immune deficiency syndromes (1999) 20050415 |
| Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents. | Journal of the American Chemical Society 20050413 |
| Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050401 |
| Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. | The Journal of infectious diseases 20050401 |
| Emtricitabine: new preparation. An antiretroviral very similar to lamivudine. | Prescrire international 20050401 |
| Emtricitabine: a novel nucleoside reverse transcriptase inhibitor. | Drugs of today (Barcelona, Spain : 1998) 20050401 |
| The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. | Journal of neurovirology 20050401 |
| Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine. | AIDS (London, England) 20050324 |
| AIDS clinical trials. More woes for novel HIV prevention approach. | Science (New York, N.Y.) 20050318 |
| Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20050301 |
| In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. | Antimicrobial agents and chemotherapy 20050301 |
| Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities. | Antimicrobial agents and chemotherapy 20050301 |
| Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice. | Journal of acquired immune deficiency syndromes (1999) 20050301 |
| Current and future treatment of chronic hepatitis B. | Minerva gastroenterologica e dietologica 20050301 |
| Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics. | Expert opinion on drug safety 20050301 |
| Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients. | AIDS patient care and STDs 20050301 |
| The trials of tenofovir trials. | Lancet (London, England) 20050301 |
| Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. | AIDS (London, England) 20050218 |
| Interventions for managing antiretroviral therapy-associated lipoatrophy. | Current opinion in infectious diseases 20050201 |
| Tenofovir-induced acute renal failure in an HIV patient with normal renal function. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050201 |
| Tenofovir: a pill to prevent HIV? | The Lancet. Infectious diseases 20050201 |
| Women testing tenofovir for HIV prevention. | AIDS patient care and STDs 20050201 |
| Collaboration begins on combined drug. | AIDS patient care and STDs 20050201 |
| Therapies for HIV and viral hepatitis coinfection. | Expert review of anti-infective therapy 20050201 |
| Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine. | AIDS (London, England) 20050128 |
| Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. | AIDS (London, England) 20050103 |
| Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine. | AIDS (London, England) 20050103 |
| Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects. | British journal of clinical pharmacology 20050101 |
| Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1. | Journal of acquired immune deficiency syndromes (1999) 20050101 |
| HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance. | Trends in pharmacological sciences 20050101 |
| The experts speak. Studying the potential of tenofovir to prevent sexual transmission of HIV: first steps. Interview by Vicki Glaser. | AIDS patient care and STDs 20050101 |
| Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection. | Drugs 20050101 |
| Tenofovir regimen compared with Combivir. | AIDS patient care and STDs 20050101 |
| Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals. | Virology journal 20050101 |
| Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid. | AIDS clinical care 20050101 |
| Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC. | AIDS clinical care 20050101 |
| Early virological failure with a combination of tenofovir, didanosine and efavirenz. | Antiviral therapy 20050101 |
| [Cost-effectiveness analysis of tenofovir versus zidovudine in combination therapy with efavirenz and lamivudine for the treatment of HIV in naive patients]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101 |
| In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1. | Antiviral therapy 20050101 |
| The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients. | Antiviral therapy 20050101 |
| Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. | Current pharmaceutical design 20050101 |
| Breakthrough Candida infections in patients receiving voriconazole. | The Annals of pharmacotherapy 20050101 |
| Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine. | Antiviral therapy 20050101 |
| [Assessment of renal abnormalities in 107 HIV patients treated with tenofovir]. | Therapie 20050101 |
| Emtricitabine: a review of its use in the management of HIV infection. | Drugs 20050101 |
| Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients. | HIV clinical trials 20050101 |
| Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. | BMC infectious diseases 20050101 |
| Drugs in development for hepatitis B. | Drugs 20050101 |
| Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy. | Antiviral therapy 20050101 |
| Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals. | Antiviral therapy 20050101 |
| Selected rare, noninfectious syndromes associated with HIV infection. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101 |
| Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments. | AIDS reviews 20050101 |
| Clinical trial results of new therapies for HBV: implications for treatment guidelines. | Seminars in liver disease 20050101 |
| Management of HBV/HIV-coinfected Patients. | Seminars in liver disease 20050101 |
| Media reporting of tenofovir trials in Cambodia and Cameroon. | BMC international health and human rights 20050101 |
| Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. | Antiviral therapy 20050101 |
| Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. | Antiviral therapy 20050101 |
| Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. | Annals of clinical microbiology and antimicrobials 20050101 |
| Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. | Clinical pharmacokinetics 20050101 |
| Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation. | Transplantation proceedings 20050101 |
| Treatment news. What's 'The T'? | Survival news (Atlanta, Ga.) 20050101 |
| Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report. | BMC infectious diseases 20050101 |
| Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. | Antiviral therapy 20050101 |
| In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs. | Antiviral chemistry & chemotherapy 20050101 |
| Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin. | HIV clinical trials 20050101 |
| Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial. | Antiviral therapy 20050101 |
| Antiretroviral-therapy-associated lipoatrophy: current status and future directions. | Sexual health 20050101 |
| Approaches to antiretroviral therapy in China. | Cell research 20050101 |
| Failure of tenofovir + abacavir + 3TC combination; full report published, more insight. | AIDS treatment news 20050101 |
| Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites. | Xenobiotica; the fate of foreign compounds in biological systems 20050101 |
| Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children. | Antiviral therapy 20050101 |
| Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS study. | HIV clinical trials 20050101 |
| Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC. | TreatmentUpdate 20050101 |
| Triple-nucleoside analog antiretroviral therapy: is there still a role in clinical practice? A review. | Journal of the International AIDS Society 20050101 |
| Genetic barriers to resistance and impact on clinical response. | Journal of the International AIDS Society 20050101 |
| New Antiretroviral Therapies for Pediatric HIV Infection. | The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20050101 |
| [Liver transplantation in a HIV-positive patient receiving potent antiretroviral therapy; the first case in The Netherlands]. | Nederlands tijdschrift voor geneeskunde 20041211 |
| CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related. | AIDS (London, England) 20041203 |
| Tenofovir therapy for lamivudine resistance following liver transplantation. | The Annals of pharmacotherapy 20041201 |
| Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. | Hepatology (Baltimore, Md.) 20041201 |
| New once-daily HIV combination better tolerated. | Expert review of anti-infective therapy 20041201 |
| Pharmacokinetics of enfuvirtide in a patient with impaired renal function. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041201 |
| Atazanavir for the treatment of human immunodeficiency virus infection. | Pharmacotherapy 20041201 |
| Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. | Journal of acquired immune deficiency syndromes (1999) 20041201 |
| Randomized, controlled trial of therapy interruption in chronic HIV-1 infection. | PLoS medicine 20041201 |
| Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg. | Antiviral therapy 20041201 |
| Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment. | AIDS (London, England) 20041119 |
| CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. | AIDS (London, England) 20041105 |
| The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. | AIDS (London, England) 20041105 |
| Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients. | AIDS (London, England) 20041105 |
| Pharmacologic perspectives for once-daily antiretroviral therapy. | The Annals of pharmacotherapy 20041101 |
| Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate. | Journal of acquired immune deficiency syndromes (1999) 20041101 |
| Tenofovir use in a patient with a severe renal impairment. | HIV medicine 20041101 |
| Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients. | AIDS patient care and STDs 20041101 |
| Pharmacokinetics of Telzir (fosamprenavir). | Journal of HIV therapy 20041101 |
| Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune. | AIDS treatment news 20041029 |
| Tenofovir, equivalence, and noninferiority. | JAMA 20041027 |
| Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations. | AIDS (London, England) 20041021 |
| Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells. | The Journal of infectious diseases 20041015 |
| Acute onset of pancreatitis with concomitant use of tenofovir and didanosine. | The Annals of pharmacotherapy 20041001 |
| Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals. | Journal of virological methods 20041001 |
| A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. | Antimicrobial agents and chemotherapy 20041001 |
| Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro. | Antimicrobial agents and chemotherapy 20041001 |
| Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. | Antimicrobial agents and chemotherapy 20041001 |
| Trial of antiretroviral for HIV prevention on hold. | The Lancet. Infectious diseases 20041001 |
| Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001 |
| Tenofovir: new indication. For first-line antiretroviral therapy: wait and see. | Prescrire international 20041001 |
| Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization. | Antiviral therapy 20041001 |
| 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Tenofovir and renal toxicity. | AIDS patient care and STDs 20041001 |
| The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection. | AIDS (London, England) 20040924 |
| Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. | AIDS (London, England) 20040924 |
| Intracellular pharmacology of emtricitabine and tenofovir. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient. | AIDS (London, England) 20040903 |
| Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs). | The international journal of biochemistry & cell biology 20040901 |
| Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors. | Journal of acquired immune deficiency syndromes (1999) 20040901 |
| New nucleoside/nucleotide backbone options: a review of recent studies. | Journal of acquired immune deficiency syndromes (1999) 20040901 |
| Resistance issues with new nucleoside/nucleotide backbone options. | Journal of acquired immune deficiency syndromes (1999) 20040901 |
| Treatment of hepatitis B virus infection in patients coinfected with HIV. | Gastroenterology clinics of North America 20040901 |
| Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir. | International journal of antimicrobial agents 20040901 |
| Box warning updated for tenofovir. | AIDS patient care and STDs 20040901 |
| HIV and the kidney: a status report after 20 years. | Current HIV/AIDS reports 20040901 |
| Management of HIV-infected patients with multidrug-resistant virus. | Current HIV/AIDS reports 20040901 |
| Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance. | AIDS (London, England) 20040820 |
| Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity? | AIDS (London, England) 20040820 |
| AIDS research. Cambodian leader throws novel prevention trial into limbo. | Science (New York, N.Y.) 20040820 |
| Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. | The American journal of medicine 20040815 |
| The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. | Journal of acquired immune deficiency syndromes (1999) 20040801 |
| Tenofovir primes rhesus macaque cells in vitro for enhanced interleukin-12 secretion. | Antiviral research 20040801 |
| Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone. | Pharmacotherapy 20040801 |
| Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate. | Pharmacotherapy 20040801 |
| Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen. | Antiviral therapy 20040801 |
| Haemolytic anaemia after nucleotide antiretroviral treatment discontinuation in a chronic hepatitis B-virus co-infected AIDS patient. | AIDS (London, England) 20040723 |
| Cambodia stops important tenofovir prevention trial. | AIDS treatment news 20040723 |
| Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. | JAMA 20040714 |
| Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results. | AIDS (London, England) 20040702 |
| Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level. | Journal of acquired immune deficiency syndromes (1999) 20040701 |
| Unexpected drug interactions and adverse events with antiretroviral drugs. | Lancet (London, England) 20040701 |
| Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults. | Lancet (London, England) 20040701 |
| Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C. | The American journal of the medical sciences 20040701 |
| Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds. | Bioorganic & medicinal chemistry 20040615 |
| Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients. | Antiviral therapy 20040601 |
| Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach. | Antiviral therapy 20040601 |
| In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. | Antiviral therapy 20040601 |
| Prevention trials starting. | AIDS patient care and STDs 20040601 |
| [New approaches in the treatment of hepatitis B]. | Deutsche medizinische Wochenschrift (1946) 20040521 |
| Fanconi's syndrome in HIV+ adults: report of three cases and literature review. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501 |
| Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. | Nature structural & molecular biology 20040501 |
| Management of hepatitis B in patients coinfected with the human immunodeficiency virus. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20040501 |
| The K65R mutation in HIV-1 reverse transcriptase. | Journal of HIV therapy 20040501 |
| Liver transplant and recurrent disease. | Clinics in liver disease 20040501 |
| Renal safety of tenofovir in HIV treatment-experienced patients. | AIDS (London, England) 20040430 |
| [Progress in the treatment of hepatitis B and C co-infection in HIV patients]. | MMW Fortschritte der Medizin 20040426 |
| [3 years' data of tenofovir. Confirmed as a valuable building block]. | MMW Fortschritte der Medizin 20040426 |
| [5 years' data are convincing. Lopinavir as primary therapy is effective and safe in the long term]. | MMW Fortschritte der Medizin 20040426 |
| Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase. | AIDS (London, England) 20040409 |
| Tenofovir-related nephrotoxicity in HIV-infected patients. | AIDS (London, England) 20040409 |
| Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. | The Journal of infectious diseases 20040401 |
| Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine? | Journal of acquired immune deficiency syndromes (1999) 20040401 |
| Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra. | AIDS treatment news 20040326 |
| Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. | Biochemical and biophysical research communications 20040319 |
| Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients. | The Journal of infectious diseases 20040301 |
| Antiretroviral therapy and HIV/hepatitis B virus coinfection. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301 |
| Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040301 |
| Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation? | International journal of STD & AIDS 20040301 |
| Tenofovir-related nephrotoxicity: case report and review of the literature. | Pharmacotherapy 20040301 |
| Management of chronic hepatitis B in the HIV-infected patient. | The AIDS reader 20040301 |
| Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies. | The AIDS reader 20040301 |
| Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. | Journal of acquired immune deficiency syndromes (1999) 20040301 |
| Anti-HIV agents. Low rate of early virologic failure seen with a combination of Trizivir and tenofovir. | TreatmentUpdate 20040301 |
| Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load. | AIDS (London, England) 20040220 |
| Newer treatments for HIV in children. | Current opinion in pediatrics 20040201 |
| Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. | Antiviral therapy 20040201 |
| Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution. | AIDS (London, England) 20040123 |
| Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. | Journal of theoretical biology 20040107 |
| Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations. | The Journal of biological chemistry 20040102 |
| Tenofovir: a nucleotide analogue reverse-transcriptase inhibitor for treatment of HIV infection. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040101 |
| Can AIDS drug also prevent HIV infection? | The AIDS reader 20040101 |
| Labeling changes for tenofovir. | AIDS patient care and STDs 20040101 |
| EU issues warning about HAART regimen. | AIDS patient care and STDs 20040101 |
| Emtricitabine/tenofovir disoproxil fumarate. | Drugs in R&D 20040101 |
| K65R, TAMs and tenofovir. | AIDS reviews 20040101 |
| New treatment of chronic hepatitis B. | Seminars in liver disease 20040101 |
| Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase. | Current topics in medicinal chemistry 20040101 |
| Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients. | Scandinavian journal of infectious diseases 20040101 |
| Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. | Clinical pharmacokinetics 20040101 |
| Pre-exposure chemoprophylaxis for HIV: it is time. | Retrovirology 20040101 |
| K65R-associated virologic failure in HIV-infected patients receiving tenofovir-containing triple nucleoside/nucleotide reverse transcriptase inhibitor regimens. | MedGenMed : Medscape general medicine 20040101 |
| Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir. | Scandinavian journal of infectious diseases 20040101 |
| Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1. | Scandinavian journal of infectious diseases 20040101 |
| Initiation of antiretroviral therapy: implications of recent findings. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20040101 |
| Emtricitabine/tenofovir disoproxil fumarate. | Drugs 20040101 |
| Predictors of virological response to atazanavir in protease inhibitor-experienced patients. | HIV clinical trials 20040101 |
| Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors). | Psychosomatics 20040101 |
| Pharmacokinetics of antiretrovirals in pregnant women. | Clinical pharmacokinetics 20040101 |
| Strategies for overcoming resistance in HIV-1 infected patients receiving HAART. | AIDS reviews 20040101 |
| Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention. | Scandinavian journal of gastroenterology. Supplement 20040101 |
| Combinations of nucleoside/nucleotide analogues for HIV therapy. | AIDS reviews 20040101 |
| Anti-HIV agents. The puzzle of virologic failure with tenofovir. | TreatmentUpdate 20040101 |
| Anti-HIV agents. No interaction between tenofovir and saquinavir. | TreatmentUpdate 20040101 |
| Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. | Biochemistry 20031223 |
| Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031215 |
| Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031215 |
| Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031215 |
| Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppression. | Lancet (London, England) 20031213 |
| Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay. | Antiviral therapy 20031201 |
| The continuing evolution of HIV therapy. | The AIDS reader 20031201 |
| French investigators warn of LPV/TDF/ddI interaction. | IAPAC monthly 20031201 |
| Acute tubular necrosis in a patient receiving tenofovir. | AIDS (London, England) 20031121 |
| Studies of molecular mechanism of tenofovir against 3TC- and AZT-resistance mutant HIV-1 reverse transcriptase. | Bioorganic & medicinal chemistry letters 20031117 |
| 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity. | Journal of medicinal chemistry 20031106 |
| Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes. | Toxicology and applied pharmacology 20031101 |
| Triple combinations regimens for HIV. | The Lancet. Infectious diseases 20031101 |
| Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Suboptimal response to once-daily abacavir + 3TC + tenofovir. | AIDS clinical care 20031101 |
| Early nonresponse for tenofovir regimen. | AIDS patient care and STDs 20031101 |
| High rate of virologic failure with once-daily ddI/3TC/TDF. | IAPAC monthly 20031101 |
| Warning against tenofovir + ddI + 3TC, and 'triple nuke' combinations. | AIDS treatment news 20031031 |
| Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir. | The Journal of infection 20031001 |
| Tenofovir disoproxil fumarate. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031001 |
| Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. | Antimicrobial agents and chemotherapy 20031001 |
| Improved method for concurrent quantification of antiretrovirals by liquid chromatography-tandem mass spectrometry. | Therapeutic drug monitoring 20031001 |
| Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. | The Journal of infectious diseases 20031001 |
| Warning issued on non-response rates. | AIDS patient care and STDs 20031001 |
| Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. | Antiviral research 20031001 |
| Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection. | Expert review of anti-infective therapy 20031001 |
| Anti-HIV agents. Trying times for tenofovir and abacavir. | TreatmentUpdate 20031001 |
| Drug points: Fatal lactic acidosis associated with tenofovir. | BMJ (Clinical research ed.) 20030927 |
| [Further indications for tenofovir]. | Deutsche medizinische Wochenschrift (1946) 20030926 |
| Cambodia: can a drug provide some protection? | Science (New York, N.Y.) 20030919 |
| Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. | Annals of internal medicine 20030902 |
| Summaries for patients. Treatment for resistant HIV-1 infection. | Annals of internal medicine 20030902 |
| Effect of tenofovir on didanosine absorption in patients with HIV. | The Annals of pharmacotherapy 20030901 |
| Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives. | Antimicrobial agents and chemotherapy 20030901 |
| Pharmacokinetics of tenofovir in haemodialysis. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030901 |
| Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected]. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030901 |
| Tenofovir, COX inhibitors and zileuton during cancer immunotherapies: up-regulated TNF-alpha increases antigen driven lymphocyte proliferation. | Molecular immunology 20030901 |
| GlaxoSmithKline halts AIDS study. | The Lancet. Infectious diseases 20030901 |
| Management of hepatitis B and C in HIV co-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20030901 |
| Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus. | AIDS patient care and STDs 20030901 |
| Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Exploring once-daily tenofovir + 3TC + abacavir: an argument for clinical-trials-based data. | AIDS clinical care 20030901 |
| BMS issues PK notice regarding ATV + TDF. | IAPAC monthly 20030901 |
| [Resistance of HIV-1 to antiretroviral drugs in Valencia (Spain): mutations and susceptibility]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030901 |
| Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030815 |
| Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines. | European journal of pharmacology 20030815 |
| Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment. | The Journal of infection 20030801 |
| Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens. | Journal of acquired immune deficiency syndromes (1999) 20030801 |
| Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. | The Journal of infectious diseases 20030801 |
| Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030801 |
| Preemptive use of antiretroviral drugs to prevent sexual transmission of HIV to high-risk uninfected MSM. | American journal of public health 20030801 |
| Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge. | Journal of medical primatology 20030801 |
| Failure of combination abacavir + tenofovir + lamivudine (3TC). | AIDS treatment news 20030725 |
| [HIV therapy: tenofir DF is available in 68 developing countries at production costs price]. | Medizinische Klinik (Munich, Germany : 1983) 20030715 |
| Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705 |
| Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication. | Antimicrobial agents and chemotherapy 20030701 |
| Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection. | The Pediatric infectious disease journal 20030701 |
| The acyclic nucleoside phosphonate analogues, adefovir, tenofovir and PMEDAP, efficiently eliminate banana streak virus from banana (Musa spp.). | Antiviral research 20030701 |
| Deoxyribonucleoside 2'- or 3'-mixed disulfides: prodrugs to target ribonucleotide reductase and/or to inhibit HIV reverse transcription. | Journal of medicinal chemistry 20030619 |
| Tenofovir disoproxil fumarate. | The Annals of pharmacotherapy 20030601 |
| Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. | The American journal of the medical sciences 20030601 |
| Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells. | Pharmacotherapy 20030601 |
| Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA. | IDrugs : the investigational drugs journal 20030601 |
| Tenofovir poses risk with didanosine. | AIDS patient care and STDs 20030601 |
| Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections. | Expert review of anti-infective therapy 20030601 |
| Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals. | AIDS (London, England) 20030523 |
| [96-week treatment outcome confirms long term efficacy of tenofovir DF]. | Deutsche medizinische Wochenschrift (1946) 20030509 |
| A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. | Journal of virology 20030501 |
| Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks. | Antiviral research 20030501 |
| Extended treatment with tenofovir disoproxil fumarate in treatment-experienced HIV-1-infected patients: genotypic, phenotypic, and rebound analyses. | Journal of acquired immune deficiency syndromes (1999) 20030501 |
| Update on mitochondrial toxicity: where are we now? | Journal of HIV therapy 20030501 |
| [Antiretroviral therapy 2003. The current status]. | MMW Fortschritte der Medizin 20030428 |
| [First nucleotide analog with noteworthy safety profile. Tenofovir effective in all stages of the infection]. | MMW Fortschritte der Medizin 20030428 |
| [Resistance in a new light. About mutations and their interactions]. | MMW Fortschritte der Medizin 20030428 |
| [Lipid profile and body fat--significant 'side effect' of antiretroviral therapy. Tenofovir: favorable profile of adverse effects]. | MMW Fortschritte der Medizin 20030428 |
| Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030415 |
| Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030415 |
| Renal lesions in HIV-1-positive patient treated with tenofovir. | AIDS (London, England) 20030411 |
| K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine. | Antiviral therapy 20030401 |
| Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy. | AIDS (London, England) 20030328 |
| Determining the relative efficacy of highly active antiretroviral therapy. | The Journal of infectious diseases 20030315 |
| Retroviruses Conference clinical news; interview with Cal Cohen, M.D. Interview by John S. James. | AIDS treatment news 20030314 |
| Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030305 |
| Current and future antiviral agents for chronic hepatitis B. | The Journal of antimicrobial chemotherapy 20030301 |
| Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation. | Gastroenterology 20030201 |
| The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1. | The Journal of antimicrobial chemotherapy 20030201 |
| Thymidine analogue-sparing highly active antiretroviral therapy (HAART). | Journal of HIV therapy 20030201 |
| Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. | The New England journal of medicine 20030109 |
| An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals. | AIDS (London, England) 20030103 |
| Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection. | Pharmacotherapy 20030101 |
| Tenofovir helps beat hepatitis B. | TreatmentUpdate 20030101 |
| Anti-HIV drug updates--three drugs on the near horizon. | Project Inform perspective 20030101 |
| New uses for tenofovir: more questions about d4T. | Project Inform perspective 20030101 |
| Tenofovir--long term results from first-line therapy. | TreatmentUpdate 20030101 |
| Kidney damage reported in some tenofovir users. | TreatmentUpdate 20030101 |
| Tenofovir drug interactions: ddI and d4T. | TreatmentUpdate 20030101 |
| HIV and hepatitis B virus: options for managing coinfection. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20030101 |
| HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset). | Antiviral chemistry & chemotherapy 20030101 |
| Correction: tenofovir disoproxil fumarate. | The Annals of pharmacotherapy 20030101 |
| Tenofovir disoproxil fumarate. | Drugs 20030101 |
| Tenofovir disoproxil fumarate. | Drugs 20030101 |
| Tenofovir disoproxil fumarate. | Drugs 20030101 |
| Phosphonomethoxyalkyl analogs of nucleotides. | Current pharmaceutical design 20030101 |
| Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. | Critical care (London, England) 20030101 |
| Viread, Epivir and Ziagen combination: failure in naïve patients with a once-daily regimen. | Positively aware : the monthly journal of the Test Positive Aware Network 20030101 |
| Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus. | Journal of hepatology 20030101 |
| Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Checking up on ddI and tenofovir in people with HIV/AIDS. | TreatmentUpdate 20030101 |
| Tenofovir (Viread(R)) access for poor countries. | AIDS treatment news 20021220 |
| Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. | The Journal of infectious diseases 20021215 |
| Fanconi syndrome and renal failure induced by tenofovir: a first case report. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20021201 |
| Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. | The American journal of the medical sciences 20021201 |
| Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine. | AIDS (London, England) 20021122 |
| Prevention: new approach will test tenofovir for persons at high risk. | AIDS treatment news 20021122 |
| Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. | The Journal of infectious diseases 20021115 |
| Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells. | AIDS (London, England) 20021108 |
| Marked elevation of the creatine phosphokinase level in a patient receiving tenofovir. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20021101 |
| Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine. | The Journal of antimicrobial chemotherapy 20021101 |
| Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report. | International journal of STD & AIDS 20021101 |
| Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta). | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20021101 |
| Can HIV infection be treated successfully with a once-daily regimen? | The AIDS reader 20021101 |
| The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. | AIDS (London, England) 20021018 |
| Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information. | Journal of acquired immune deficiency syndromes (1999) 20021001 |
| Editorial comment: a tale of two viruses. | The AIDS reader 20021001 |
| Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. | Clinical therapeutics 20021001 |
| [Treatment of chronic hepatitis C in patients coinfected with HIV-HCV/HBV]. | Revista de gastroenterologia de Mexico 20021001 |
| HIV medicine after Barcelona conference: interview with Howard Grossman, M.D. Interview by John S. James. | AIDS treatment news 20020906 |
| The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. | Journal of acquired immune deficiency syndromes (1999) 20020901 |
| [First nucleotide analog against HIV. Lowers viral load also in drug resistance]. | MMW Fortschritte der Medizin 20020822 |
| [Tenofovir in Study 903. Also effective and tolerable in first-line therapy]. | MMW Fortschritte der Medizin 20020822 |
| Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. | Antiviral research 20020801 |
| Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. | Drug metabolism and disposition: the biological fate of chemicals 20020801 |
| Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication. | Hepatology (Baltimore, Md.) 20020801 |
| Tenofovir gel studied. | AIDS patient care and STDs 20020801 |
| Anti-HIV agents. Tenofovir looks good in initial therapy. | TreatmentUpdate 20020801 |
| Anti-HIV agents. Tenofovir and Videx (ddi) EC--some caution required. | TreatmentUpdate 20020801 |
| ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase. | Antimicrobial agents and chemotherapy 20020701 |
| Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. | Antimicrobial agents and chemotherapy 20020701 |
| Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. | Antiviral research 20020701 |
| New drugs 2002, part III. | Nursing 20020701 |
| Vaccines. Monkey puzzles. | Science (New York, N.Y.) 20020628 |
| Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. | AIDS (London, England) 20020614 |
| Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. | AIDS (London, England) 20020614 |
| Drugs in development. | AIDS patient care and STDs 20020501 |
| Antiviral Research - 15th International Conference. Mega-HAART and tenofovir. 17-21 March 2002, Prague, Czech Republic. | IDrugs : the investigational drugs journal 20020501 |
| [Nucleotide analog shows effectiveness in previously treated patients. The new kind of HAART]. | MMW Fortschritte der Medizin 20020409 |
| [No comparison with NRTI. Tenofovir is robust against resistance trouble]. | MMW Fortschritte der Medizin 20020409 |
| [Improving resistance profile, simplifying administration mode. New antiretroviral drugs]. | MMW Fortschritte der Medizin 20020409 |
| [First nucleotide analog on the market. New drug for the pretreated patient]. | MMW Fortschritte der Medizin 20020409 |
| Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. | Antiviral research 20020401 |
| [Tenofovir--a new option for combination therapy]. | Medizinische Monatsschrift fur Pharmazeuten 20020401 |
| 8th European Conference on Clinical Aspects and Treatment of HIV Infection, Athens, 28-31 October 2001. | Sexually transmitted infections 20020401 |
| Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. | Antimicrobial agents and chemotherapy 20020301 |
| Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). | Journal of acquired immune deficiency syndromes (1999) 20020301 |
| New antiretroviral for HIV infection. | American family physician 20020301 |
| Tenofovir helps experienced patients. | AIDS patient care and STDs 20020301 |
| Anti-HIV therapy update. | Project Inform perspective 20020301 |
| Strategies for third line therapy. | Project Inform perspective 20020301 |
| Promising new agents on the horizon. | AIDS clinical care 20020301 |
| Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. | Blood 20020115 |
| Prodrug of tenofovir diphosphate approved for combination HIV therapy. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020101 |
| Tenofovir (viread) receives FDA approval. | AIDS alert 20020101 |
| Nutrient deficiency associated with new HIV medication. | Survival news (Atlanta, Ga.) 20020101 |
| Gilead sciences releases Viread. | Survival news (Atlanta, Ga.) 20020101 |
| FDA approves Viread for HIV-1 infection. | FDA consumer 20020101 |
| FDA approves tenofovir. | AIDS patient care and STDs 20020101 |
| Use of tenofovir. | AIDS patient care and STDs 20020101 |
| Tenofovir disoproxil fumarate (Viread). | The Journal of the Association of Nurses in AIDS Care : JANAC 20020101 |
| Highlights of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). | The Body positive 20020101 |
| [Tenofovir (Viread)]. | SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY 20020101 |
| From the Food and Drug Administration. | JAMA 20011205 |
| Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate. | Journal of acquired immune deficiency syndromes (1999) 20011201 |
| The potential place of tenofovir in antiretroviral treatment regimens. | International journal of clinical practice 20011201 |
| Viread gets FDA nod. | Positive living (Los Angeles, Calif.) 20011201 |
| Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. | Cancer research 20011101 |
| Tenofovir approved: broad indication. | AIDS treatment news 20011026 |
| Tenofovir: FDA hearing on important new antiretroviral. | AIDS treatment news 20011019 |
| Tenacious tenofovir struts its stuff in a virtual ICAAC. | GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20011001 |
| Expanded access to tenofovir. | TreatmentUpdate 20011001 |
| Tenofovir: FDA hearing October 3, public comment deadlines September 26. | AIDS treatment news 20010824 |
| Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. | The Journal of infectious diseases 20010815 |
| Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408. | Journal of acquired immune deficiency syndromes (1999) 20010815 |
| Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance. | AIDS research and human retroviruses 20010810 |
| Antiviral drugs: current state of the art. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801 |
| Tenofovir ready for approval. | AIDS patient care and STDs 20010701 |
| Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication. | Antiviral therapy 20010601 |
| Tenofovir: Gilead applies for approval; expanded access liberalized. | AIDS treatment news 20010511 |
| Encouraging results for tenofovir. | AIDS patient care and STDs 20010501 |
| Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphono methoxypropyl)adenine. | Antiviral chemistry & chemotherapy 20010501 |
| Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA. | Bioorganic & medicinal chemistry letters 20010423 |
| [Once daily administration improves therapy adherence in HAART. New substance class with more powerful reserves against virus resistance]. | MMW Fortschritte der Medizin 20010402 |
| Mechanisms of HIV-1 nucleoside reverse transcriptase inhibitor resistance: is it all figured out? | Current opinion in investigational drugs (London, England : 2000) 20010301 |
| New antiretroviral agents. | The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20010301 |
| Tenofovir DF expanded access. Criteria for U.S. program. | AIDS treatment news 20010223 |
| More uses for tenofovir? | AIDS treatment news 20010125 |
| Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. | Proceedings of the National Academy of Sciences of the United States of America 20010116 |
| Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA. | Virology 20010105 |
| Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. | Virology 20010105 |
| Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Purification of PMPA amidate prodrugs by SMB chromatography and x-ray crystallography of the diastereomerically pure GS-7340. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution. | Nucleosides, nucleotides & nucleic acids 20010101 |
| LC/MS determination of the intracellular concentration of two novel aryl phosphoramidate prodrugs of PMPA and their metabolites in dog PBMC. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. | Nucleosides, nucleotides & nucleic acids 20010101 |
| The importance of sequencing in treatment options. | Positively aware : the monthly journal of the Test Positive Aware Network 20010101 |
| Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon. | Positive living (Los Angeles, Calif.) 20010101 |
| In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. | Antiviral research 20001101 |
| A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus. | Antiviral research 20000901 |
| Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. | Journal of viral hepatitis 20000101 |
| Selective activity of various antiviral compounds against HHV-7 infection. | Antiviral research 19990801 |
| Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro. | The Journal of infectious diseases 19990101 |
| Effect of acyclic nucleoside phosphonates on the HIV-1 integrase in vitro. | Nucleosides & nucleotides 19990101 |
| Comparison of antiviral compounds against human herpesvirus 6 and 7. | Antiviral research 19981201 |
| Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine. | The Journal of biological chemistry 19981016 |
| Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice. | Antimicrobial agents and chemotherapy 19980701 |
| Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains. | Antimicrobial agents and chemotherapy 19980601 |
| Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication. | Antiviral chemistry & chemotherapy 19980501 |
| Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. | Antimicrobial agents and chemotherapy 19980301 |
| Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses. | Antiviral research 19971101 |
| Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. | Journal of leukocyte biology 19970701 |
| Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. | Antimicrobial agents and chemotherapy 19970301 |
| Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro. | Antimicrobial agents and chemotherapy 19960901 |
| Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. | Biochemical and biophysical research communications 19960215 |
| Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. | Science (New York, N.Y.) 19951117 |
| Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture. | Antimicrobial agents and chemotherapy 19940901 |
| Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. | Antimicrobial agents and chemotherapy 19931001 |
| Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. | Antimicrobial agents and chemotherapy 19930201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.